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Abstract 
Aging is a complex biological phenomenon that is caused by a multitude of extrinsic and 
intrinsic factors. At the level of the organism aging can be defined as the loss of resistance to 
factors promoting pathologies over time, while at the population level it is more accurately 
reflected by the increased mortality rate with the age of the population. Understanding the 
underlying intrinsic and extrinsic factors is key to understanding, and perhaps mitigating age-
related functional decline. In our lab we use Saccharomyces cerevisiae as a model organism for 
studying the cellular and molecular mechanisms that regulate cellular aging. In the course of my 
project I sought to investigate the role of mitochondrial quality control, as well as lipid 
metabolism and storage in regulating the aging process in yeast. We found that deletion of 
Atg32p shortened yeast chronological lifespan (CLS) under caloric restriction growth conditions 
and abrogated the life-extending capabilities of lithocholic acid (LCA) – a bile acid that extends 
CLS even under caloric restriction conditions.  Deletion of Atg32p also resulted in aberrant 
morphology, membrane lipid composition, and a reduction in the mitochondrial functional state.  
To address why deletion of Atg32p negated the beneficial effects of LCA we sought to first 
locate into which subcellular compartment LCA accumulates. It was found that LCA enters yeast 
cells and accumulates largely in the inner mitochondrial membrane. I observed that treatment 
with LCA alters mitochondrial lipid composition, size, and morphology. In the atg32Δ deletion 
background, mitochondrial lipid composition was aberrant, and these cells were highly 
susceptible to both H2O2 induced apoptosis and fatty acid induced liponecrotic cell death.  From 
this I sought to understand the mechanisms through which exogenous monounsaturated fatty 
acids induced cell death. Using a combination of electron microscopy, biochemical assays, and 
mass spectrometry it was found that exogenous palmitoleic acid (POA) causes a type of cell 
death which is characterized by morphological and biochemical features which are unique from 
the three best characterized types of programmed cell death- apoptosis, necrosis, and autophagic 
cell death – and has henceforth been referred to as liponecrotic cell death. In addition to this, we 
showed that mitophagy as well as lipid storage pathways and peroxisomal beta-oxidation of free 
fatty acids are protective processes against POA induced programmed cell death.  Together this 
data allowed for the formulation of a working model integrating mitochondrial quality control 
processes and those involved in lipid metabolism and storage in mediating the regulation of 
chronological lifespan in yeast. 
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 Aging is a complex biological phenomenon that is caused by a multitude of extrinsic and 
intrinsic factors. At the level of the organism aging can be defined as the loss of resistance to 
factors promoting pathologies and disease over time, while at the population level it is more 
accurately reflected by the increased in mortality rate with the age of the cohort 
1
. Understanding 
the underlying intrinsic and extrinsic factors is key to understanding why the rate of aging is 
apparently different amongst organisms. In itself, this is very interesting – but this should also 
give valuable insight not just to our understanding of the aging process but also to our 
understanding of various human pathologies – including cancers, cardiovascular diseases, 
Alzheimer’s disease, etc. – since age is the predominant risk factor for the majority of them 2,3. 
 
1.1 Aging and age related dysfunction can be mitigated through genetic, dietary, and 
chemical interventions  
 Aging of multicellular and unicellular eukaryotic organisms is a multifactorial biological 
phenomenon that has various causes, and affects a plethora of cellular activities. Yet despite the 
seeming complexity of the aging process there are a number of interventions that can slow down 
its progression.  Mutations in close to 100 genes have been found to increase the lifespan of 
Saccharomyces cerevisiae and the same is true for the evolutionarily distant worm C. elegans 
4–7
. 
Many of these mutations, which increase lifespan, target components of a relatively narrow set of 
nutrient- and energy-sensing signaling pathways that are conserved across phyla. These include 
the insulin/insulin-like growth factor 1 (IGF-1), AMP-activated protein kinase/target of 
rapamycin (AMPK/TOR) and cAMP/protein kinase A (cAMP/PKA) pathways. By sharing many 
protein kinases and adaptor proteins, the insulin/IGF-1, AMPK/TOR and cAMP/PKA form a 
network that regulates lifespan 
3,8–10
.  Of interest, humans with dwarfism that harbour mutations 
in the GHR gene  (which would reduce IGF-1 signalling) have an extremely low incidence of 
cancers and diabetes 
11
. 
 In addition to the various pro-longevity mutations, diet plays an important role in 
defining organismal energy and nutrient status, which has been shown to be critical in 
influencing the aging process in a number of organisms. Caloric restriction (CR) is a diet that 
extends lifespan of a number of evolutionarily distant species which is based on the lowering of 
caloric intake but maintaining a healthy level of amino acids, vitamins and other nutrients 
3
. It is 
 2 
also important to note that starvation is not a condition for CR to extend lifespan. For yeast 
cultures this is implemented by lowering the concentration of glucose in the growth medium 
from 2% to 0.2-0.5% 
12,13
. In yeast this has been shown to greatly slow the aging process in part 
by attenuating adaptable pro-aging pathways 
14–17
.  
 In addition to genetic and dietary interventions that extend longevity, treatment with 
certain small molecules can extend longevity and/or increase health-span of evolutionarily 
diverse organisms. The majority of the known compounds that extend longevity of yeast only 
work under non-CR or normal conditions. For this reason it is thought that these compounds 
simply mimic the effects of CR on gene expression, metabolic processes, and stress response 
pathways 
18–20
. The majority of these compounds are thought to act on the aforementioned 
limited set of nutrient responsive signal transduction pathways including the insulin/IGF-1 and 
AMPK/TOR pathways as well as the sirtuin pathway. In addition to this, some CR mimetics 
have been shown to only be able to increase life span under non-CR conditions 
21–24
. Some 
evidence suggests this is also the case for humans 
20
. This observation leads to the idea that most, 
if not all, longevity pathways are adaptable in that they modulate longevity only in response to 
certain extrinsic signals – for example the concentration of glucose in the culture media. In 
contrast to this a number of compounds have been identified that extend lifespan even under CR 
conditions 
25–27
, indicating that some non-adaptable processes may also play a critical role in 
defining the longevity of organisms. Lithocholic acid which is an extremely hydrophobic bile 
acid, was demonstrated to greatly increase lifespan in both normal and under CR conditions 
27
. 
Of interest, elevated levels of a variety of bile acids and bile acid derivates have been found in 
higher concentrations in the plasma of humans with longer leukocyte telomere length which is 




1.2 Yeast as a model for studying programmed cell death and aging  
 The budding yeast Saccharomyces cerevisiae is a unicellular eukaryote, which is 
amenable to biochemical, genetic, and systems analyses. Because many of the genes and 
pathway that are already implicated in regulating aging and programmed cell death (PCD) are 
found in yeast, this model organism serves as an ideal model for their further elucidation. Yeast 
has already contributed a wealth of information about the various processes that underlie the 




 Yeast as a model organism for the study of aging can be classified into two general 
paradigms- namely the replicative aging model and the chronological model. In the replicative 
model of yeast aging, lifespan is defined by how many buds a mother cell can produce before 
senescing. This system is meant to model the way that mitotically active cells in higher eukarya 
might age 
31
. The chronological model of yeast aging studies how long cells can remain viable 
after entering into a non-dividing state (stationary phase). This is measured by measuring 
clonogenicity by comparing the total number of cells in a culture to the total number of colony 
forming units (CFU) over time. This paradigm models the way that post-mitotic or non-dividing 




Figure 1: Mechanism linking non-CR conditions to FFA induced PCD. Caloric restriction (CR) and lithocholic acid 
delay aging by remodeling lipid dynamics in the endoplasmic reticulum (ER), lipid bodies (LB) and peroxisomes. 
The thickness of arrows correlates with the rates of metabolic processes in yeast entered stationary growth phase in 
nutrient-rich medium. T-bars denote inhibition of the process. The metabolites accumulated in bulk quantities are 




1.3 Interorganellar dynamics of lipid metabolism and storage as a key mediator of cell 
death and aging in yeast 



































 In addition to having conserved components of the mammalian apoptotic machinery, 
yeast also undergo a variety of other forms of PCD including auotphagic, necrotic, and other 
uncharacterized types of cell death 
33
. This makes yeast a suitable model for studying the 
mechanisms that regulate PCD. 
 The term “PCD” refers to a genetically programmed and regulated form of cell death 34. 
Several PCD subroutines are presently known; these subroutines have different underlying 
mechanisms, display different morphological and biochemical traits, and are controlled by 




 The most well characterized 
examples of PCD subroutines include extrinsic apoptosis, caspase-dependent or -independent 
intrinsic apoptosis, regulated necrosis, and autophagic cell death. 
 Our lab has published and unpublished data that shows that one of the key processes 
mediating cell death and aging in yeast is lipid metabolism in the peroxisomes, lipid droplets 
(LD), and the ER (ER) 
32
. Under non-CR conditions yeast primarily ferment glucose to ethanol 
13,37
. The accumulation of ethanol impinges on the ability of the peroxisome to metabolize free 
fatty acids (FFA) derived from the lipolytic degradation of triglycerides (TAG) in LD by 
decreasing the expression of enzymes involved in peroxisomal β-oxidation 37. This causes an 
accumulation of FFA within the ER and LD, ultimately leading to FFA induced PCD (Figure 1). 
CR reduces the amount of ethanol that is accumulated, and thus prevents the inhibition of 
peroxisomal oxidation of FFA. This reduces the amount of FFA in the ER and LD and decreases 
the cellular susceptibility to FFA induced PCD (Figure 2B). Likewise CR yeast cultures treated 
with lithocholic acid (LCA) exhibit increased expression of enzymes involved in TAG 
biosynthesis and decreased levels of enzymes involved in lipolytic degradation of TAG to FFAs. 
This in turn reduces the amount of FFA to a more optimal level than in CR alone. In addition to 
this LCA induces the increased import of acetyl-CoA into the mitochondria thereby supplying 
the mitochondria with a key metabolic intermediate as well as sequestering it from ER confined 
FFA biosynthetic processes (Figure 1, Figure 2A). In addition to this, both CR and LCA induce 
changes to the functional state of the mitochondria resulting in increased mitochondrial 
membrane potential into stationary phase, increased expression of proteins involved in the citric 
acid cycle and electron transport chain, and reduced mitochondrial fragmentation resulting in a 





Figure 2: CR and LCA extend yeast CLS by remodelling lipid metabolism in the peroxisome, ER, and LD. See 
figure legend of Figure 1 for details. Reproduced with permission from 
32
. 
 Together this model implicates lipid metabolism – specifically the levels of FFA – in 
causing PCD in yeast, as well as illustrating the importance of mitochondrial functionality in 
defining processes involved in PCD and aging. However the exact mechanisms linking the 
accumulation of FFA to cell death, and how mitochondrial fitness is important in mitigating PCD 
have not been established. 
 We previously published that treating yeast cultures with palmitoleic acid (POA) - a 
mono unsaturated sixteen carbon FFA - induces cell death in yeast in a concentration dependent 
manner 
27,39
. What was unknown was the mechanisms underlying POA induced PCD and 
whether it fit into one of the three major PCD subroutines – namely apoptotic, autophagic, or 
necrotic cell deaths. Based on this we were interested in understanding if POA induced cell death 
represented an age dependent type of cell death, and whether or not it is programmed or 
accidental in terms of how it is carried out. We sought to find out if certain genetic mutations 
could either increase or decrease a population’s susceptibility to POA induced cell death, and last 
we wanted to understand whether the cell death could be part of a subroutine corresponding to 
previously characterized types of PCD. Additionally, if POA induced cell death represents a 


















FFA FA-CoA Ac-CoA 
ETC 
DAG 
























FFA FA-CoA Ac-CoA 
ETC 
DAG 






CR + LCA; very long-lived cells 
Cell Cycle (2011) 10:3042-3044 
A       B 
 6 
various other PCD subroutines. My findings contributed to the discovery that exogenously added 
POA causes PCD in a concentration and age-dependent fashion, and that this type of PCD has a 
unique set of morphological and biochemical features which suggest that it is an as yet 
previously uncharacterized type of PCD. My findings also gave valuable insight into the role that 
mitochondrial quality control processes play in (I) mitigating POA induced PCD by sustaining a 
functional pool of mitochondria which are necessary for generating energy for the storage of 
FFAs as TAGs in LDs as well as maintaining respiratory fitness into stationary phase while 
producing an optimal level of ROS, (II) modulating the lipid composition of various 
biomembranes and thus affecting a variety of biophysical properties including permeability and 
curvature, and (III) being essential for Lithocholic acid to increase yeast CLS. Together these 
data intricately link regulation of lipid metabolism to the regulation of longevity in yeast. 
 
Thesis Outline and Contributions 
 Chapter 2 of this thesis deals with the initial discovery of lithocholic acid (LCA), a bile 
acid which greatly extends yeast chronological lifespan (CLS) under both normal and caloric 
restriction growth conditions. Specifically, the data I present in this chapter illustrates our 
attempt to gain a mechanistic understanding of how the beneficial effects of LCA are attained. 
LCA extends yeast CLS by modulating certain housekeeping longevity assurance pathways that 
modulate a number of cellular activities- among them are those involved in the metabolism and 
storage of lipids. In addition to this, I also present our finding that LCA actually utilizes parts of 
known adaptive signalling pathways (nutrient responsive signal transduction pathways) in a 
surprising way to extend CLS under normal growth media conditions (2% glucose). 
 Chapter 2 of this thesis is adapted from published work in Goldberg, A.*, Richard, V.*, 
Kyryakov, P.*, Bourque, S. D.*, Beach, A., Burstein, M. T., Titorenko, V. I. (2010). Chemical 
genetic screen identifies lithocholic acid as an anti-aging compound that extends yeast 
chronological life span in a TOR-independent manner, by modulating housekeeping longevity 
assurance processes. Aging. * Denotes an equally contributing author. All presented data was 
primarily done by myself with the assistance of Simon Bourque in the measurement of various 
lipid species. 
 Chapter 3 is essentially a continuation of chapter 2 where I describe our efforts to attain a 
mechanistic understanding of the effects of LCA at the subcellular level. Specifically, we used 
 7 
subcellular fractionation followed by mass spectrometry to discover that of the majority of the 
intracellular, organelle localized pool of LCA was localized to the inner mitochondrial and outer 
mitochondrial membranes 
40
. Based on this and our understanding of the integration of 
mitochondria into processes involved in the biosynthesis and transport of membrane 
phospholipids, we hypothesized and demonstrated that LCA modulates the lipid composition of 
the mitochondrial membrane. In addition to this, we demonstrated that alterations to the 
mitochondrial lipid composition correlated with changes in the size, number, and structure of 
these organelles. Together the presented data contribute to the establishment of the importance of 
the mitochondrial membrane lipidome in regulating chronological lifespan in yeast.  
 The work presented in chapter 3 is adapted from our published data in Beach, A.*, 
Richard, V. R.*, Leonov, A.*, Burstein, M. T., Bourque, S. D., Koupaki, O.*, Titorenko, V. I. 
(2013). Mitochondrial membrane lipidome defines yeast longevity. Aging. I conducted the 
lipidomic analyses with the assistance of Simon Bourque. Electron micrographs were acquired 
by Mylene Juneau (NSERC summer student). 
 Chapter 4 investigates a potential physiological role for mitochondria specific 
macroautophagy (mitophagy) in defining yeast CLS under CR conditions. We made use of the 
atg32Δ deletion mutant, which is incapable of carrying out this type of macroautophagy to 
discover that loss of mitophagy results in (I) insensitivity to the beneficial effects of LCA, and 
(II) pleiotropic alterations to the lipid composition of the mitochondria, but also the plasma 
membrane and the endoplasmic reticulum. This suggests that the maintenance of proper 
membrane lipid homeostasis under caloric restriction is dependent on the maintenance of a 
functional population of mitochondria, and that this is contributes to defining longevity in yeast. 
 The work presented in chapter 4 is adapted from our published data in Richard, V. R., 
Leonov, A., Beach, A., Burstein, M. T., Koupaki, O., Gomez-Perez, A., Titorenko, V. I. (2013). 
Macromitophagy is a longevity assurance process that in chronologically aging yeast limited in 
calorie supply sustains functional mitochondria and maintains cellular lipid homeostasis. Aging. 
I conducted all of the experimental work shown in this chapter. 
 Chapter 5 discusses the discovery of liponecrosis, which is a newly identified PCD 
subroutine in yeast. Liponecrosis is induced artificially by adding an excessive quantity of free 
fatty acids to the culture medium. In these studies we used palmitoleic acid, which is a sixteen-
carbon monounsaturated fatty acid, which had been known to cause cell death from our previous 
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studies. We hypothesized that this mode of cell death is distinct from previously characterized 
forms of cell death due to a number of unique morphological, as well as physiological and 
biochemical parameters, which do not coincide with the major three known types of PCD. In 
connection with chapter 4, we investigated the importance of mitophagy in mitigating this PCD 
subroutine and found it to be critical for preventing POA induced cell death. 
 The data presented in chapter 5 is adapted from the following publication Sheibani, S., 
Richard, V., & Beach, A. Vladimir, Titorenko. (2013). Macromitophagy, neutral lipids synthesis, 
and peroxisomal fatty acid oxidation protect yeast from “liponecrosis”, a previously unknown 
form of programmed cell death. Cell Cycle. Sevan Mattie and Sara Sheibani acquired the 
electron micrographs presented in this chapter. Alejandra Gomez assisted in measurement of 
CLS of all strains tested as well as measurement of all parameters in figure 20. 
 Chapter 6 continues from chapter 5 to further develop a mechanistic understanding of 
how exactly an abnormal accumulation of fatty acids – namely palmitoleic acid – within yeast 
cells commits them to liponecrotic cell death. What we discovered was that the cells capacity to 
shunt exogenously added fatty acids into lipid storage pathways (i.e. for the biosynthesis of sterol 
esters and triacylglycerols), determines the cellular susceptibility to liponecrotic cell death. What 
was also discovered was that this buffering capacity due to the biosynthesis of “storage” lipids is 
ablated in cells deficient in mitochondria specific autophagy. This phenomenon was also found 
to be age related – thus indicating that this cell death modality may play an important part in 
cellular aging. Furthermore, this chapter illustrates a “pro-death” role for the alkaline pH and 
membrane phospholipid homeostasis responsive Rim101 pathway in committing cells to 
liponecrotic cell death. Finally a model is constructed integrating interorganellar lipid 
metabolism and storage with a model implicating the mitochondrial functional state and 
maintenance through mitophagy in regulating CLS in yeast. 
 The data presented in this chapter is from a manuscript, which is in the process of 
submission as Richard, V. R., Beach, A., Leonov, A., Piano, A., Titorenko, V. I. (2014). 
Mechanism of liponecrosis, a distinct mode of programmed cell death. Microbial Cell. I 
conducted all of the mass spectrometry work in this chapter, as well as all the assays for 
oxidatively damaged biomolecules. Measurement of culture pH was performed by Pavlo 
Kyryakov. Alejandra Gomez assisted in measurement of CLS of all strains tested. 
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2. Chemical genetic screen identifies lithocholic acid as an anti-aging compound that 
extends yeast chronological life span in a TOR-independent manner, by modulating 
lipid storage pathways 
  
2.1 Introduction 
 The extension of lifespan caused by caloric restriction was previously shown to be 
mediated by both adaptable – nutrient responsive - and non-adaptable or “housekeeping” 
processes within the cell 
9,27
. In previous studies from our lab, a mechanism of how caloric 
restriction increases yeast chronological lifespan was found to be mitigated through the 
regulation of storage and metabolism of fatty acids within the endoplasmic reticulum (ER), lipid 
droplets (LD), and peroxisomes.  This model posited that because under caloric restriction yeast 
produce less ethanol via fermentation than under normal conditions, fatty acid metabolism in the 
peroxisome could be carried out more efficiently. Ethanol had been shown to repress the 
expression of FOX1, FOX2, and FOX3 involved in free fatty acid metabolism via B-oxidation in 
the peroxisome. Under caloric restriction conditions fatty acid oxidases 1-3 as well as 
triacylglycerol lipases 1-4 show increased expression. This is evidenced by the observation of 
increased lipolytic degradation of lipid droplets (LD) via BODIPY fluorescence microscopy, as 
well as increased consumption of triacylglycerol (TAG) and ergosteryl ester (EE) species via 




With this in mind we sought to identify small molecules that increase the CLS of yeast 
under CR conditions by targeting lipid metabolism and modulating cellular processes that are not 
considered to be the primary adaptable signalling pathways involved in longevity regulation. A 
chemical genetic screen was carried out which identified lithocholic acid (LCA) as a potent 
regulator of yeast CLS 
9
. 
 The chemical genetic screen was carried out in the pex5 mutant background. Pex5p is a 
peroxisomal matrix import receptor necessary for the import of fatty acid oxidases to the 
peroxisomal matrix 
41
. The pex5 deletion results in shortened CLS and changes in lipid 
metabolism, lipid-induced necrotic cell death, mitochondrial morphology and fitness, stress 
resistance, mitochondria-controlled apoptosis, and stability of nuclear and mitochondrial DNA 
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27
. It was discovered that a group of bile acids could significantly extend the CLS of the pex5, 
amongst these lithocholic acid was the most efficacious 
27
. We found that LCA also greatly 
increases the mean and maximum CLS of WT yeast both under normal and caloric restriction 
conditions 
27
. Treatment with LCA also altered various parameters of mitochondrial fitness; 
perhaps contributing to the compounds beneficial effect on yeast CLS. This finding prompted us 
to investigate how the exposure of WT cells to LCA under CR conditions influences other 
longevity-related processes impaired in the pex5 mutant – namely the regulation of lipid 
metabolism. 
 I provided evidence that LCA extends longevity of chronologically aging yeast through 
two different mechanisms. In one mechanism, this bile acid targets a set of “housekeeping” 
longevity assurance processes regulating lipid storage. These processes are not known to be 
directly regulated by the adaptable TOR and cAMP/PKA pathways and yet have been implicated 
in the regulation of longevity. In the other mechanism, the longevity extending capacity of LCA 
is dependent on the adaptable cAMP/PKA pathway under non-CR conditions implying a 
surprising pro-longevity role for the PKA pathway.  
 
 2.2 Materials and Methods 
 
2.2.1 Yeast strains and growth conditions 
The WT strain BY4742 (MATα his31 leu20 lys20 ura30) and single-gene-deletion mutant 
strains in the BY4742 genetic background (all from Open Biosystems) were grown in YP 
medium (1% yeast extract, 2% peptone) containing 0.2% 0.5%, 1% or 2% glucose as carbon 
source, 2% glucose representing “normal” culture conditions, and 0.2% and 0.5% glucose 
representing caloric restriction conditions. Cells were cultured at 30
o
C with rotational shaking at 
200 rpm in Erlenmeyer flasks at a “flask volume/medium volume” ratio of 5:1. 
 
2.2.2 Pharmacological manipulation of CLS 
CLS analysis was performed as previously described 
13
. Briefly, samples of yeast cells were 
taken and a fraction of the sample was diluted in order to determine the cell titer using a 
hemacytometer. Another fraction of sample was then serially diluted and plated in duplicate on 
YP plates containing 2% glucose as carbon source. Plates were cultured at 30°C After 2 days of 
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incubation at 30°C, the number of colony forming units (CFU) per plate was counted. The 
number of CFU was defined as the number of viable cells in a sample. For each culture, the 
percentage of viable cells was calculated as follows: (number of viable cells per ml/total number 
of cells per ml) x 100. The percentage of viable cells in mid-logarithmic phase was set at 100%. 
Lithocholic acid (L6250) and all other tested bile acids were from Sigma. Their stock solutions 
in DMSO were made on the day of adding each of these compounds to cell cultures. Compounds 
were added to growth medium at the indicated concentration immediately following cell 
inoculation. The final concentration of DMSO in yeast cultures supplemented with a bile acid 
(and in control cultures supplemented with DMSO) was 1% (v/v). 
 
2.2.3 Quantitative Analysis of Yeast Lipids by Mass Spectrometry  
Mass spectrometry based lipidomics was conducted as previously described 
42
. Briefly, yeast 
cells were harvested from culture (~5x10
7 
cells) by centrifugation at 3000 x g for 1 minute. Cells 
were washed twice with ice cold water, spiked with an internal standard mix prepared in LC-MS 
grade chloroform:methanol (1:1) according to Table 1, and then subjected to lipid extraction by a 
modified Bligh & Dyer method 
42,43
.  Yeast lipid extracts were directly infused into a Micromass 
Q-ToF 2 (Waters, Milford, MA, USA) mass spectrometer equipped with a nano-electrospray 
source. The mass spectrometer was operated in both positive and negative ion modes at a flow 
rate of 1 μL/min. Spectra were converted to centroid format. Lipid species were identified and 
quantified using deconvoluted spectral data processed in homemade excel sheets. Putative lipid 
identities were validated by MSMS. 
 
2.2.4 Fluorescence Microscopy 
The Annexin V / Propidium Iodide assay kit (Invitrogen) for apoptotic/necrotic cell death was 











Figure 3 LCA alters the levels of various lipid classes and prevents fatty acid induced cell death in chronologically 
aging yeast grown under CR conditions into stationary phase. (A - C) Levels of triacylglycerols and free fatty acids 
measured by mass spectrometry (A and B) and of diacylglycerols monitored by TLC (C) in WT cells grown in 
medium with or without LCA. (D - F) Viability of WT cells pre-grown in medium with or without LCA and then 
treated for 2 h with palmitoleic acid (D), oleic acid (E) or DiC8 diacylglycerol (F). (G - I) Percent of WT cells (pre-
grown in medium with or without LCA) that following their treatment with palmitoleic acid (G), oleic acid (H) or 




) staining characteristic 
of necrotic cell death. Data are presented as means ± SEM (n = 3-9; ***p < 0.001; **p < 0.01). WT cells grown on 
0.2% glucose in the presence or absence of LCA were taken for analyses at day 7, when they reached reproductive 




2.3.1 LCA extends the CLS of WT yeast under CR by modulating free fatty acid storage 
pathways 
 In order to evaluate whether the observed effects of LCA were due to alterations to 
processes involved in lipid metabolism, I quantitatively profiled the yeast lipidome using mass 
spectrometry. The method that was used allowed for the comprehensive analysis of the yeast 
lipidome including most of the major phospholipids, free fatty acids, and neutral lipids were 
measured in a quantitative manner. From this analysis it was observed that LCA elevated the 
concentration of TAG in WT cells that entered the non-proliferative ST phase under CR at 0.2% 
glucose (Figure 3A). Furthermore, under these conditions LCA also substantially reduced the 
intracellular levels of FFA and DAG in WT yeast that reached reproductive maturation by 
entering into ST phase (Figure 3B,C). Moreover, LCA greatly reduced the susceptibility of 
reproductively mature WT cells under CR to necrotic cell death that was caused by a short-term 




 staining (Figure 3D-I). 
These findings were consistent with what we hypothesized – namely that the compound rescues 
the pex5 mutant by targeting lipid metabolism in the ER, lipid bodies and peroxisomes since 
these are the principal sites of synthesis, storage, and degradation of lipids within the cell. 
 
2.3.2 LCA extends yeast CLS independent of TOR, by modulating housekeeping longevity 
assurance pathways 
 To assess whether the effects of LCA were dependent on “adaptable” or nutrient 
responsive signal transduction pathways which are known to regulate chronological lifespan in 
yeast we assessed how the cAMP/PKA pathway influences the ability of LCA to extend CLS in 
yeast under normal as well as caloric restriction conditions. To do this we measured viability of 
several mutants of the cAMP/PKA pathway with or without LCA. Among these, was ras2 - a 
GTP-binding protein that activates adenylate cyclase and is responsible for the synthesis of the 
PKA activator cAMP 
44
, resulting in loss of PKA kinase activity. Deletion of ras2 resulted in a 
partial reduction in the effect of LCA, however it still significantly increased CLS under CR and 





Figure 4 LCA partially increases the mean and maximum CLS of yeast lacking Ras2p under both CR and Non-CR 
conditions. (A and B) Effect of LCA on the mean (A) and maximum (B) life spans of chronologically aging ras2Δ 
strain. Data are presented as means ± SEM (n = 4-7; ***p < 0.001; **p < 0.01; *p < 0.05). (C and D) Effect of LCA 
on the fold increase in the mean (C) or maximum (D) life spans of chronologically aging ras2Δ and WT strains. 
Data are presented as means ± SEM (n = 4-7). Cells in A to D were cultured in medium initially containing 0.2%, 
0.5%, 1% or 2% glucose in the presence of LCA (50 μM) or in its absence. Reproduced from 27. 
From this, it would seem that LCA modulates lifespan of yeast through two different 
mechanisms. In the first mechanism LCA targets certain housekeeping longevity assurance 
pathways that act to positively regulate longevity. These targets would be independent of the 
adaptable cAMP/PKA pathway modulated by calorie availability (Figure 6B). Because of the 
partial reduction in the effect of LCA on yeast CLS, we propose that a second mechanism might 
involve PKA acting surprisingly as a prolongevity factor by activating PKA-dependent 
phosphorylation of the cytosolic pool of Rim15p (Figure 6B). While phosphorylation of Rim15p 
inactivates its protein kinase activity 
44
, and the nuclear pool of Rim15p has a well established 
anti-aging function 
3,10,14,44
, it is possible that the cytosolic pool of this nutrient-sensory protein 
 16 
kinase plays an important pro-aging role by phosphorylating a number of proteins that promote 
aging only if phosphorylated (Figure 6B). In fact, some of the cytosolic phosphorylation targets 
of Rim15p are involved in longevity regulation 
45
. We hypothesized that under non-CR 
conditions, activated PKA is involved in some of the anti-aging effects of LCA, perhaps through 
regulation of Rim15p kinase activity. This is consistent with the fact that lack of Ras2p only 
partially reduced the ability of LCA to extend lifespan, and this occurred to an equal extent under 
both CR and non-CR conditions (Figure 4C,D). The loss of PKA activity resulting from the 
ras2 deletion would thus inhibit the ability of PKA to regulate the pro-aging effects of the 
cytosolic Rim15p pool.  
 
Figure 5 LCA partially increases the mean and maximum CLS of yeast lacking Rim15p under both CR and Non-CR 
conditions.  Effect of LCA on the mean (A) and maximum (B) life spans of chronologically aging rim15Δ strain. 
Data are presented as means ± SEM (n = 5-7; ***p < 0.001; **p < 0.01). Effect of LCA on the fold increase in the 
mean (C) or maximum (D) life spans of chronologically aging rim15Δ and WT strains. Data are presented as means 
± SEM (n = 5-7). Cells in A to D were cultured in medium initially containing 0.2%, 0.5%, 1% or 2% glucose in the 
presence of LCA (50 μM) or in its absence. . Adapted from 27. 
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 The TOR and cAMP/PKA pathways both act to phosphorylate Rim15p when nutrients 
are abundant 
10,44
. The Rim15p nuclear pool plays an important role in regulating the life-
extending effect of CR by enabling the establishment of a pro-longevity transcriptional program 
which activates various stress responsive factors including Msn2p, Msn4p and Gis1p (Figure 
6A) 
3,10,14,44
. Interestingly, LCA was still able to extend lifespan in the rim15 mutant, although 
only partially (Figure 5A,B). Also worth noting is that by eliminating a key nutrient-sensory 
protein kinase on which the adaptable TOR and cAMP/PKA pathways converge to regulate 
longevity in a calorie availability-dependent fashion, the rim15 mutation abolished the 
dependence of the anti-aging efficacy of LCA on the number of available calories (Figure 5C,D).  
 
2.4 Discussion 
2.4.1 LCA extends yeast CLS by modulating housekeeping longevity assurance processes 
that are not regulated by the adaptable TOR and cAMP/PKA signaling pathways  
 These findings imply that LCA extends longevity of chronologically aging yeast by 
targeting two distinct mechanisms. One mechanism extends longevity in a manner that is 
independent of the availability of nutrients outside the cell (i.e. glucose). This mechanism 
involves the LCA-governed modulation of certain housekeeping longevity assurance pathways 
that do not overlap with the adaptable TOR and cAMP/PKA pathways (Figure 6B). The data 
presented here shows evidence of at least one such pathway, in that LCA modulates the 
regulation of lipid storage and metabolism. This effectively suppresses the pro-aging process 
13,37,46
 of lipid-induced necrotic cell death, likely by reducing the intracellular levels of FFA and 
DAG that trigger programmed necrotic cell death.  
 In addition to modulation of myriad of housekeeping pathways, LCA appears to be able 
to utilize the PKA pathway to promote longevity specifically under non-CR conditions. This 
mechanism is devised of a regulatory relationship between LCA and PKA, a key player in the 
adaptable cAMP/PKA pathway. We propose that LCA causes PKA to act as a pro-longevity 
factor by activating PKA-dependent phosphorylation of the cytosolic pool of Rim15p, a key 
nutrient-sensory protein kinase on which the adaptable TOR and cAMP/PKA pathways converge 
to regulate longevity in a calorie availability-dependent fashion (Figure 6B). Of note, the nuclear 
pool of Rim15p is well known for its anti-aging role in governing the life-extending effect of CR 




. Based on the presented data we hypothesized that 1) unlike Rim15p in the nucleus, the 
cytosolic pool of Rim15p acts as a pro-aging factor presumably by phosphorylating target 
proteins within the cytosol 
45
 that promote aging when phosphorylated (Figure 6B). In addition 
to this, under non-CR conditions LCA may somehow enhance the PKA-dependent 
phosphorylation of Rim15p (Figure 6B); causing inactivation of the kinase activity of Rim15p 
allowing for the dephosphorylation of its cytosolic targets
44
. However, it remains to be tested 
whether deletion of the cytosolic targets of Rim15p has an affect on the ability of LCA to 
modulate lifespan. 
 
Figure 6 Outline of pro- and anti-aging processes that are controlled by the TOR and/or cAMP/PKA signalling 
pathways and are modulated by LCA or rapamycin (RAP) in chronologically aging yeast. The currently accepted 
(A) and updated, based on this study (B), outlines of pro- and anti-aging processes are shown. Activation arrows and 
inhibition bars denote pro-aging processes (displayed in green color), anti-aging processes (displayed in red color) 
or processes whose role in longevity regulation was unknown (displayed in black color). Dotted lines denote 




3. Mitochondrial membrane lipidome defines yeast longevity 
 
3.1 Introduction 
 As mentioned previously, we identified lithocholic acid (LCA), a bile acid, as a natural 
compound that acts synergistically with CR to cause a substantial increase in yeast chronological 
lifespan under longevity-extending CR conditions. In addition to the ability of LCA to protect 
yeast from cell death caused by the exposure to exogenously added fatty acids in the culture 
medium by altering lipid metabolism and storage, LCA also induced a number of beneficial 
effects including alterations in mitochondrial morphology, functionality, stress resistance, 
mitochondria-controlled apoptosis, and stability of both nuclear and mitochondrial genomes 
47
.  
 Based on this we decided to examine a mechanism underlying the potent anti-aging effect 
of LCA in yeast cultured under CR. What was found was that exogenously added LCA enters 
yeast cells and primarily accumulates in the mitochondria. This was discovered through use of 
subcellular fractionation followed by mass spectrometry to quantitatively assess in which 
subcellular fraction LCA would accumulate 
40
. Of the pool of LCA that gets into yeast cells, it 
primarily associated with the inner mitochondrial membrane (IMM), and to a lesser extent in the 
outer mitochondrial membrane (OMM). From this we decided to conduct another mass 
spectrometry based lipid-profiling experiment – this time of purified mitochondria. What we 
found was that LCA greatly affected glycerophospholipid synthesis and movement within both 
mitochondrial membranes, causing significant age-related changes in the mitochondrial 
membrane lipidome. These changes coincided with altered size, number and morphology, as 
well as mitochondrial respiration, membrane potential, ATP synthesis and reactive oxygen 
species (ROS) homeostasis 
47
. Together this data suggests that the ability of LCA to extend yeast 
CLS is at least partly dependent on its capacity to reconfigure the mitochondrial membrane 
lipidome. 
 Based on an expanding knowledge-base about the basic science of cellular aging, it is 
now widely accepted that the functional state of the mitochondria in eukaryotic cells plays an 
important role in regulating cellular and organismal aging 
48–51
. The age-related decline in 
mitochondrial function is considered to be one of the major hallmarks of aging in eukaryotic 
organisms across evolutionarily distinct organisms 
52
. Mitochondria play a key role in the aging 
process because they are responsible for supplying the cell with the majority of its requirement 
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for ATP, which is synthesized via oxidative phosphorylation coupled to the electron transport 
chain in the inner mitochondrial membrane (IMM) 
48,53,54
. This process is known to generate 
reactive oxygen species (ROS) which play a critical role in the development of a pro- or anti-
aging cellular routines 
55–60
.  The mitochondria is also involved in producing and releasing a 
plethora of metabolites, iron-sulphur clusters (ISC), proteins, peptides and DNA fragments that 
are essential for establishing cellular commitment to certain cell death modalities, and thus 




3.2 Materials and Methods 
Yeast strains, media and growth conditions 
The wildtype strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 lys20 ura30) 
[Thermo Scientific/Open Biosystems; #YSC1054] was grown in YP medium (1% yeast extract, 
2% peptone) [both from Fisher Scientific; #BP1422-2 and #BP1420-2, respectively] containing 
0.2% glucose [#D16-10; Fisher Scientific] as carbon source. Cells were cultured at 30
o
C with 
rotational shaking at 200 rpm in Erlenmeyer flasks at a “flask volume/medium volume” ratio of 
5:1. 
Pharmacological manipulation of chronological lifespan 
Chronological lifespan assay and pharmacological manipulation of chronological lifespan by 
addition of lithocholic acid (LCA) [Sigma; #L6250] were performed as previously described 
27,62
. LCA was added to growth medium in DMSO or water at the final concentration of 50 µM 
immediately following cell inoculation into the medium. The final concentration of DMSO in 
yeast cultures supplemented with LCA (and in the corresponding control cultures supplemented 
with compound vehicle) was 1% (v/v). 
 
Mitochondrial Lipidomics 
Purification and sub fractionation of mitochondria was carried out as previously described 
63
. 
Extraction of lipids from purified mitochondria was conducted by a modified Bligh & Dyer 
method as described previously 
42
. The following mass spectrometric identification and 
quantitation of various lipid species were performed according to established procedures 
62
.   
 The “unsaturation index” for each molecular form of glycerophospholipids was 
calculated as previously described 
64
. For the PA, PG, PS, PE, PC and PI species of 
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glycerophospholipids, the unsaturation index was calculated as the “glycerophospholipids with 
one or two unsaturated acyl chains (i.e., Cn:1 and Cn:2 species)/glycerophospholipids without 
unsaturated acyl chains (i.e., Cn:0 species)” ratio. For the MLCL species of glycerophospholipids, 
the unsaturation index was calculated as the “glycerophospholipids with one, two or three 
unsaturated acyl chains (i.e., Cn:1, Cn:2 and Cn:3 species)/glycerophospholipids without 
unsaturated acyl chains (i.e., Cn:0 species)” ratio. For the CL species of glycerophospholipids, the 
unsaturation index was calculated as the “glycerophospholipids with unsaturated acyl chains 
/glycerophospholipids without unsaturated acyl chains (i.e., Cn:0 species)” ratio.  
 
Subcellular Fractionation and Purification of Organelles 
Subcellular fraction followed by purification of Mitochondria 
63
, was conducted according to 
established protocols that are summarized below. 
 
Isolation of crude mitochondrial fractions 
 Yeast cells were harvested at 3,000 × g for 5 min at room temperature, washed with water 
and resuspended in DTT buffer (100 mM Tris-H2SO4, pH 9.4, 10 mM dithiothreitol [DTT]). 
Cells were incubated in DTT buffer incubated for 20 min at 30°C to weaken the cell wall. The 
cells then were washed with Zymolyase buffer (1.2 M sorbitol, 20 mM potassium phosphate, pH 
7.4) and centrifuged at 3,000 × g for 5 min at room temperature. Cells were then incubated with 
3 mg/g (wet weight) of Zymolyase-100T in 7 ml/g (wet weight) Zymolyase buffer for 45 min at 
30°C. Following an 8-min centrifugation at 2,200 × g at 4°C, the isolated spheroplasts were 
washed in ice-cold homogenization buffer (5 ml/g) (0.6 M sorbitol, 10 mM Tris-HCl, pH7.4, 1 
mM EDTA, 0.2% (w/v) BSA) and centrifuged at 2,200 × g for 8 min at 4°C. Spheroplasts were 
homogenized in ice-cold homogenization buffer using glass dounce homogenizer 15 strokes. 
Cell debris was removed by centrifuging the resulting homogenates at 3,000 × g for 10 min at 
4°C. The resulting supernatant was then centrifuged at 12,000 × g for 15 min at 4°C to pellet 
mitochondria. The remnant cell debris was removed by centrifuging the mitochondrial fraction at 
3,000 × g for 5 min at 4°C. The resulting supernatant was then centrifuged at 12,000 × g for 15 
min at 4°C to obtain the crude mitochondrial pellet, which was then resuspended in 3 ml of SEM 
Buffer (250 mM sucrose, 1 mM EDTA, 10 mM MOPS, pH 7.2) and used for the purification of 
mitochondria as described below. 
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Purification of mitochondria devoid of microsomal and cytosolic contaminations 
 A sucrose gradient was made by overlaying 1.5 ml of 60% sucrose with 4 ml of 32% 
sucrose, 1.5 ml of 23% sucrose, and then 1.5 ml of 15% sucrose (all in EM buffer; 1 mM EDTA, 
10 mM MOPS, pH 7.2). Finally, a 3-ml aliquot of the crude mitochondrial fraction in SEM 
buffer was applied to the gradient and centrifuged at 134,000 × g (33,000 rpm) for three hours at 
4°C in vacuum (Rotor SW40Ti, Beckman). The purified mitochondria found at the 60%/32% 
sucrose interface were carefully removed and stored at - 80°C until lipids were extracted for 
mass spectrometry. 
Miscellaneous procedures 
Electron microscopy and the morphometric analysis of the resulting images were performed as 
previously described 
65
. Protein concentration in samples of purified mitochondria was 




3.3.1 Mitochondrial membranes of yeast cultured in the presence of LCA exhibit altered 
concentrations of various glycerophospholipid species 
 The phospholipid composition of both the inner and outer mitochondrial membranes is 
related to the membrane composition of the endoplasmic reticulum (ER) through a network of 
highly dynamic processes. These processes include the synthesis of the glycerophospholipids 
phosphatidic acid (PA), cytidine diphosphate-diacylglycerol (CDP-DAG), phosphatidylserine 
(PS), phosphatidylcholine (PC) and phosphatidylinositol (PI) by enzymes residing in the ER. 
Additionally, the enzymes involved in the biosynthesis of CDP-DAG, phosphatidylglycerol 
(PG), cardiolipin (CL) and monolysocardiolipin (MLCL) are located in the IMM. The result is 
such that a bidirectional movement of glycerophospholipids via mitochondria-ER junctions (also 
called mitochondria-ER contact sites) is necessary to maintain proper membrane lipid 
composition. The mitochondria-ER junctions represent zones of close apposition between the 
OMM and the mitochondria-associated membrane (MAM) domain of the ER. To complicate 
matters, there also exists a CL-dependent inhibition of PA transport from the OMM to the IMM 




 Based on our observation that LCA accumulates in the IMM and is also present in the 
OMM 
40
, we hypothesized that LCA may alter the relative concentrations of various 
glycerophospholipid species in mitochondrial membranes – perhaps by affecting the activity of 
enzymes involved in glycerophospholipid synthesis within the IMM, affecting 
glycerophospholipid exchange between the mitochondrial and ER membranes via mitochondria-
ER junctions, and/or impinging on the Ups1p-driven shuttling of PA between the two 
mitochondrial membranes. 
 To determine whether mitochondria-confined LCA alters the glycerophospholipid 
composition of the mitochondrial membranes, we used mass spectrometry to compare the 
membrane lipidomes of mitochondria purified from yeast cultured under CR conditions with or 
without LCA, either dissolved in water or DMSO. We found that, regardless of the presence of 
DMSO, exogenously added LCA increased the glycerophospholipid/protein ratio of 
mitochondrial membranes in an age dependent manner (Figure 7). In fact, LCA had no effect on 
the glycerophospholipid/protein ratio of mitochondrial membranes in cells recovered at diauxic 
(D) growth phase on day 2 of cell culturing, but caused a moderate (but significant) increase in 
this ratio in cells recovered at post-diauxic (PD) growth phase. This ratio was significantly 
elevated in cells recovered upon entering stationary (ST) phase on day 7 of cell culturing (Figure 
7). 
 
Figure 7 In yeast cultures containing exogenously added LCA, this bile elevates the glycerophospholipid/protein 
ratio of mitochondrial membranes in an age-dependent manner. Cells were cultured in the nutrient-rich YP medium 
initially containing 0.2% glucose with 50 µM LCA or without it, in the presence of 1% DMSO (A) or in its absence 
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(B). Mitochondria were purified from cells recovered on day 2, 4 or 7 of cell culturing. Protein concentration 
measurement in samples of purified mitochondria, extraction of mitochondrial membrane lipids, and mass 
spectrometric identification and quantitation of the extracted glycerophospholipid species were carried out as 
described in Methods. Based on these data, the “total membrane glycerophospholipids /total membrane protein” 
ratios were calculated as nanomoles of glycerophospholipid/mg of protein for mitochondria that were purified from 
cells recovered on day 2, 4 or 7 of cell culturing. Data are presented as means ± SEM (n = 3; *p < 0.01; ns, not 




 In addition to this, LCA treatment induced differential effects on the concentrations of 
different molecular forms of mitochondrial membrane glycerophospholipids; moreover, these 
effects of LCA were age-dependent. Indeed, we found that LCA causes a rise in the levels of 
mitochondrial PA, PG, PS, PC and PI calculated as nanomoles of glycerophospholipid/mg of 
protein. These effects increased with the chronological age of yeast cells yet for the PG and PI 
species of mitochondrial membrane glycerophospholipids, this effect of LCA can be seen only in 
cells recovered at PD or ST growth phase on day 4 or 7 (Figure 8). In contrast, our mass 
spectrometric identification and quantitation of mitochondrial membrane glycerophospholipids 
revealed that (I) LCA elicits a decline in the levels of mitochondrial CL, MLCL and PE 
calculated as nanomoles of glycerophospholipid/mg of protein; (II) the extent of such effect of 
LCA on CL, MLCL and PE levels (calculated as nanomoles of glycerophospholipid/mg of 
protein) decreases with the chronological age of yeast cells; and (III) for the MLCL species of 
mitochondrial membrane glycerophospholipids , this effect of LCA can be seen only in cells 
recovered at PD or ST growth phase on day 4 or 7 (respectively) of cell culturing (Figure 8). 
These effects were not dependent on whether LCA was solubilized in water or DMSO. 
 Although a similar trend of the differential effect of LCA on the concentrations of 
different molecular forms of mitochondrial membrane glycerophospholipids was observed if 
their relative levels were calculated as molar percentage of all glycerophospholipids, the extent 
to which LCA increased the relative levels of mitochondrial PA, PG, PS and PC or decreased the 
relative levels of mitochondrial CL, MLCL and PE gradually progressed with the chronological 
age of yeast cells (Figure 9). Moreover, LCA did not alter the relative level of PI if it was 
calculated as molar percentage of all glycerophospholipids (Figure 9). 
 Importantly, while LCA elicited substantial differential effects on the relative levels of 
different molecular forms of mitochondrial membrane glycerophospholipids (calculated as molar 
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percentage of all glycerophospholipids), it did not cause a significant change in the “unsaturation 
index” for any of the glycerophospholipid species (Figure 10). This index is calculated as the 
ratio of glycerophospholipids with one, two, three or four unsaturated acyl chains / 
glycerophospholipids without unsaturated acyl chains (i.e., Cn:0 species)” ratio 
70
. We found that 
the unsaturation index was high for each molecular form of mitochondrial membrane 
glycerophospholipids, ranging from 4.2 to 63.3 (Figure 10). For PG, PS, PC, PI and PE, the 
unsaturation index is known to play a pivotal role in defining whether each of these 
glycerophospholipid species acquires the bilayer forming shape of a cylinder or it attains the 
non-bilayer forming shape, either that of a cone or an inverted cone (Figure 11A-D) 
66,71,72
. Of 
note, PA, CL and MLCL are known to be always present in the non-bilayer forming shape of a 
cone, regardless of their unsaturation indexes (Figure 11A-D) 
66,71,72
. Thus, the observed 
differential effects of LCA on the relative levels of different molecular forms of mitochondrial 
membrane glycerophospholipids (Figure 9) and the demonstrated lack of its effect on the 
unsaturation index for each of these molecular forms (Figure 10) imply that this bile acid alters 
only the relative levels of bilayer forming and non-bilayer forming glycerophospholipid species, 
but does not affect the molecular shape of any of them. The observed unsaturation indices were 





Figure 8 LCA exhibits age-dependent differential effects on the concentrations of different species of mitochondrial 
membrane glycerophospholipids. Cells were cultured in the nutrient-rich YP medium initially containing 0.2% 
glucose with 50 µM LCA or without it (A, C and E) or in its absence (B, D and F). Mitochondria were purified from 
cells recovered on day 2, 4 or 7 of culturing. Based on these data, the concentrations of different molecular forms of 
mitochondrial membrane glycerophospholipids were calculated as nanomoles of glycerophospholipid/mg of protein 
for mitochondria that were purified from cells recovered on day 2, 4 or 7 of cell culturing. Data are presented as 






Figure 9 LCA exhibits age-dependent differential effects on the molar percentage of different molecular forms of 
mitochondrial membrane glycerophospholipids. Cells were cultured in the nutrient-rich YP medium initially 
containing 0.2% glucose with 50 µM LCA or without it, in the presence of 1% DMSO (A, C and E) or in its absence 
(B, D and F). Mitochondria were purified from cells recovered on day 2, 4 or 7 of cell culturing. Based on these 
data, the relative levels of different species of mitochondrial membrane glycerophospholipids were calculated as 
molar percentage of all glycerophospholipids for mitochondria that were purified from cells recovered on day 2, 4 or 






Figure 10 LCA does not cause a significant change in the “unsaturation index” for any of the glycerophospholipid 
species. Cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose with 50 μM LCA or 
without it, in the presence of 1% DMSO (A, C and E) or in its absence (B, D and F). Based on these data, the 
unsaturation index for each molecular form of mitochondrial membrane glycerophospholipids was calculated as 
detailed in Methods. This index represents the “glycerophospholipids with one, two, three or four unsaturated acyl 
chains (i.e., Cn:1, Cn:2, Cn:3 and Cn:4 species)/glycerophospholipids without unsaturated acyl chains (i.e., Cn:0 
species)” ratio. Data are presented as means ± SEM (n = 3; ns, not significant). Reproduced from 40. 
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3.3.2 Mitochondrial membranes of yeast cultured in the presence of LCA display reduced 
concentration of non-bilayer forming glycerophospholipids and elevated concentrations of 
their bilayer forming species 
 Glycerophospholipids have a shape that is defined by the relative sizes of the cross-
sectional areas of its hydrophilic head group and hydrophobic acyl chains (Figure 11A-C) 
66,71,72
. 
If the cross-sectional areas of the hydrophilic head group and hydrophobic acyl chains of a 
glycerophospholipid are equally sized, it has a cylindrical shape (Figure 11C) 
66,71,72
. A 
glycerophospholipid with a hydrophilic head group that is smaller than the cross-sectional area 
of the hydrophobic acyl chains has a cone shape, whereas a glycerophospholipid that exhibits the 
opposite trend is shaped as an inverted cone (Figure 11C) 
66,71,72
. 
 The relative levels of cylinder-, cone- and inverted cone-shaped glycerophospholipids in 
a membrane are known to define membrane curvature; thus, changes in the relative levels of the 
differently shaped lipids within a membrane can alter its curvature 
66,71,72
. For the IMM, a rise in 
the relative levels of glycerophospholipids having the bilayer forming shape of a cylinder 
reduces the extent of membrane curving 
66,71,72
.  This causes a number of morphological changes 
including a reduction in positive and negative membrane curvature (that is either toward or away 
from the mitochondrial matrix respectively), as well as an increase in the proportion of 
membranes having a flat bilayer conformation. (Figure 11D) 
66,71,72
. Likewise, an increase in the 
proportion of cone- and inverted cone-shaped glycerophospholipids increases the degree of 
membrane curvature, increasing the number of mitochondrial contact sites and mitochondrial 




    
Figure 11 LCA reduces the relative levels of non-bilayer forming glycerophospholipids and elevates the relative 
levels of bilayer forming species. (A) Relative sizes of the cross-sectional areas of hydrophilic head group for 
different glycerophospholipid species. (B) Saturated and unsaturated hydrophobic acyl chains of 
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glycerophospholipids. (C) The shape of a glycerophospholipid molecule is defined by the relative sizes of the cross-
sectional areas of its hydrophilic head group and hydrophobic acyl chains. (D) The relative levels of cylinder-, cone- 
and inverted cone-shaped glycerophospholipids in a membrane define membrane curvature, including that of the 
IMM. (E - H) Cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose with 50 µM 
LCA or without it, in the presence of 1% DMSO (E and G) or in its absence (F and H). Data are presented as means 
± SEM (n = 3; *p < 0.01). Reproduced from 
40
. 
 Mitochondria were purified from cells recovered on day 2, 4 or 7 of cell culturing. 
Extraction of mitochondrial membrane lipids, and mass spectrometric identification and 
quantitation of the glycerophospholipid species were performed as described in Methods. Based 
on these data, the relative levels of non-bilayer forming and bilayer forming 
glycerophospholipids were calculated as molar percentage of all membrane 
glycerophospholipids.  
 Based on our data on mass spectrometric identification and quantitation of mitochondrial 
membrane glycerophospholipids, we calculated the relative levels of their species having the 
non-bilayer forming shape of a cone or an inverted cone as well as the relative levels of 
glycerophospholipid species exhibiting the bilayer forming shape of a cylinder. The relative 
levels of non-bilayer forming and bilayer forming glycerophospholipids were calculated as molar 
percentage of all membrane glycerophospholipids. We found that, regardless of the presence of 
DMSO in yeast cultures containing exogenously added LCA, this bile acid reduces the relative 
levels of non-bilayer forming glycerophospholipids (Figure 11E,F) and elevates the relative 
levels of their bilayer forming species (Figure 11G,H). We therefore hypothesized that LCA may 
(I) reduce the abundance of the IMM domains displaying negative curvature characteristic of 
mitochondrial contact sites between the IMM and OMM; (II) decrease the abundance of the 
IMM domains exhibiting positive curvature typical of mitochondrial cristae formed by the IMM; 
and (III) increase the abundance of the IMM domains having flat bilayer conformation.  
 
3.3.3 Mitochondria of yeast cultured in the presence of LCA are enlarged, their number is 
reduced and their morphology is altered 
 Membrane lipid composition is known to influence their structure and function 
64,66,74,75
.  
In fact mitochondrial morphology is known to be determined by the phospholipid composition of 
its inner and outer membranes 
66,76–78
. Treatment of yeast cultures with LCA causes an age-
related increase in the glycerophospholipid/protein ratio of mitochondrial membranes and 
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induces an age related change in the relative levels of different molecular forms of 
glycerophospholipids within these membranes, we sought to investigate how LCA influences 
mitochondrial morphology and abundance in chronologically aging yeast. We used electron 
microscopy to reveal that in yeast cultures entering stationary phase (day 7 of culturing) grown 
under CR on 0.2% glucose, LCA induced a substantial increase in the size of mitochondria 
(Figure 12C, I), as well as significantly reduction in their number (Figure 12D, J). Whether LCA 
was dissolved in DMSO had no influence on this finding (Figure 12A-D, G-J).  
 From this, we deduced that what is most likely occurring is that the substantial 
enlargement of mitochondria and the resulting expansion of both mitochondrial membranes 
observed in yeast cultured with exogenously added LCA (Figure 12A-C and Figure 12G-I) was 
an effect of the age-related increase in the glycerophospholipid/protein ratio of mitochondrial 
membranes (Figure 7). It is possible that the decrease in mitochondrial number in yeast grown in 
the presence of exogenous LCA (Figure 12A,B, D, G, H, J) was caused by the differential effects 
of this bile acid on the relative levels of different glycerophospholipid species within 
mitochondrial membranes (Figure 9). In support of this, LCA increased the relative level of 




  In these cultures, LCA also significantly altered the morphology of the IMM and 
mitochondrial cristae. It was observed by electron microscopy that LCA treatment substantially 
lowered the proportion of mitochondria with cristae extending from the IMM by reducing the 
extent of connectivity between cristae and the inner boundary membrane (Figure 12A, B, E, G, 
H, K). This resulted in a significant increase in the total length of mitochondrial cristae relative 
to the total length of the OMM (Figure 12A, B, F, G, H and L). The formation of mitochondrial 
cristae by the IMM domains having positive curvature (i.e., membrane curving towards the 
mitochondrial matrix) is known to require both glycerophospholipids having the non-bilayer 
forming shape of a cone and glycerophospholipids exhibiting the non-bilayer forming shape of 
an inverted cone (Figure 11D) 
66,72,81
. From this we hypothesized that the observed alterations to 
the morphology of the IMM and mitochondrial cristae were the result of the reduction of non-
bilayer forming lipids in these membranes (Figure 12A, B, E-H, K and L). Moreover, it is 
plausible that the observed build-up of cristae disconnected from the IMM, and thus exhibiting 
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flat bilayer conformation was caused by the substantial rise in the relative levels of bilayer 
forming mitochondrial glycerophospholipids seen in these cells. 
 
 
Figure 12 LCA enlarges the mitochondria, reduces their number and alters their morphology. Cells were cultured in 
the nutrient-rich YP medium initially containing 0.2% glucose with 50 µM LCA or without it, in the presence of 1% 
DMSO (A - F) or in its absence (G - L). (A, B, G and H) Transmission electron micrographs of yeast cells recovered 
on day 7 of cell culturing. M, mitochondrion. Bar, 1 µm. (C and I) Percentage of mitochondria having the indicated 
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relative area of mitochondrion section. The relative area of mitochondrion section was calculated as (area of 
mitochondrion section/area of cell section) × 100%. Data are presented as means ± SEM (transmission electron 
micrographs of at least 100 cells were subjected to morphometric analysis for each kind of culturing conditions; *p 
< 0.01). (D and J) Numbers of mitochondria in yeast cells. The data of morphometric analysis are expressed as the 
number of mitochondria per μm3 of cell section ± SEM (transmission electron micrographs of at least 100 cells were 
subjected to morphometric analysis for each kind of culturing conditions; *p < 0.01). (E and K) Percentage of 
mitochondria that exhibit cristae extending from the IMM. Data are presented as means ± SEM (transmission 
electron micrographs of at least 100 cells were subjected to morphometric analysis for each kind of culturing 
conditions; *p < 0.01). (F and L) Percentage of mitochondria having the indicated relative length of mitochondrion 
cristae. The relative length of mitochondrion cristae was calculated as [the total length of mitochondrial cristae 
(including both cristae extending from the IMM and cristae disconnected from the inner boundary membrane)/the 
total length of the OMM] x 100%. Data are presented as means ± SEM (transmission electron micrographs of at 






 In the data presented in this chapter, I contributed to some of the first evidence that the 
lipid composition of the mitochondrial membrane plays an essential role in defining the lifespan 
of yeast. What we now know is that LCA delays chronological aging in yeast by accumulating in 
both mitochondrial membranes and altering their lipid compositions. These alterations to the 
lipid composition of the IMM and OMM may be responsible for causing the observed changes in 
mitochondrial size, number and morphology. These changes coincide with alterations to various 
lifespan-defining cellular processes that are regulated by the mitochondria. In addition to this, 
LCA induces these changes under caloric restriction conditions. This signifies that LCA works 
synergistically with CR to induce an even greater extension of yeast CLS. 
 From this data, we developed a model to explain how LCA influences longevity by 
inducing changes to the mitochondrial lipidome and subsequently improving it’s functional state 
(Figure 13). First, exogenous LCA enters yeast cells and is sorted to mitochondria. Although in 
the presence of DMSO used as a vehicle for delivering exogenous LCA into a cell it also resides 
in the cytosol, the almost exclusive confinement of the intracellular pool of this bile acid to 
mitochondria if added without DMSO implies that, regardless of the presence of DMSO in yeast 
cultures, the potent anti-aging effect of LCA is due to its accumulation in mitochondria. Almost 
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75% of the total pool of mitochondrial LCA resides in the IMM, and approximately 25% of this 
pool is also confined to the OMM (Figure 13). 
          The model also posits that the IMM pool of LCA exerts an effect on activities of different 
enzymes involved in glycerophospholipid synthesis within the inner boundary membrane. The 
most likely explanation for these changes is that this bile acid specifically alters the hydrophobic 
environment within the IMM to slow down the Psd1p- and Crd1p-dependent reactions (Figure 
13); the Psd1p reaction is known to lead to the conversion of PS to PE, whereas the Crd1p 
reaction produces CL from PG 
66,68
. The resulting reduction in the concentration of CL limits its 
availability for the later acyl chain remodeling steps (Figure 13), which involve the sequential 
action of the phospholipase Cld1p and the transacylase Taz1p 
66,68
. This, in turn, lowers the level 
of MLCL as well as reduces the flow and elevates the level of PC (Figure 13), the only known 
donor of acyl chains for the remodeling of newly synthesized CL 
66,68
. Our model also suggests 
that a reduction in CL within the IMM attenuates a negative feedback loop that involves a CL-
dependent inhibition of PA transport from the OMM to the IMM by Ups1p, a protein that 
shuttles PA between the two mitochondrial membranes (Figure 13) 
66,68
. The acceleration of the 
Ups1p-driven transport of PA from the OMM to the IMM may in turn accelerate the movement 
of PA from the MAM domain of the ER to the OMM; such movement is known to occur via 
mitochondria-ER junctions 
66–68
 and could be stimulated by the accumulated in the OMM pool of 
LCA (Figure 13). The transport of PA from the MAM domain of the ER to the OMM and then to 
the IMM acts synergistically with the aforementioned LCA-dependent deceleration of the Crd1p 
reaction to increase the levels of PA and PG within the IMM (Figure 13).  
 
3.5 Conclusions  
 To summarize, the remodeling of glycerophospholipid synthesis within the IMM, 
attenuation of the CL-dependent inhibition of PA transport from the OMM to the IMM and 
acceleration of PA movement from the MAM domain of the ER to the OMM in cells cultured 
with LA cause: (I) a decline in the relative levels of PE, CL and MLCL within mitochondrial 
membranes; and (II) a rise in the relative levels of PA, PS, PC and PG within mitochondrial 
membranes (Figure 13). In our model, none of these LCA-driven processes in the IMM and 
OMM alters the relative level of PI within mitochondrial membranes (Figure 13), just as it was 
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demonstrated by our mass spectrometric quantitation of various molecular forms of 
mitochondrial membrane glycerophospholipids (Figure 9). 
 
Figure 13 - A model for a mechanism underlying the ability of LCA to extend yeast longevity by accumulating in 
mitochondria, altering mitochondrial membrane lipidome, and affecting mitochondrial morphology and function. 
Exogenously added LCA enters yeast cells and accumulates mainly in the inner mitochondrial membrane (IMM). In 
so doing LCA causes a remodeling of glycerophospholipid synthesis within the IMM, attenuating the cardiolipin 
(CL)-dependent inhibition of phosphatidic acid (PA) transport from the OMM to the IMM and accelerating PA 
movement from the mitochondria-associated membrane (MAM) domain of the ER to the OMM via mitochondria-
ER junctions. The LCA-driven progressive remodeling of mitochondrial membrane lipidomes with the 
chronological age of a yeast cell causes major changes in mitochondrial size, number and morphology. The elicited 
by LCA substantial changes in mitochondrial membrane lipidome and the resulting major changes in mitochondrial 
morphology act in synergy to alter the age-related chronology of mitochondrial respiration, electrochemical 
membrane potential, ATP synthesis and ROS homeostasis. Because of these LCA-dependent changes in the age-
related dynamics of the four longevity-defining processes confined to mitochondria, chronologically “old” cells 
cultured with exogenous LCA exhibit higher mitochondrial respiration, electrochemical membrane potential, ATP 
level and ROS concentration. This increases their long-term viability and stress resistance and, thus, extends their 
longevity. Arrows next to the names of lipid species denote those of them whose concentrations are elevated (red 
arrows) or reduced (blue arrows) in cells cultured with exogenous LCA and therefore accumulating this bile acid in 
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 Our model indicates that by altering the biosynthesis and transport of several different 
membrane phospholipid species, LCA causes significant changes in the number and structure of 
mitochondria. These age-related changes include an increase in the abundance of mitochondrial 
glycerophospholipids (Figure 7), thereby leading to an expansion of both mitochondrial 
membranes and the resulting enlargement of mitochondria (Figure 12). In addition to this LCA 
causes a rise in the level of mitochondrial PA (Figure 9), which is likely involved in the apparent 
reduction in mitochondrial number (Figure 12) - perhaps by stimulating mitochondrial fusion 
which PA has been implicated in 
66,79,80
. LCA also induced a decline in the relative levels of non-
bilayer forming (i.e., cone- and inverted cone-shaped) mitochondrial phospholipids (Figure 11), 
resulting in a decrease in the proportion of mitochondria with cristae extending from the IMM 
(Figure 12). This is possibly due to the fact that mitochondrial cristae formation by the IMM 
domains having positive curvature is known to require both these differently shaped non-bilayer 
forming glycerophospholipids 
66,72,81
.  Lastly, LCA induced a rise in the relative levels of bilayer 
forming (i.e., cylinder-shaped) mitochondrial glycerophospholipids, thereby leading to an 
accumulation within the mitochondrial matrix of cristae disconnected from the IMM and thus 
exhibiting flat bilayer conformation - perhaps due to the known ability of bilayer forming 






4. Macromitophagy is a longevity assurance process that in chronologically aging yeast 
limited under caloric restriction conditions maintains cellular lipid homeostasis 
 
Abstract 
 Macromitophagy controls mitochondrial quality and quantity. It involves the 
sequestration of dysfunctional or excessive mitochondria within double-membrane 
autophagosomes, which then fuse with the vacuole/lysosome to deliver these mitochondria for 
degradation. To investigate a physiological role of macromitophagy in yeast, we examined how 
the atg32Δ-dependent mutational block of this process influences the chronological lifespan of 
cells grown in a nutrient-rich medium containing low (0.2%) concentration of glucose. Under 
these longevity-extending conditions of caloric restriction (CR) yeast cells are not starving. Our 
findings imply that macromitophagy is a longevity assurance process underlying the beneficial 
effects of CR on yeast lifespan. Our analysis of how the atg32Δ mutation influences 
mitochondrial morphology, composition and function revealed that macromitophagy is required 
to maintain a network of healthy mitochondria. Our comparative analysis of the membrane 
lipidomes of organelles purified from wildtype and atg32Δ cells revealed that macromitophagy is 
required for maintaining cellular lipid homeostasis. We concluded that macromitophagy defines 
yeast longevity by modulating vital cellular processes inside and outside of mitochondria.  
 
4.1 Introduction 
 Mitophagy is a key mechanism of mitochondrial quality and quantity control responsible 
for the autophagic degradation of aged, dysfunctional, damaged or excessive mitochondria 
82–84
. 
Macromitophagy refers to the sequestration of targeted mitochondria into double-membrane-
bounded structures known as autophagosomes 
2, 4
. Following fusion of these autophagosomes 
with the vacuole/lysosome, sequestered mitochondria are degraded by acid hydrolases 
85
 . 
 A micromitophagic mode of mitophagy involves the engulfment of such mitochondria 
through direct invagination of the vacuolar/lysosomal boundary membrane 
85,86
, whereas its 
macromitophagic mode refers to the sequestration of targeted mitochondria into double-
membrane-bounded structures known as autophagosomes 
85,87
. Following fusion of these 





 Only the macromitophagic mode of mitophagy has been described in mammals 
90,91
. 
Macromitophagy in mammalian cells is known to play essential roles in several vital biological 
processes underlying organismal aging, development and differentiation, including (I) selective 
degradation of depolarized mitochondria in dopaminergic neurons in the substantia nigra, a 
PINK1/Parkin-dependent process impaired in autosomal recessive forms of Parkinson’s disease; 
(II) massive elimination of mitochondria driven by Nix, a protein in the outer mitochondrial 
membrane, during reticulocyte-to-erythrocyte maturation; and (III) selective clearance of surplus 




 The physiological role of mitophagy in yeast remains obscure. To provide further insight 
into the physiological functions of selective macroautophagic mitochondrial removal in the yeast 
Saccharomyces cerevisiae, in this study our lab examined how the atg32Δ-dependent mutational 
block of macromitophagy affects the chronological lifespan of yeast cultured in a nutrient-rich 
medium initially containing low (0.2%) concentration of glucose. It has been shown that under 
CR conditions yeast cells undergo an extensive remodeling of their metabolism in order to match 
the level of ATP produced under longevity-shortening non-CR conditions 
13
. It has recently been 
demonstrated that LCA, a bile acid, is a potent anti-aging natural compound that acts in synergy 
with CR to enable a significant further extension of yeast lifespan under CR conditions 
27
.  
Specifically it was shown that the inhibition of mitochondrial specific macroautophagy 
(mitophagy) through deletion of Atg32p drastically impairs the ability of both a caloric 
restriction diet, as well as LCA to extend yeast CLS 
62
. It was also demonstrated that Atg32p is 
necessary for maintaining a pool of functional mitochondria capable maintaining the efficiency 
of aerobic respiration 
62
. Moreover, because mitochondria are known to be dynamically 
integrated into a network governing lipid metabolism and transport not only within these 
organelles but also within the endoplasmic reticulum (ER) and the plasma membrane (PM) 
66,67,78,94–96,
 we investigated whether mitochondrial quality control via macromitophagy were 
critical for maintaining normal lipid homeostasis. I used mass spectrometry to compare the 
membrane lipidomes of purified mitochondrial, ER, and PM membranes from wildtype (WT) 
and atg32Δ cells that were cultured under CR on 0.2% glucose. The findings provide evidence 
that macromitophagy defines longevity of chronologically aging yeast limited in calorie supply 
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through the maintenance of normal organellar membrane lipid homeostasis. 
 
4.2 Materials and Methods 
Yeast strains, media and growth conditions. 
 The wildtype strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 lys20 ura30) 
as well as the single-gene-deletion mutant strains atg32Δ (MAT his31 leu20 lys20 ura30 
atg32::kanMX4) [from Thermo Scientific/Open Biosystems; #YSC1054 and #YSC1021-
550234 respectively] were grown in YP medium (1% yeast extract, 2% peptone) [both from 
Fisher Scientific; #BP1422-2 and #BP1420-2, respectively] containing 0.2% glucose [#D16-10; 
Fisher Scientific] as carbon source. Cells were cultured at 30°C with rotational shaking at 200 
rpm in Erlenmeyer flasks at a “flask volume/medium volume” ratio of 5:1. 
 
Subcellular Fractionation and Purification of Organelles 
 




, and plasma membrane 
98
 
were conducted according to established protocols that are summarized below. 
 
Isolation of the crude ER and mitochondrial fractions 
Yeast cells were harvested at 3,000 × g for 5 min at room temperature, washed with water and 
resuspended in DTT buffer (100 mM Tris-H2SO4, pH 9.4, 10 mM dithiothreitol [DTT]). Cells 
were incubated in DTT buffer incubated for 20 min at 30°C to weaken the cell wall. The cells 
then were washed with Zymolyase buffer (1.2 M sorbitol, 20 mM potassium phosphate, pH 7.4) 
and centrifuged at 3,000 × g for 5 min at room temperature. Cells were then incubated with 3 
mg/g (wet weight) of Zymolyase-100T in 7 ml/g (wet weight) Zymolyase buffer for 45 min at 
30°C. Following an 8-min centrifugation at 2,200 × g at 4°C, the isolated spheroplasts were 
washed in ice-cold homogenization buffer (5 ml/g) (0.6 M sorbitol, 10 mM Tris-HCl, pH7.4, 1 
mM EDTA, 0.2% (w/v) BSA) and centrifuged at 2,200 × g for 8 min at 4°C. Spheroplasts were 
homogenized in ice-cold homogenization buffer using 15 strokes. Cell debris was removed by 
centrifuging the resulting homogenates at 3,000 × g for 10 min at 4°C. The resulting supernatant 
was then centrifuged at 12,000 × g for 15 min at 4°C to pellet mitochondria. The remnant cell 
debris was removed by centrifuging the mitochondrial fraction at 3,000 × g for 5 min at 4°C. The 
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resulting supernatant was then centrifuged at 12,000 × g for 15 min at 4°C to obtain the crude 
mitochondrial pellet, which was then resuspended in 3 ml of SEM Buffer (250 mM sucrose, 1 
mM EDTA, 10 mM MOPS, pH 7.2) and used for the purification of mitochondria as described 
below. 
 
Purification of mitochondria and ER devoid of microsomal and cytosolic contaminations 
A sucrose gradient was made by overlaying 1.5 ml of 60% sucrose with 4 ml of 32% sucrose, 1.5 
ml of 23% sucrose, and then 1.5 ml of 15% sucrose (all in EM buffer; 1 mM EDTA, 10 mM 
MOPS, pH 7.2). Finally, a 3-ml aliquot of the crude mitochondrial fraction in SEM buffer was 
applied to the gradient and centrifuged at 134,000 × g (33,000 rpm) for three hours at 4°C in 
vacuum (Rotor SW40Ti, Beckman). The purified mitochondria found at the 60%/32% sucrose 
interface, and the purified ER found primarily at the 15%/23% sucrose interface were carefully 
removed and stored at - 80°C until lipids were extracted for mass spectrometry. 
 
Purification of Plasma Membrane 
First, yeast cultures were harvested by centrifugation at 5,000 x g (5,300 rpm) for 5 min at 4
o
C in 
a JA-10 rotor (Beckman). Cells were washed and resuspended in 13.7% sucrose in 25mM 
imidazole/HCl buffer (6.81g imidazole/100mL water adjusted to pH 7.0 w HCl). Cells were then 
pelleted at 5,000 x g for 10 min at 4
o
C in a JA-17 rotor (Beckman). The supernatant was 
removed, and the cells were lysed with an equal volume of glass beads followed by 2 minute 
pulses by vortex and then placed on ice. This was repeated for a total of combined time of ~10 
minutes. The cell suspension were diluted in 13.7% sucrose in 25 mM imidazole/HCl buffer and 
centrifuged at 1,000 x g for 10 minutes to pellet unbroken cells in a JA-17 rotor (Beckman) at 
4
o
C. Mitochondria were removed by centrifugation at 10,000 × g (8,200 rpm) for 20 min at 4
o
C 
in a JA-17 rotor. Crude plasma membrane was then collected by centrifugation of the remaining 
supernatant at 30,000 x g for 30 min at 4
o
C in a JA-17 rotor (Beckman). Crude plasma 
membrane was further purified by centrifugation on a sucrose gradient. The gradient was made 
by carefully overlaying 2.5 mL of 77% sucrose in imidazole/HCl (pH 7) with 2.5 mL of 56.5% 
sucrose in imidazole/HCl (pH 7), with 2.5 mL of 37.7% sucrose in imidazole/HCl (pH 7), with 
2.5 mL of 13.7% sucrose in imidazole/HCl (pH 7). 1 mL of crude plasma membrane suspension 
was layered on each gradient made in tubes for the SW41Ti rotor (Beckman). Samples were 
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centrifuged at 200,000 x g for 3 hours at 4
o
C.  The samples were fractionated and the fractions 
enriched in purified plasma membrane were stored at -80
 o
C until extraction of lipids for mass 
spectrometry.  
 
Analysis of lipids by mass spectrometry 
Extraction of lipids from purified mitochondria, ER and PM and following mass spectrometric 
identification and quantitation of various lipid species were carried out as previously described 
42
. Mass spectrometric analyses were performed with a Thermo Orbitrap Velos mass 
spectrometer equipped with a HESI-II ion source (#10145339; Thermo Scientific) operating at a 
flow rate of 5 μl/minute. Lipid species were analyzed by top 10 data dependent FT-MS/MS at a 
resolution of 100,000 for MS scans and 30,000 for dependent MS/MS. Fragmentation was 
carried out using HCD at a normalized collision energy of 35 in negative ion mode and 65 in 
positive ion mode. Acquired mass spectra were converted from proprietary Thermo RAW format 
to either mzXML or mzML using MSConvert as part of the ProteoWizard suite (freely available 
from http://proteowizard.sourceforge.net/). The raw data were then imported into LipidXplorer 
(freely available from https://wiki.mpi-cbg.de/wiki/lipidx/index.php/Main_Page) for lipid 




4.3.1 Macromitophagy is required for maintaining the homeostasis of membrane lipids in 
mitochondria, the ER and the PM 
 Mitochondria are currently believed to be the only site within eukaryotic cells where 
cardiolipin (CL), the signature glycerophospholipid of these organelles, is synthesized 
66,78
. 
Additionally, yeast mitochondria house the synthesis of the glycerophospholipid 
phosphatidylethanolamine (PE), minor quantities of which are also formed in the Golgi 
apparatus 
78
. Both CL and PE are synthesized in the inner membrane of yeast mitochondria from 
their precursor lipid species cytidine diphosphate-diacylglycerol (CDP-DAG), which is formed 
exclusively in the ER. CDP-DAG also serves as a precursor for CL, whereas the 
glycerophospholipid phosphatidylserine (PS) is a precursor for PE (Figure 14) 
66
. Because of 
this, the biosynthesis of CL and PE in yeast cells relies on a delivery of their CDP-DAG and PS 
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precursors from the ER to the IMM 
66,99,100
. Moreover, the mitochondrially synthesized PE 
serves as a precursor for the glycerophospholipid phosphatidylcholine (PC), which is synthesized 
only in the ER (Figure 14) 
67,78
. For this reason ER synthesized PC must be transported to 
mitochondria – which is incapable of synthesizing this essential glycerophospholipid (Figure 14) 
66,99
. Additionally, the glycerophospholipids phosphatidic acid (PA) and phosphatidylinositol 
(PI) are synthesized in the ER but not in mitochondria of yeast cells; therefore, these two lipid 
species need to be translocated to these membranes from the site of their synthesis in the ER 
(Figure 14) 
66,78
. Altogether, this indicates that for the normal functioning of yeast mitochondria, 
a bidirectional exchange of lipids between the mitochondrial and ER membranes is required. 
Such an exchange occurs between zones of close apposition, known as membrane contact sites 
or junctions. These occur between the outer mitochondrial membrane and the mitochondria-
associated membrane (MAM) domain of the ER. It is estimated that 80 to 110 of these 
mitochondria-ER junctions are believed to exist per yeast cell (Figure 14) 
67,100,101
. Of note, 
following their synthesis within the ER and inner mitochondrial membranes, lipids can be 
translocated to the PM; as many as 1,100 PM-ER junctions per yeast cell are involved in lipid 





Figure 14 - Lipid synthesis in the ER and mitochondria and lipid transport via mitochondria-ER and PM-ER 
junctions. After being synthesized in the mitochondria-associated membrane (MAM) domain of the ER, cytidine 
diphosphate-diacylglycerol (CDP-DAG) and phosphatidylserine (PS) are transported via mitochondria-ER junctions 
to the outer mitochondrial membrane (OMM). Following their translocation from the OMM to the inner 
mitochondrial membrane (IMM), CDP-DAG and PS are used as substrates for the synthesis of cardiolipin (CL) and 
phosphatidylethanolamine (PE), respectively. PE is then transported through mitochondria-ER junctions to the 
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MAM domain of the ER, where it is converted to phosphatidylcholine (PC). After being formed in the MAM, PC is 
translocated via mitochondria-ER junctions to mitochondria, which are incapable of synthesizing this 
glycerophospholipid. The glycerophospholipids phosphatidic acid (PA) and phosphatidylinositol (PI) are also 
synthesized in the MAM domain of the ER, from which they are delivered through mitochondria-ER junctions to 
mitochondria known to lack enzymes required for the synthesis of these two glycerophospholipids. After being 
synthesized within the ER and inner mitochondrial membranes, lipids can be translocated via the PM-ER junctions 
from the PM-associated membrane (PAM) domain of the ER to the plasma membrane (PM). Unlike 
glycerophospholipids, various molecular forms of the neutral lipids triacylglycerols (TG) cannot be moved from the 
site of their synthesis in the ER to either mitochondria or the PM. Reproduced from 
62
. 
 With the role of the mitochondria in regulating lipid homeostasis within the 
mitochondria, ER, and the PM in mind, it was hypothesized that by inhibiting the ability of yeast 
cells to eliminate morphologically distinct, dysfunctional, or oxidatively damaged mitochondria 
through the deletion of Atg32p, yeast lipid homeostasis could be distorted. One could therefore 
expect that the atg32Δ-dependent mutational block of macromitophagy may alter membrane 
lipid composition not only in mitochondria but also in the ER and the PM.  
 The validity of this hypothesis was validated using mass spectrometry to compare the 
membrane lipidomes of mitochondria, ER and PM purified from WT and atg32Δ cells that were 
cultured under CR on 0.2% glucose and recovered on day 1, 2 or 4 of culturing. It was observed 
that the atg32Δ mutation altered the levels of several membrane lipid species in mitochondria, 
ER and PM. Additionally, the effect of atg32Δ on the membrane lipidomes of mitochondria, the 
ER, and the PM was different in cells recovered on day 1, 2 or 4 of culturing  - indicating the 
effects are age-related (Figure 15).    
 In cells recovered at logarithmic growth phase (day 1), the atg32Δ mutation (I) increased 
the levels of PE (a glycerophospholipid delivered to the ER after its synthesis in the IMM) in 
mitochondria and the PM, and reduced its level in the ER; (II) lowered the level of CL (a 
mitochondrially synthesized and accumulated glycerophospholipid) in mitochondria; (III) 
decreased the level of PC (a glycerophospholipid synthesized in the ER membrane and then 
delivered to other membranes) in the PM, but did not alter its abundance in mitochondria or the 
ER; (IV) elevated the levels of PI (a glycerophospholipid synthesized in the ER membrane and 
then delivered to other membranes) in mitochondria and the ER, but did not alter its abundance 
in the PM;  (V) lowered the level of TAG (neutral lipid species synthesized in the ER but not in 
mitochondria or the PM) in the ER; and (VI) did not affect the levels of PA and PS (two 
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glycerophospholipids synthesized in the ER membrane and then delivered to other membranes) 
in mitochondria, the ER and the PM (Figure 15 A, D, G).       
          Furthermore, in cells recovered at diauxic growth phase on day 2, the atg32Δ mutation (I) 
reduced the level of PE in the ER membrane but not in mitochondria or the PM; (II) elevated the 
level of CL in mitochondria; (III) decreased the levels of PC in mitochondria and the PM, but did 
not alter its abundance in the ER; (IV) reduced the level of PI in mitochondria and elevated the 
level of this glycerophospholipid in the ER, but did not alter its abundance in the PM; (V) 
lowered the level of TAG in the ER; (VI) increased the level of PA in the ER membrane, but did 
not alter its abundance in mitochondria or the PM; and (VII) reduced the level of PS in the ER 
and elevated the level of this glycerophospholipid in the PM, but did not alter its abundance in 
mitochondria (Figure 15 B, E and H).       
          Moreover, in cells recovered at post-diauxic growth phase on day 4, the atg32Δ mutation 
(I) elevated the levels of PE in mitochondria and the PM, and reduced its abundance in the ER; 
(II) decreased the level of CL in mitochondria; (III) reduced the level of PC in the ER and 
increased the level of this glycerophospholipid in the PM, but did not alter its abundance in 
mitochondria; (IV) lowered the levels of PI in mitochondria and the ER, but did not alter its 
abundance in the PM; (V) did not alter the level of TAG in the ER; (VI) elevated the levels of 
PA in mitochondria and the ER, and reduced its abundance in the PM; and (VII) decreased the 
level of PS in mitochondria, but increased the levels of this glycerophospholipid in the ER and 
the PM (Figure 15 C, F, I). 
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Figure 15 - Under CR conditions, the atg32Δ mutation alters levels of several membrane lipid species in 
mitochondria, the ER and the PM. WT and atg32Δ strains were cultured in the nutrient-rich YP medium initially 
containing 0.2% glucose. Mitochondria, the ER and the PM were purified from WT and atg32Δ cells recovered on 
day 1, 2 or 4 of culturing. Following extraction of membrane lipids from purified mitochondria, ER and PM, various 
lipid species were identified and quantitated by mass spectrometry as described in Methods. Data are presented as 
means ± SEM (n = 3; *p < 0.01; ns, not significant). Reproduced from 
62
. 
 Altogether, these findings imply that under CR conditions macromitophagy is essential 
for sustaining the homeostasis of membrane lipids in mitochondria, the ER and the PM. It is 
plausible that the observed in macromitophagy-deficient atg32Δ cells age-related changes in the 
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membrane lipidomes of mitochondria, the ER and the PM may shorten yeast longevity by 
establishing a pro-aging cellular pattern. 
 
4.4 Discussion 
 The observed age-related changes in the membrane lipidomes of mitochondria, the ER 
and the PM of the atg32Δ mutant imply that macromitophagy selectively eliminates 
mitochondria exhibiting an imbalance of their membrane lipidome. This is perhaps due to age-
associated alterations in the synthesis, stability and/or oxidative state of some lipid species. 
Because mitochondria are convolutedly integrated into a network governing lipid dynamics not 
only within these organelles but also within the ER and the PM (Figure 14), it is reasonable to 
assume that the inability of macromitophagy-deficient atg32Δ cells to eliminate mitochondria 
exhibiting such an age-related imbalance of their membrane lipidome (I) can also compromise 
lipid metabolism and transport in the ER and the PM; and (II) could be responsible for the 
changes in the membrane lipidomes of the mitochondria, ER, and PM observed in atg32Δ cells. 
 Based on these observations,  a working model for the mechanism underlying the age-
dependent alteration to lipid synthesis in the ER and mitochondria was formulated (Figure 16). 
During logarithmic growth phase, lipid synthesis and transport is remodelled in atg32Δ cells 
leading to the following changes in the membrane lipidomes of mitochondria, the ER and the 
PM: (I) an activated conversion of PS into PE in the IMM and a simultaneous inhibition of PE 
transport from mitochondria to the MAM domain of the ER via mitochondria-ER (MAM) 
junctions elevate PE concentration in mitochondria and reduce its concentration in the ER; (II) 
an activated synthesis of PI from CDP-DAG in the MAM domain of the ER, along with an 
activation of PI transport from this ER domain to mitochondria via mitochondria-ER (MAM) 
junctions, rise PI concentration in both mitochondria and the ER; (III) an inhibition of 
TAGsynthesis from PA in the MAM domain of the ER reduces TAGconcentration in this 
organelle; (IV) an inhibition of CL synthesis from CDP-DAG in the IMM is responsible for the 
observed decline of CL concentration in mitochondria; (V) an activated transport of PE from the 
PAM domain of the ER to the PM via PM-ER (PAM) junctions increases PE concentration in the 
PM; and (VI) an inhibition of PC transport from the PAM domain of the ER to the PM via PM-
ER (PAM) junctions reduces PC concentration in the PM (Figure 16A). During diauxic growth 
phase, atg32Δ cells undergo a remodelling of lipid synthesis and transport causing the following 
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alterations to membrane lipid concentrations in mitochondria, the ER and the PM: (I) an 
inhibited conversion of CDP-DAG into PS in the MAM domain of the ER and an inhibition of 
PE transport from mitochondria to this ER domain via mitochondria-ER (MAM) junctions 
reduce the concentrations of both PS and PE in the ER; (II) an inhibition of PC transport from 
the MAM domain of the ER to mitochondria via mitochondria-ER (MAM) junctions lowers the 
concentration of this glycerophospholipid in mitochondria; (III) an inhibited transport of PI from 
the MAM domain of the ER to mitochondria via mitochondria-ER (MAM) junctions reduces PI 
concentration in mitochondria and rises its level in the ER; (IV) an activation of CL synthesis 
from CDP-DAG in the IMM leads to the observed increase of CL concentration in mitochondria; 
(V) an inhibited conversion of PA into TAG in the MAM domain of the ER is responsible for the 
observed rise of PA and decline of TAGconcentrations in this organelle; (VI) an activated 
transport of PS from the PAM domain of the ER to the PM via PM-ER (PAM) junctions 
increases its concentration in the PM; and (VI) an inhibition of PC transport from the PAM 
domain of the ER to the PM via PM-ER (PAM) junctions reduces PC level in the PM (Figure 
16B). During post-diauxic growth phase, a remodelling of lipid synthesis and transport in atg32Δ 
cells alters the membrane lipidomes of mitochondria, the ER and the PM as follows: (I) an 
inhibition of PS transport from the MAM domain of the ER to mitochondria and a simultaneous 
inhibition of PE transport in the opposite direction via mitochondria-ER (MAM) junctions, along 
with an activated conversion of PS into PE in the IMM, not only rise the concentrations of PS in 
the ER and PE in mitochondria but also reduce the levels of PE in the ER and PS in 
mitochondria; (II) an inhibited synthesis of PC from PE in the MAM domain of the ER lowers 
PC concentration in this organelle; (III) an inhibition of the conversion of CDP-DAG into PI in 
the MAM domain of the ER reduces PI levels both in the ER and in mitochondria; (IV) an 
inhibited synthesis of CL from CDP-DAG in the IMM lowers CL concentration in mitochondria; 
(V) an activated transport of PS, PE and PC from the PAM domain of the ER to the PM via PM-
ER (PAM) junctions increases their concentrations in the PM; and (VI) an inhibition of PA 
transport from the PAM domain of the ER to the PM via PM-ER (PAM) junctions not only 
reduces PA level in the PM but may also be responsible for the observed rise of PA 
concentrations in the ER and mitochondria (Figure 16C).               
          It has been previously established that the spatiotemporal dynamics of lipid synthesis, 
deposition and degradation play an essential role in longevity regulation in evolutionarily distant 
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organisms, including yeast 
13,32,37,102
. Therefore it is possible that these observed age-related 
alterations in these organellar lipidomes, and especially those seen in the short-lived atg32Δ 
mutant may lead to the establishment of a pro-aging cellular pattern and may ultimately shorten 
yeast longevity.  
  
4.5 Conclusion 
 In conclusion it has now been established that macromitophagy is a longevity assurance 
process that is crucial to the beneficial effects of CR and LCA on yeast CLS. In addition to this 
we showed perhaps the first evidence that macromitophagy is necessary for maintaining normal 
lipid homeostasis in a variety of organellar membranes. We concluded that macromitophagy 
defines yeast longevity by modulating vital cellular processes inside and outside of 
mitochondria.  
 In the future, it would be important to identify longevity-defining cellular processes that 
are responsive to the observed in atg32Δ cells alterations in the repertoires of membrane lipids 
constituting mitochondria, the ER and the PM. These cellular processes may include (I) a 
mitochondria-controlled, age-related mode of apoptotic cell death known to be modulated in 
response to changes in CL concentration within the IMM 
103,104
; and (II) a non-selective pathway 
of macroautophagy shown to be responsive to certain alterations in lipid metabolism within and 







Figure 16 - A working model for a mechanism that in atg32Δ cells underlies the spatiotemporal dynamics of age-
related changes in lipid synthesis in the ER and mitochondria as well as in lipid transport via mitochondria-ER 
(MAM) and PM-ER (PAM) junctions. During logarithmic (A), diauxic (B) and post-diauxic (C) phases of growth 
under CR conditions, a remodelling of lipid synthesis and transport in atg32Δ cells alters the membrane lipidomes of 
mitochondria, the ER and the PM. From the data of lipidomic analysis, we inferred an outline of lipid synthesis and 
transport processes that were activated (red arrows) or inhibited (blue arrows) by the atg32Δ-dependent mutational 
block of macromitophagy; the thickness of these arrows correlates with the rates of the processes taking place in 
atg32Δ cells. Arrows next to the names of lipid species denote those of them whose concentrations are elevated (red 
arrows) or reduced (blue arrows) in atg32Δ cells. Reproduced from 62. 
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5. Macromitophagy, neutral lipid synthesis and peroxisomal fatty acid oxidation protect 
yeast from “liponecrosis”, a previously unknown form of programmed cell death  
 
 
5.1 Abstract  
 We identified a form of cell death called liponecrosis (see chapter 4). It can be elicited by 
an exposure of the yeast Saccharomyces cerevisiae to exogenous palmitoleic acid (POA). Our 
data imply that liponecrosis is (I) a programmed, regulated form of cell death rather than an 
accidental, unregulated cellular process; and (II) an age-related form of cell death. Cells 
committed to liponecrotic death: (I) do not exhibit features characteristic of apoptotic cell death; 
(II) do not display plasma membrane rupture, a hallmark of programmed necrotic cell death; (III) 
akin to cells committed to necrotic cell death, exhibit an increased permeability of the plasma 
membrane for propidium iodide; (IV) do not display excessive cytoplasmic vacuolization, a 
hallmark of autophagic cell death; (V) akin to cells committed to autophagic death, exhibit a 
non-selective en masse degradation of cellular organelles and require the cytosolic 
serine/threonine protein kinase Atg1p for executing the death program; and (VI) display a 
hallmark feature that has not been reported for any of the currently known cell death modalities – 
namely, an excessive accumulation of lipid droplets where non-esterified fatty acids (including 
POA) are deposited in the form of neutral lipids. We therefore concluded that liponecrotic cell 
death subroutine differs from the currently known subroutines of PCD. Our data suggest a 
hypothesis that liponecrosis is a cell death module dynamically integrated into a so-called PCD 
network, which also includes the apoptotic, necrotic and autophagic modules of PCD. Based on 
our findings, we propose a mechanism underlying liponecrosis.  
  
5.2 Introduction 
 In multicellular organisms, the homeostasis of cell number in various tissues and in the 
entire organism is sustained via a regulated balance between the fundamental biological 
processes of cell division, cell differentiation and PCD. PCD refers to a genetically programmed, 
regulated form of cell death - as opposed to an accidental, unregulated cellular process 
34
. As a 
genetically programmed, regulated cellular process, a PCD subroutine should be intensified or 




. Furthermore, a PCD subroutine should be a cellular process comprised of a 
cascade of consecutive cellular events initiated in response to a certain stimulus, following each 
other in a certain order and orchestrated by a certain signaling pathway or network 
34,108
. 
Moreover, a PCD subroutine should be a cellular process that provides a certain benefit for 
development, survival and/or stress resistance of a cell population or an organism 
34,108
. Several 
PCD subroutines are presently known; these subroutines have different underlying mechanisms, 
exhibit different morphological and biochemical traits, and are orchestrated by different 
(although partially overlapping) signaling pathways 
34,108
. The initial classification of various 
types of PCD into apoptosis, autophagic cell death and necrosis was based mostly on 




The most recent classification of PCD subroutines is based on a combination of numerous 
morphological and biochemical traits typical of each of them; the well-characterized PCD 
subroutines include extrinsic apoptosis, caspase-dependent or -independent intrinsic apoptosis, 
regulated necrosis, autophagic cell death and mitotic catastrophe.
3
 Some of the currently known 
PCD subroutines are characterized in much less details with respect to their morphological traits 
and biochemical features; these other PCD subroutines include anoikis, excitotoxicity, Wallerian 




Molecular mechanisms underlying these PCD subroutines and integrating them into a PCD 
network remain to be established. 
 The use of yeast as a model organism in cell death research has already greatly 
contributed to the current understanding of the molecular and cellular mechanisms underlying 
various PCD subroutines 
109–115
. We recently demonstrated that a short-term exposure of yeast 




In this study we 
provide evidence that POA-induced cell death in yeast is an age-related subroutine of genetically 
programmed, regulated cell death rather than an accidental, unregulated cellular process. We 
concluded that POA-induced cell death is a PCD subroutine because: (I) it is intensified or 
attenuated by genetic manipulations that eliminate only certain proteins involved in maintaining 
functional mitochondria, metabolizing lipids or macroautophagically degrading cellular 
constituents; and (II) it represents a cascade of consecutive cellular events that are initiated in 
response to POA and follow each other in a certain order. We call this previously unknown PCD 
subroutine “liponecrosis”. Based on our findings, we propose a model for molecular mechanisms 
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underlying liponecrosis. Our data suggest that liponecrosis represents a cell death module 
dynamically integrated into a so-called PCD network; this network also includes the apoptotic, 
necrotic and autophagic modules of PCD. 
 
5.3 Materials and Methods 
 
Yeast strains, media and growth conditions 
 The wildtype strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 lys20 
ura30) as well as the single-gene-deletion mutant strains atg1Δ (MAT his31 leu20 lys20 
ura30 atg1::kanMX4), atg32Δ (MAT his31 leu20 lys20 ura30 atg32::kanMX4), 
are2Δ (MAT his31 leu20 lys20 ura30 are2::kanMX4), cyc3Δ (MAT his31 leu20 
lys20 ura30 cyc3::kanMX4), dga1Δ (MAT his31 leu20 lys20 ura30 dga1::kanMX4) 
and fox1Δ (MAT his31 leu20 lys20 ura30 fox1::kanMX4) in the BY4742 genetic 
background (all from Thermo Scientific/Open Biosystems) were grown in YP medium (1% yeast 
extract, 2% peptone; both from Fisher Scientific; #BP1422-2 and #BP1420-2, respectively) 
initially containing 0.2% glucose (#D16-10; Fisher Scientific) as carbon source. Cells were 
cultured at 30
oC with rotational shaking at 200 rpm in Erlenmeyer flasks at a “flask 
volume/medium volume” ratio of 5:1. 
 
Cell viability assay for monitoring the susceptibility of yeast to a mode of cell death induced 
by palmitoleic acid (POA)  
 A sample of cells was taken from a culture at days 1, 2 and 4 of culturing. A fraction of 
the sample was diluted in order to determine the total number of cells using a hemacytometer. 8 
× 10
7
 cells were harvested by centrifugation for 1 min at 21,000 × g at room temperature and 
resuspended in 8 ml of YP medium containing 0.2% glucose as carbon source. Each cell 
suspension was divided into 8 equal aliquots. Three pairs of aliquots were supplemented with 
POA (#P9417; Sigma) from a 50 mM stock solution (in 10% chloroform, 45% hexane and 45% 
ethanol; #650498, #248878 and #34852, respectively; all from Sigma). The final concentration 
of POA was 0.05 mM, 0.1 mM or 0.15 mM for each pair of aliquots; in all these aliquots, the 
final concentrations of chloroform, hexane and ethanol were 0.03%, 0.135% and 0.135%, 
respectively. One pair of aliquots was supplemented only with chloroform, hexane and ethanol 
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added to the final concentrations of 0.03%, 0.135% and 0.135%, respectively. All aliquots were 
then incubated for 2 h at 30
o
C on a Labquake rotator (#400110; Thermolyne/Barnstead 
International) set for 360
o
 rotation. Serial dilutions of cells were plated in duplicate onto plates 
containing YP medium with 2% glucose as carbon source. After 2 d of incubation at 30
o
C, the 
number of colony forming units (CFU) per plate was counted. The number of CFU was defined 
as the number of viable cells in a sample. For each aliquot of cells exposed to POA, the % of 
viable cells was calculated as follows: (number of viable cells per ml in the aliquot exposed to 
POA/number of viable cells per ml in the control aliquot that was not exposed to POA) × 100. 
 
Cell viability assay for monitoring the susceptibility of yeast to a mode of cell death induced 
by hydrogen peroxide  
 A sample of cells was taken from a culture at days 1, 2 and 4 of culturing. A fraction of 
the sample was diluted in order to determine the total number of cells using a hemacytometer. 8 
× 10
7
 cells were harvested by centrifugation for 1 min at 21,000 × g at room temperature and 
resuspended in 8 ml of YP medium containing 0.2% glucose as carbon source. Each cell 
suspension was divided into 8 equal aliquots. Three pairs of aliquots were supplemented with 
hydrogen peroxide (#H325-500; Fisher Scientific) to the final concentration of 0.5 mM, 1.5 mM 
or 2.5 mM for each pair. One pair of aliquots remained untreated. All aliquots were then 
incubated for 2 h at 30
o
C on a Labquake rotator (#400110; Thermolyne/Barnstead International) 
set for 360
o
 rotation. Serial dilutions of cells were plated in duplicate onto plates containing YP 
medium with 2% glucose as carbon source. After 2 d of incubation at 30
o
C, the number of CFU 
per plate was counted. The number of CFU was defined as the number of viable cells in a 
sample. For each aliquot of cells exposed to hydrogen peroxide, the % of viable cells was 
calculated as follows: (number of viable cells per ml in the aliquot exposed to hydrogen 
peroxide/number of viable cells per ml in the control aliquot that was not exposed to hydrogen 
peroxide) × 100. 
 
Miscellaneous procedures  
 BODIPY 493/503 (4,4-Difluoro-1,3,5,7,8-Pentamethyl-4-Bora-3a,4a-Diaza-s-Indacene; 
#D-3922; Life Technologies/Molecular Probes) staining for monitoring neutral lipids deposited 
in lipid droplets, DAPI (4′,6-Diamidino-2-phenylindole dihydrochloride; #D-9542; Sigma) 
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staining for visualizing nuclei,
 
Annexin V (#630109; Clontech Laboratories, Inc.) staining for 
visualizing externalized phosphatidylserine (PS),
 
and propidium iodide (PI; #P3566; Life 
Technologies/Molecular Probes) staining for visualizing the extent of plasma membrane 
permeability for small molecules
 
were performed according to established procedures 
117,118
. 
Fluorescence and electron microscopies followed by morphometric analyses of the resulting 





Statistical analysis was performed using Microsoft Excel’s (2010) Analysis ToolPack-VBA. All 





5.4.1 Macromitophagy protects yeast from a mode of cell death triggered by exogenous 
palmitoleic fatty acid (POA) 
 An exposure of wildtype (WT) yeast cells to exogenous POA has been demonstrated to 
induce cell death, thereby significantly reducing clonogenic survival of these cells in a POA 
concentration-dependent manner 
27,116
. Noteworthy, the pex5Δ mutation previously known for its 
ability to impair peroxisomal fatty acid oxidation 
119
 has been recently demonstrated not only to 
greatly reduce mitochondrial functionality but also to enhance the susceptibility of yeast to a 
form of cell death elicited by a brief exposure to exogenous POA 
27
. This finding suggested that 
the maintenance of a healthy population of functional mitochondria might protect yeast from 
POA-induced cell death modality. Macromitophagy, a selective macroautophagic degradation of 
dysfunctional mitochondria, is known to sustain such healthy population of functional 
mitochondria in chronologically aging yeast cells 
62
. We therefore sought to investigate the 
importance of macromitophagy in protecting yeast from a mode of cell death triggered by 
exogenous POA. To attain this objective, we used the single-gene-deletion mutant strain atg32Δ. 
Because this mutant strain lacks a mitochondrial receptor for macromitophagy, it is known to be 
impaired only in the mitophagy pathway but not in other pathways of selective or non-selective 
macroautophagy 
84,120
. We found that the atg32Δ mutation significantly reduces clonogenic 
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survival of yeast cells briefly exposed to various concentrations of POA (Figure 17A-C). This 
indicated that by removing dysfunctional mitochondria, macromitophagy is a longevity 
assurance process that protects yeast from a form of cell death triggered by this monounsaturated 
fatty acid. Of note, the susceptibility of both WT and atg32Δ cells to a death mode elicited by 
exogenous POA increased with the chronological age of these cells (Figure 17A-C). Because the 
degree to which this death mode reduces cell viability appears to progress with the chronological 
age of a yeast cell, we concluded that it is an age-related modality of cell death. 
 Noteworthy, it was demonstrated that the atg32Δ mutation also significantly reduced 
clonogenic survival of yeast cells following their short-term (for 2 h) exposure to various 
concentrations of exogenous hydrogen peroxide (Figure 17D-F). The susceptibility of WT cells 
to a death mode elicited by exogenous hydrogen peroxide decreased with the chronological age 
of these cells, whereas the opposite trend was seen for chronologically aging atg32Δ cells 
(Figure 17D-F). Hence, a selective macroautophagic degradation of dysfunctional mitochondria 
protects yeast from an age-related form of cell death triggered by exogenous hydrogen peroxide.   
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Figure 17 Deletion of Atg32p increases yeast susceptibility to cell death induced by palmitoleic acid (POA) and 
hydrogen peroxide. By removing dysfunctional mitochondria, macromitophagy protects yeast from age-related 
forms of cell death elicited by a short-term exposure to exogenous POA or hydrogen peroxide. WT and atg32Δ cells 
were recovered at days 1, 2 and 4 of culturing in a nutrient-rich YP medium initially containing 0.2% glucose as 
carbon source. Cell survival was assessed by measuring the clonogenicity of WT and atg32Δ cells after 2 h of 




5.4.2 POA induces “liponecrosis”, a mode of cell death that differs from apoptotic, 
regulated necrotic and autophagic cell death subroutines 
 To provide a mechanistic insight into the demonstrated essential role of macromitophagy 
in protecting yeast from a POA-induced mode of cell death, we used electron and fluorescence 
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microscopies (EM and FM, respectively) to examine WT and atg32Δ cells exposed to various 
concentration of this monounsaturated fatty acid. Our objectives were: (I) to define 
morphological traits characteristic of the cell death subroutine triggered by exogenous POA; and 
(II) to compare these traits to the well-established 
108–111,122
 morphological features of the 
currently known apoptotic, regulated necrotic and autophagic cell death modalities.  
 We found that only minor fractions of WT and atg32Δ cells treated with various 
concentrations of POA exhibit such characteristic traits of a mitochondria-controlled mode of 
apoptotic cell death as nuclear fragmentation and phosphatidylserine (PS) translocation from the 
inner to the outer leaflet of the plasma membrane (Figure 18A, Figure 19A, Figure 20A,B). 
Thus, the mode of cell death elicited by the exposure of both WT and an atg32Δ strain to 
exogenous POA is not an apoptotic cell death subroutine. 
 Of note, significant portions of WT and atg32Δ cells exposed to exogenous hydrogen 
peroxide displayed fragmented nucleus and externalized PS (Figure 18B, Figure 20A, Figure 
20A,B). Although the percentages of both WT and atg32Δ cells exhibiting these hallmarks of the 
apoptotic cell death subroutine following treatment with hydrogen peroxide were proportional to 
its concentration, the atg32Δ mutation significantly increased the fraction of such cells (Figure 
18B, Figure 19A, Figure 20A,B). In sum, these microscopic analyses imply that (I) a short-term 
exposure of both WT and atg32Δ cells to exogenous hydrogen peroxide added at the 
concentrations ranging from 0.5 mM to 2.5 mM triggers an apoptotic form of cell death; and (II) 
macromitophagy protects yeast from this form of cell death.    
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Figure 18 Morphological traits characteristic of the cell death subroutines triggered by a short-term exposure to 
exogenous POA or hydrogen peroxide. WT and atg32Δ cells were recovered at day 1 of culturing in a nutrient-rich 
YP medium initially containing 0.2% glucose as carbon source. Transmission electron micrographs of WT and 
atg32Δ cells after 2 h of treatment with various concentrations of exogenous POA (A) or hydrogen peroxide (B) are 




 Furthermore, our EM analysis revealed that WT and atg32Δ cells treated with various 
concentrations of POA do not exhibit rupture of the plasma membrane (Figure 18A, Figure 19B), 
a hallmark trait of a necrotic mode of PCD 
109,123
. However, our FM analysis demonstrated that 
significant portions of WT and atg32Δ cells exposed to exogenous POA display propidium 
iodide (PI) positive staining (Figure 20C). This staining pattern is characteristic of a significantly 
increased permeability of the plasma membrane for PI and other small molecules, a hallmark 
trait of a necrotic mode of PCD 
109,123
. Altogether, these EM and FM analyses demonstrate that a 
form of cell death triggered by an exposure of both WT and atg32Δ cells to exogenous POA is 
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not a typical necrotic cell death subroutine. Indeed: (I) unlike conventional necrotic cell death, 
this POA-induced form of cell death does not lead to plasma membrane rupture; but (II) akin to 
conventional necrotic cell death, this POA-induced form of cell death significantly increases 
plasma membrane permeability for PI and other small molecules. 
 
Figure 19 Percentage of WT and atg32Δ cells that display nuclear fragmentation (A), plasma membrane rupture (B), 
LD accumulation (C) or lack of all cellular organelles (D). WT and atg32Δ cells were recovered at days 1, 2 and 4 of 
culture in a nutrient-rich YP medium initially containing 0.2% glucose as carbon source. Transmission electron 
micrographs of WT and atg32Δ cells after 2 h of treatment with various concentrations of exogenous POA or 
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hydrogen peroxide were used for morphometric analysis; at least 100 cells of each strain were used for 




Figure 20 Percentage of WT and atg32Δ cells that display nuclear fragmentation (A), phosphatidylserine (PS) 
externalization (B), and propidium iodide (PI) positive staining (C) or LD accumulation (D). WT and atg32Δ cells 
were recovered at days 1, 2 and 4 of culturing in a nutrient-rich YP medium initially containing 0.2% glucose as 
carbon source. Fluorescence microscopy images of cells stained with DAPI (A), Annexin V (B), PI (C) or BODIPY 
493/503 (D) were used for morphometric analysis; at least 800 cells of each strain were used for quantitation at each 
time-point. Data are presented as means ± SEM (n = 3; *p < 0.01). Reproduced from 
121
. 
 Importantly, our EM and FM analyses uncovered that WT cells treated with various 
concentrations of POA exhibit an excessive accumulation of lipid droplets (LD) (Figure 18A, 
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Figure 19C and Figure 20D); LD are known to serve as a deposition site for stockpiling non-
esterified (“free”) fatty acids and sterols in the forms of triacylglycerols (TAG) and ergosteryl 
esters (EE), the two major neutral lipids synthesized in the endoplasmic reticulum 
37,124
. This 
hallmark morphological feature of a POA-induced form of cell death has not been reported for 
any of the currently known apoptotic, regulated necrotic and autophagic cell death modalities 
108–
111,122,125
. We therefore concluded that POA triggers a previously unknown form of cell death in 
yeast. We call this novel cell death modality “liponecrosis”. 
 
5.4.3 Macromitophagy, functional mitochondria and neutral lipids synthesis protect yeast 
from liponecrotic cell death elicited by POA 
 It should be stressed that the atg32Δ-dependent mutational block of macromitophagy 
abolished the accumulation of LD in yeast cells committed to liponecrotic death triggered by cell 
exposure to POA (Figure 18A, Figure 19C and Figure 20D). Moreover, the atg32Δ mutation also 
significantly reduced clonogenic survival of yeast cells exposed to this monounsaturated fatty 
acid (Figure 17A, B, C). Based on these findings, we hypothesized that (I) the excessive 
accumulation of LD, a deposition site for stockpiling non-esterified fatty acids (including POA), 
protects yeast from a liponecrotic mode of cell death; (II) functional mitochondria are required 
for such accumulation of LD, likely because these organelles provide energy needed for a pro-
survival process of depositing non-esterified fatty acids (including POA) within LD; and (III) 
macromitophagy protects yeast cells from liponecrotic death by sustaining a healthy population 
of functional mitochondria capable of providing energy for depositing non-esterified fatty acids 
(including POA) within LD. In support of this hypothesis, we found that the single-gene-deletion 
mutations dga1Δ and are2Δ reduce clonogenic survival of yeast cells committed to POA-induced 
liponecrotic death (Figure 21A, B); these two mutations are known to attenuate LD formation by 
eliminating redundant enzymes involved in the synthesis of TAG and EE (respectively), the two 
major neutral lipids synthesized in the ER 
124
. Furthermore, this hypothesis is also supported by 
our observation that the single-gene-deletion mutation cyc3Δ reduces clonogenic survival of 
yeast cells committed to liponecrotic death triggered by POA (Figure 21A, B); this mutation is 
known to abolish mitochondrial respiration by eliminating cytochrome c heme lyase and thereby 




 In sum, these findings validate our hypothesis that macromitophagy protects yeast cells 
from liponecrosis by maintaining a healthy population of functional mitochondria capable of 
providing energy that is needed for a pro-survival process of depositing non-esterified fatty acids 
(including POA) within LD. 
 
Figure 21 WT, dga1Δ, are2Δ, cyc3Δ and fox1Δ cells were recovered at days 1, 2 and 4 of culturing in a nutrient-rich 
YP medium initially containing 0.2% glucose as carbon source. Cell survival was assessed by measuring the 





5.4.4 Peroxisomal fatty acid oxidation protects yeast from liponecrotic cell death triggered 
by POA 
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 We previously demonstrated that the single-gene-deletion mutation pex5Δ decreases 
clonogenic survival of yeast cells exposed to POA 
27
; this mutation is known to impair 
peroxisomal import of the first two enzymes of the fatty acid β-oxidation pathway 119, thereby 
decelerating a conversion of immature (dysfunctional) peroxisomal precursors to mature 
(functional) peroxisomes 
127
. We therefore hypothesized that β-oxidation of non-esterified fatty 
acids (including POA) within functional peroxisomes may protect yeast from liponecrotic cell 
death by operating as a pro-survival process of reducing the cellular level of POA. In support of 
this hypothesis, we found that the single-gene-deletion mutation fox1Δ reduces clonogenic 
survival of yeast committed to POA-induced liponecrotic death (Figure 21D); this mutation is 
known to eliminate the first enzyme of the fatty acid β-oxidation pathway, thereby abolishing β-




5.4.5 Non-selective macroautophagy executes liponecrotic cell death elicited by POA 
 Our EM analysis revealed that an exposure of WT cells to various concentrations of POA 
caused a POA concentration-dependent rise in the fraction of cells lacking all cellular organelles 
(Figure 18, Figure 19D). Importantly, we found that the atg32Δ mutation significantly increases 
the portion of such organelle-less cells that are committed to POA-induced liponecrotic death 
(Figure 18, Figure 19D). Of note, the percentages of WT and atg32Δ cells lacking all cellular 
organelles following an exposure to POA increased with the chronological age of these cells 
(Figure 18, Figure 19D). Based on these findings, we hypothesized that a non-selective en masse 
degradation of cellular organelles executes a liponecrotic form of cell death. This hypothesis is 
supported by our observation that the single-gene-deletion mutation atg1Δ increases clonogenic 
survival of yeast cells committed to liponecrotic death triggered by POA (Figure 22A-C). This 
mutation is known to abolish all pathways of non-selective and selective autophagic degradation 
of cellular organelles and macromolecules in yeast cells by eliminating a cytosolic 
serine/threonine protein kinase that governs these pathways 
128
. We therefore concluded that 
liponecrosis is an age-related form of PCD that is executed by a non-selective en masse 
autophagic degradation of cellular organelles and macromolecules in a process orchestrated by 
the cytosolic serine/threonine protein kinase Atg1p.      
 Of note, unlike the effect of atg1Δ on POA-elicited liponecrotic cell death, this mutation 
significantly reduced clonogenic survival of yeast cells following an exposure to various 
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concentrations of exogenous hydrogen peroxide (Figure 22D-F). This study demonstrated that a 
short-term exposure of yeast to exogenous hydrogen peroxide added at the concentrations 
ranging from 0.5 mM to 2.5 mM triggers an apoptotic form of cell death (see above). Thus, 
although a non-selective en masse autophagic degradation of cellular organelles and 
macromolecules executes an orchestrated by Atg1p form of POA-induced liponecrotic cell death, 
such degradation operates as a pro-survival process in yeast committed to apoptotic death that is 




Figure 22 A non-selective en masse autophagic degradation of cellular organelles and macromolecules executes an 
orchestrated by Atg1p form of POA-induced liponecrotic cell death, whereas such degradation operates as a pro-
survival process in yeast committed to apoptotic death that is triggered by cell exposure to exogenous hydrogen 
peroxide. WT and atg1Δ cells were recovered at days 1, 2 and 4 of culturing in a nutrient-rich YP medium initially 
containing 0.2% glucose as carbon source. Cell survival was assessed by measuring the clonogenicity of WT and 
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 This study revealed a previously unknown form of cell death, which we call 
“liponecrosis”.  Liponecrosis is initiated in response to a short-term exposure of yeast to 
exogenous POA, a monounsaturated fatty acid. We demonstrate that (I) mutations eliminating 
certain proteins involved in maintaining functional mitochondria, metabolizing lipids and 
macroautophagically degrading cellular constituents either enhance or attenuate liponecrosis; and 
(II) liponecrosis is a cascade of consecutive cellular events that are initiated in response to POA 
and follow each other in a certain order. Thus, akin to apoptotic, regulated necrotic and 
autophagic cell death modalities,
108,110,111,123,125
  liponecrosis is a programmed, regulated form of 
cell death rather than an accidental, unregulated cellular process. Moreover, liponecrosis is an 
age-related form of cell death. Indeed, we found that the degree to which it reduces cell viability 
progresses with the chronological age of a yeast cell.  
 Our conclusion that the liponecrotic cell death modality differs from the currently known 
apoptotic, regulated necrotic and autophagic cell death subroutines is based on the following 
findings. First, yeast cells committed to POA-induced liponecrotic death do not exhibit nuclear 
fragmentation and PS externalization; these two morphological features are known to be 
hallmarks of the apoptotic cell death subroutine 
111
. Second, yeast cells committed to POA-
induced liponecrotic death do not display plasma membrane rupture, a morphological trait 
known to be characteristic of a necrotic cell death subroutine 
109,123
. However, it should be 
stressed that liponecrosis and regulated necrosis have at least one common feature, specifically a 
significantly increased permeability of the plasma membrane for PI 
109,123
. Our unpublished data 
suggest that the abnormally high permeability of the plasma membrane for PI and other small 
molecules in yeast cells committed to POA-induced liponecrotic death is likely due to (I) a 
specific remodeling of the plasma membrane lipidome; and (II) an excessive internalization of 
phosphatidylethanolamine caused by its translocation from the outer to the inner leaflet of the 
plasma membrane (Richard et al., in preparation). Third, yeast cells committed to POA-induced 
liponecrotic death do not exhibit excessive cytoplasmic vacuolization caused by the 
accumulation of autophagosomes; this morphological trait is known to be a hallmark of the 
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autophagic cell death subroutine 
108,110,123
. Interestingly, liponecrosis and autophagic cell death 
share at least two characteristic features, including (I) a non-selective en masse degradation of 
cellular organelles; and (II) a requirement for Atg1p, a cytosolic serine/threonine protein kinase 
that orchestrates both these subroutines of PCD 
108,110,123
. Fourth, yeast cells committed to POA-
induced liponecrotic death exhibit an excessive accumulation of LD, a deposition site for 
stockpiling non-esterified fatty acids (including POA) in the form of neutral lipids. This 
characteristic morphological trait of the liponecrotic cell death subroutine has not been reported 
for any of the currently known apoptotic, regulated necrotic and autophagic cell death modalities 
108,110,111,123,125
. 
 A body of recent evidence supports the view that the individual pathways known to 
orchestrate the apoptotic, regulated necrotic and autophagic subroutines of cell death constitute 
modules that are dynamically integrated into a so-called PCD network 
115,129–135
. The concept of 
a PCD network provides a suitable explanation for the reported here and in several recent studies 
observations that (I) in response to some death triggers, in certain cell types and/or under specific 
circumstances a cell committed to a programmed death subroutine can exhibit a mix of 
morphological and biochemical traits that are characteristic of different currently known cell 
death modalities; and (II) several proteins can be actively involved in orchestrating more than 
one programmed death subroutine 
115,129–135
. From this it was hypothesized that liponecrosis is a 
previously unknown module dynamically integrated into the PCD network. In our hypothesis, 
the liponecrotic cell death module partially overlaps with three other modules comprising the 
network, namely the apoptotic, necrotic and autophagic modules of PCD.   
 
5.6 Conclusions 
 Based on our findings, we propose the following model for molecular mechanisms 
underlying liponecrosis (Figure 23). This PCD subroutine is initiated in response to an excessive 
cellular stress that is created due to an incorporation of bulk quantities of POA into POA-
containing phospholipids and the subsequent build-up of these POA-containing phospholipids in 
various cellular membranes. Our unpublished data support this hypothesis; as we found, 
excessive quantities of POA-containing phospholipids accumulate in both membranes of 
mitochondria as well as in the endoplasmic reticulum and the plasma membrane (see chapter 6). 
A non-selective en masse autophagic degradation of cellular organelles and macromolecules 
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executes the liponecrotic subroutine of PCD that is triggered by the extreme cellular stress 
caused by the excessive accumulation of POA-containing phospholipids in various cellular 
membranes (Figure 23). This autophagic execution of the liponecrotic cell death program is 
orchestrated by the cytosolic serine/threonine protein kinase Atg1p. Our model posits that 
several cellular processes play a pro-survival role in yeast exposed to POA by reducing the flow 
of POA into phospholipid synthesis pathways. These pro-survival processes protect yeast from 
liponecrosis by alleviating the excessive cellular stress caused by the build-up of POA-
containing phospholipids in various cellular membranes. One of these pro-survival processes is 
an incorporation of POA into neutral lipids that are then deposited in LD (Figure 23). Indeed, we 
found that liponecrosis can be enhanced by genetic manipulations that impair neutral lipids 
synthesis and, thus, attenuate LD formation. Our model envisions that mitochondria provide 
energy driving the pro-survival process of depositing non-esterified fatty acids (including POA) 
within LD in the form of neutral lipids (Figure 23). This assumption is based on our findings that 
liponecrosis can be enhanced by genetic manipulations that abolish mitochondrial respiration by 
impairing cytochrome c functionality or impede a selective macroautophagic degradation of 
dysfunctional mitochondria. In our model, β-oxidation of non-esterified (“free”) fatty acids 
(including POA) within functional peroxisomes also plays a pro-survival role in yeast exposed to 
POA (Figure 23). By reducing the flow of POA into phospholipid synthesis pathways, this pro-
survival process contributes to the alleviation of the excessive cellular stress that is elicited by 
the build-up of POA-containing phospholipids in various cellular membranes. Indeed, we found 
that liponecrosis can be enhanced by genetic manipulations that impair peroxisomal import of 
the first two enzymes of the fatty acid β-oxidation pathway or eliminate the first enzyme of this 
pathway normally confined to mature, functional peroxisomes. 
 Based on a unique combination of morphological traits characteristic of liponecrosis, this 
PCD modality differs from (I) a mitochondria-dependent necrotic cell death subroutine initiated 
in response to an exposure of the yeast S. cerevisiae to exogenous polyunsaturated fatty acids 
112
; 
and (II) a mitochondria-dependent, metacaspase-independent cell death subroutine exhibiting 
morphological features of both apoptosis and necrosis following an exposure of the yeast S. 
cerevisiae to exogenous membrane-permeable C2-ceramide 
136
. Moreover, unlike cells of the 
yeast S. cerevisiae committed to liponecrosis, cells of the fission yeast Schizosaccharomyces 
pombe mutant strain deficient in TAG synthesis undergo a lipoapoptotic form of death upon 
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entry into stationary phase; these cells display hallmarks of an apoptotic cell death subroutine, 
including chromatin condensation, nuclear DNA fragmentation, PS externalization and reactive 
oxygen species accumulation 
46,137
. 
 In the future, it would be important to identify other cellular processes that play essential 
pro-death or pro-survival roles in the liponecrotic cell death subroutine. These cellular processes 
may include (I) phospholipid synthesis in the endoplasmic reticulum and mitochondrial 
membranes and a bidirectional phospholipid exchange between them through membrane contact 
sites; (II) a transfer of phospholipids from the endoplasmic reticulum to the plasma membrane 
via membrane contact sites; (III) a maintenance of the non-random distribution of several 
phospholipid species within a bilayer of the plasma membrane; (IV) cellular signal transduction 
modulated by alterations in plasma membrane phospholipid asymmetry; and (V) cellular protein 
homeostasis. Another challenge for the future will be to explore mechanisms underlying the 
predicted here integration of the liponecrotic cell death module into the PCD network known to 
include the apoptotic, necrotic and autophagic modules of PCD.  
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Figure 23 A model for molecular mechanisms underlying programmed liponecrotic cell death elicited by POA. An 
incorporation of POA into POA-containing phospholipids (PL) and their consequent accumulation in various 
cellular membranes may operate as pro-death processes that create excessive cellular stress, thereby triggering 
liponecrosis. This subroutine of PCD is executed by a non-selective en masse autophagic degradation of cellular 
organelles and macromolecules in a process orchestrated by the cytosolic serine/threonine protein kinase Atg1p. 
Alternatively, in a pro-survival process POA can be incorporated into neutral lipids (neutral lipids) that are then 
deposited in lipid droplets (LD). Macromitophagy protects yeast cells from liponecrosis by maintaining a healthy 
population of functional mitochondria capable of providing energy that is needed for a pro-survival process of 
depositing non-esterified fatty acids (including POA) within LD. Moreover, in a pro-survival process POA can be 
oxidized in peroxisomes. β-oxidation of non-esterified (“free”) fatty acids (FFA; including POA) within functional 
peroxisomes protects yeast from liponecrotic cell death by operating as a pro-survival process of reducing the 





6. Mechanism of liponecrosis, a distinct mode of programmed cell death  
 
6.1 Introduction 
 We recently identified a form of PCD that differs from the currently known PCD 
subroutines, such as apoptosis, autophagic cell death and necrosis. We named this PCD 
subroutine “liponecrosis” since it can be instigated by a short-term exposure of yeast to 
exogenous palmitoleic acid (POA) 
138
. The cell death modality in this case meets all of the 
criteria established for defining a PCD subroutine 
34,108
. Specifically we discovered that 
liponecrotic PCD is a genetically programmed, regulated cellular process that can be modulated 
by genetic manipulations impairing functionality of only certain proteins. These proteins are 
important for enabling the maintenance of functional mitochondria, metabolism of certain 
molecular forms of lipids or autophagic degradation of some cellular constituents. The PCD 
modality induced by POA treatment also operates as a series of consecutive cellular processes 
that are triggered by POA and that follow each other in a certain order; and is likely to provide 
some benefits for the development and/or survival of a population of yeast cells because it 
represents an age-related mode of PCD - i.e., the degree to which it reduces cell viability 
following an exposure to POA appears to progress with the chronological age of a yeast cell 
138
. 
Additionally, yeast cells committed to liponecrotic PCD do not exhibit a combination of 
morphological traits and biochemical features characteristic of cells committed to any of the 
presently known apoptotic, autophagic or necrotic subroutines of PCD 
138
. Moreover, yeast cells 
committed to liponecrotic PCD display an excessive accumulation of lipid droplets where non-
esterified fatty acids are deposited in the form of neutral lipids; this hallmark feature of 
liponecrotic PCD has not been reported for any of the currently known PCD modalities 
138
. 
Collectively, these findings imply that liponecrosis is a mode of PCD which differs from the 
currently known ones. 
 The data presented in this chapter reflect our attempts to establish a comprehensive 
model outlining how yeast cells commit to, and ultimately execute this particular cell death 
modality. To do this, we investigated how the commitment of yeast to POA-induced liponecrotic 
PCD alters lipid compositions of various cellular membranes, impacts the asymmetrical 
distribution of phospholipids across the plasma membrane bilayer, modulates a lipid-asymmetry-
responsive signaling pathway, changes the extent of oxidative damage to cellular proteins and 
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lipids, affects the active maintenance of cellular protein homeostasis, and remodels various 
pathways for selective and non-selective autophagic degradation of “stressed”, damaged and 
dysfunctional organelles. Based on our findings, we propose a molecular mechanism underlying 
liponecrotic PCD subroutine.   
 
6.2 Materials and Methods 
 
Yeast strains and growth conditions 
The WT strain BY4742 (MATα his31 leu20 lys20 ura30) and single-gene-deletion mutant 
strains in the BY4742 genetic background (all from Thermo Scientific/Open Biosystems) were 
grown in YP medium (1% yeast extract, 2% peptone) initially containing 0.2% glucose as carbon 
source. Cells were cultured at 30
o
C with rotational shaking at 200 rpm in Erlenmeyer flasks at a 
“flask volume/medium volume” ratio of 5:1. 
 
Cell viability assay for monitoring the susceptibility of yeast to liponecrotic PCD 
A sample of cells was taken from a culture at days 1, 2 and 4 of culturing after one day of pre-
culture in the same growth medium. A fraction of the sample was diluted in order to determine 
the total number of cells using a hemacytometer. 8 × 10
7
 cells were harvested by centrifugation 
for 1 min at 21,000 × g at room temperature and resuspended in 8 ml of YP medium containing 
0.2% glucose as carbon source. Each cell suspension was divided into 8 equal aliquots. Three 
pairs of aliquots were supplemented with POA from a 50 mM stock solution (in 10% 
chloroform, 45% hexane and 45% ethanol). The final concentration of POA was 0.05 mM, 0.1 
mM or 0.15 mM for each pair of aliquots; in all these aliquots, the final concentrations of 
chloroform, hexane and ethanol were 0.03%, 0.135% and 0.135%, respectively. One pair of 
aliquots was supplemented only with chloroform, hexane and ethanol added to the final 
concentrations of 0.03%, 0.135% and 0.135%, respectively. All aliquots were then incubated for 
2 h at 30
o
C on a Labquake rotator set for 360
o
 rotation. Serial dilutions of cells were plated in 
duplicate onto plates containing YP medium with 2% glucose as carbon source. After 2 d of 
incubation at 30
o
C, the number of colony forming units (CFU) per plate was counted. The 
number of CFU was defined as the number of viable cells in a sample. For each aliquot of cells 
exposed to POA, the % of viable cells was calculated as follows: (number of viable cells per ml 
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in the aliquot exposed to POA/number of viable cells per ml in the control aliquot that was not 
exposed to POA) × 100. 
 
 Miscellaneous procedures 
Mass spectrometry based lipidomics was carried out as described previously 
139
 and described in 
detail in appendix A.3. Measurement of changes in the pH of culture medium was carried out 
according to established methods
13
. Measurement of PE level in the extracellular leaflet of the 
PM was conducted by using a cinnamycin based assay described by Ikeda et al. 
140
. 
Immunodetection of carbonyl groups of oxidatively damaged cellular proteins was carried out 
using the OxyBlot assay kit (Millipore Corp.)
141
. Oxidatively damaged lipids were measured 




 was performed as 
previously described.  
 
Statistical analysis 
Statistical analysis was performed using Microsoft Excel’s (2010) Analysis ToolPack-VBA. All 




6.3.1 The extent of POA incorporation into neutral lipids and phospholipids defines the 
susceptibility of yeast to liponecrotic PCD 
 We recently proposed a hypothesis for a mechanism that underlies liponecrotic PCD 
elicited by an exposure of yeast to exogenous POA 
138
. The hypothesis stipulated that (I) 
exogenous POA can be incorporated into membrane phospholipids that accumulate within 
various organellar membranes as well as into neutral lipids (neutral lipids) that amass in lipid 
droplets (LD); (II) exogenous POA can also be oxidized within peroxisomes; (III) an excessive 
accumulation of POA-containing phospholipids within various cellular membranes is a pro-death 
process which triggers liponecrotic PCD; (IV) both POA incorporation into neutral lipids and 
POA oxidation within peroxisomes are pro-survival processes since they prevent the buildup of 
POA-containing phospholipids within cellular membranes; and (V) mitophagy, an Atg32p-
driven selective macroautophagic degradation of dysfunctional mitochondria 
120,143
, is a pro-
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survival process which sustains a population of functional mitochondria needed for POA 
incorporation into neutral lipids and subsequent deposition of neutral lipids within LD 
138
.  
 To assess the validity of this hypothesis, mass spectrometry was used to compare the 
lipidomes of wildtype (WT) and mitophagy-deficient atg32Δ cells that were exposed to various 
concentrations of POA. It was observed that an exposure of WT cells to POA (0.05 mM) induced 
a dramatic shift in the relative proportions of neutral to polar phospholipids. Specifically, it was 
observed that POA treatment (0.05 mM) induced an increase in the relative proportion of TAG 
species, a major form of neutral lipids that are synthesized in the endoplasmic reticulum (ER) 
and then deposited within LD (Figure 24). Of interest, when WT cells were exposed to higher 
concentrations of POA (0.1 mM to 0.15 mM) the relative proportion of phospholipids to TAG 
was increased (Figure 24). Unsurprisingly, the major portion of molecular species of TAG and 
also phospholipids undergoing such characteristic changes in their levels following an exposure 
of WT cells to various concentrations of POA were their palmitoleic acid containing (C16:1) 
species (Figure 24, Figure 25). Of note, this effect was observed for all major forms of 
phospholipids, such as phosphatidic acid (PA), phosphatidylserine (PS), 
phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidylinositol (PI) and 
cardiolipin (CL) (Figure 26, Figure 27). Some of these phospholipids forms (such as PA, PS, PC 
and PI) are known to be synthesized exclusively in the ER and to be then transported to 
mitochondria via mitochondria-ER junctions and to the plasma membrane (PM) via PM-ER 
junctions 
47,67,78,94,96,139,144–146
 (Figure 28). Other forms of phospholipid (such as PE and CL) have 
been shown to be formed only in the inner membrane of mitochondria; PE is then transported 
from mitochondria to the ER via mitochondria-ER junctions and from the ER to the PM via PM-
ER junctions 
67,78,94,96,144–146
 (Figure 28).  
 Using mass spectrometry together with clonogenic survival assays, it was demonstrated 
that the concentration of exogenous POA added to WT cells is inversely related to the 
accumulation of TAG species within these cells, and that the relative level of phospholipids 
containing POA increases (Figure 26, Figure 27). This trend also correlated with the 
susceptibility of these cells to liponecrosis 
121
 (Figure 29). Taken together, the quantitative mass 
spectrometric and clonogenic survival analyses of WT cells treated with various concentrations 
of POA support the following key aspects of our hypothesis: (I) exogenous POA can be 
incorporated into phospholipids that accumulate within various cellular membranes, including 
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the ER, mitochondrial membranes and the PM (Figure 28); (II) exogenous POA can also be 
incorporated into TAG, a major form of neutral lipids that are synthesized in the ER and then 
deposited within LD (Figure 28); (III) an excessive accumulation of POA-containing 
phospholipids in the ER, mitochondrial membranes and the PM is a pro-death process which 
commits yeast to liponecrotic PCD; and (IV) an incorporation of POA into neutral lipids 
deposited within LD is a pro-survival process which protects yeast from liponecrotic PCD. 
 To assess the role of mitophagy in mitigating liponecrotic cell death, the same type of 
analyses were conducted using the atg32Δ mutant. In these analyses it was observed that 
inhibition of mitophagy (I) substantially reduced the extent to which an exposure to POA 
increases the cellular levels of all molecular species of TAG (Figure 25, Figure 24); and (II) 
significantly elevates the degree to which such an exposure increases the cellular levels of all 
molecular species of various forms of phospholipids - including POA containing species (Figure 
26, Figure 27). As mentioned in the previous chapter, the atg32Δ mutation substantially 
increases the susceptibility of yeast to POA-induced liponecrotic PCD 
138
. In sum, these findings 
support a key aspect of our hypothesis on the essential pro-survival role of Atg32p-driven 
mitophagy in protecting yeast from the liponecrotic mode of PCD. Our mass spectrometry based 
lipidomic analysis of yeast treated with various concentrations of POA suggests that mitophagy 
acts as a pro-longevity process through its ability to sustain a population of functional 
mitochondria. These functional mitochondria are required for POA incorporation into neutral 
lipids (Figure 25, Figure 24), a process that prevents the buildup of POA-containing 
phospholipids within various cellular membranes (Figure 26, Figure 27) - likely by reducing the 




 The hypothesis was further validated by examining how various single-gene-deletion 
mutations (each eliminating an enzyme involved in POA transport to the ER or in POA 
incorporation into phospholipids and/or neutral lipids within the ER) influence the susceptibility 
of yeast to POA-induced liponecrotic PCD. Importantly, all these enzymes are redundant and 
none of them is an essential protein in yeast 
78,124
. Thus, although none of these single-gene-
deletion mutations completely abolishes the incorporation of POA into phospholipids and/or 
neutral lipids, each of them causes significant changes in the cellular levels of phospholipids 
and/or neutral lipids 
78,124
. Deletion of Fat1p results in loss of a fatty acyl-CoA synthetase and 
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fatty acid transporter that activates imported fatty acids for use in the biosynthesis phosphatidic 
acid – a central metabolite in lipid metabolism 78. This mutant showed a reduction in 
susceptibility to POA-induced liponecrotic PCD (Figure 29). Deletion of Fat1p decreases the 
cellular uptake of POA and, thus, mitigates the incorporation of POA into both phospholipids 
and neutral lipids 
148
 (Figure 28). Furthermore, the gpt2Δ, ayr1Δ and ale1Δ mutations make yeast 
less susceptible to POA-induced liponecrotic PCD (Figure 29B-D); all these mutations attenuate 
POA incorporation into phospholipids 
78,124
 (Figure 28). Moreover, the dga1Δ and lro1Δ 
mutations increase the susceptibility of yeast to POA-induced liponecrotic PCD (Figure 29 E, F); 
both these mutations have been shown to decrease the incorporation of POA into TAG, a major 
form of neutral lipids 
78,124
 (Figure 28). In addition, it was recently demonstrated that the are2Δ 
mutation makes yeast more susceptible to POA-induced liponecrotic PCD 
121
. This mutation is 
known to mitigate POA incorporation into ergosteryl esters, a form of neutral lipids 
78,124
.  
 Altogether, the data of our analysis of how various single-gene-deletion mutations having 
the opposite effects on the extent of POA incorporation into phospholipids and neutral lipids 
impact the susceptibility of yeast to POA-induced liponecrotic PCD strongly support the 
proposed hypothesis that: (I) an excessive accumulation of POA-containing phospholipids in the 
ER (and then in mitochondrial membranes and in the PM) is a pro-death process which commits 
yeast to liponecrotic PCD; and (II) an incorporation of POA into neutral lipids deposited within 
LD is a pro-survival process which protects yeast from liponecrotic PCD - likely because it 
prevents the buildup of POA-containing phospholipids within various cellular membranes by 
attenuating the flow of POA into pathways for phospholipid biosynthesis and interorganellar 
transport. 
 Noteworthy, it was found that the extent to which exogenous POA alters the cellular 
levels of neutral lipids and phospholipids in WT and atg32Δ cells increases with the 
chronological age of these cells (Figure 25, Figure 26, Figure 24, Figure 27). Moreover, these 
findings imply that the degree to which the liponecrotic mode of PCD reduces cell viability 
appears to progress with the chronological age of WT and each of the single-gene-deletion 
mutant strains tested (Figure 29). Collectively, the data further support the notion that 
liponecrosis is an age-related modality of PCD 
121
.   
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Figure 24 - An exposure of WT cells to various concentrations of exogenous POA elicits differential age-dependent 
effects on the relative levels of all molecular species of phospholipids and TAG, and the atg32Δ-dependent 
mutational block of mitophagy alters these effects. WT and atg32Δ cells were recovered at days 1, 2 and 4 of 
culturing in nutrient-rich YP medium initially containing 0.2% glucose as carbon source. Extraction of cellular 
lipids, and mass spectrometric identification and quantitation of various molecular species of non-esterified (“free”) 
fatty acids (FFA), phospholipids (PL) and triacylglycerols (TAG) were carried out as described in Materials and 
Methods. The relative level of all molecular species for each lipid form (i.e., FFA, phospholipids and TAG) was 






Figure 25 - An exposure of WT cells to various concentrations of exogenous POA elicits differential age-dependent 
effects on the relative levels of C16:1 molecular species (i.e., POA-containing species) of phospholipids and TAG, 
and the atg32Δ-dependent mutational block of mitophagy alters these effects. WT and atg32Δ cells were recovered 
at days 1, 2 and 4 of culturing in nutrient-rich YP medium initially containing 0.2% glucose as carbon source. The 
relative level of POA-containing molecular species for each lipid form (i.e., FFA, phospholipids and TAG) was 
calculated as molar percentage of all these lipid forms. Data are presented as means ± SEM (n = 3; *p < 0.01; ns, not 
significant). For FFA, POA-containing molecular species are their POA-containing species. For the PA, PS, PE, PC 
and PI forms of PL, POA-containing molecular species are the C32:1, C32:2, C34:1 and C34:2 species of each of 
them. POA-containing cardiolipin species are its C64:4, C66:4, C68:4, C70:4 species. For TAG, POA-containing 
molecular species are their C48:2, C48:3, C50:2, C50:3, C52:2, C52:3 species. 
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Figure 26 - An exposure of WT cells to various concentrations of exogenous POA elicits differential age-dependent 
effects on the levels of C16:1 molecular species (i.e., POA-containing species) of all major forms of phospholipids, 
and the atg32Δ-dependent mutational block of mitophagy alters these effects. WT and atg32Δ cells were recovered 
at days 1, 2 and 4 of culturing in nutrient-rich YP medium initially containing 0.2% glucose as carbon source. The 
relative level of POA-containing molecular species for each form of phospholipids (i.e., PA, PS, PE, PC, PI and CL) 
was calculated as molar percentage of all these phospholipids forms. Data are presented as means ± SEM (n = 3; *p 
< 0.01; ns, not significant). For PA, PS, PE, PC and PI, POA-containing molecular species are the C32:1, C32:2, 
C34:1 and C34:2 species of each of them. For the CL form of PL, POA-containing molecular species are its C64:4, 
C66:4, C68:4, C70:4 species. 
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Figure 27 An exposure of WT cells to various concentrations of exogenous POA elicits differential age-dependent 
effects on the relative levels of all molecular species of all major forms of phospholipids, and the atg32Δ-dependent 
mutational block of mitophagy alters these effects. WT and atg32Δ cells were recovered at days 1, 2 and 4 of 
culturing in nutrient-rich YP medium initially containing 0.2% glucose as carbon source. The relative level of all 
molecular species for each form of phospholipids (i.e., PA, PS, PE, PC, PI and CL) was calculated as molar 
percentage of all these phospholipids forms. Data are presented as means ± SEM (n = 3; *p < 0.01). 
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Figure 28 Outline of the flow of exogenous POA into pathways for phospholipids synthesis in the ER and mitochondria, 
phospholipid transport via mitochondria-ER and PM-ER junctions, TAG synthesis in the ER, and TAG deposition within LD. 
Following cellular uptake of POA, it is incorporated into various phospholipids. Some of these forms (such as PA, PS, PC and 
PI) are synthesized exclusively in the ER; these are then transported to mitochondria via mitochondria-ER junctions and to the 
PM via PM-ER junctions. Other forms of phospholipids (such as PE and CL) are formed only in the inner membrane of 
mitochondria; PE is then transported from mitochondria to the ER via mitochondria-ER junctions and from the ER to the PM via 
PM-ER junctions. In the ER, POA is also incorporated into TAG (as shown) and ergosteryl esters; these two forms of neutral 
lipids are then deposited within LD. The names of proteins that when deleted cause a decrease or increase of the susceptibility to 
POA-induced liponecrotic PCD are displayed in blue or red color, respectively.  
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Figure 29 Various single-gene-deletion mutations eliminating enzymes involved in POA transport to the ER or lipid 
biosynthesis elicit differential age-dependent effects on the susceptibility of yeast to POA-induced liponecrotic 
PCD. WT, fat1Δ, gpt2Δ, ayr1Δ, ale1Δ, dga1Δ and lro1Δ cells were recovered at days 1, 2 and 4 of culture in a 
nutrient-rich YP medium initially containing 0.2% glucose. Cell survival was assessed by measuring the 
clonogenicity of WT and mutant cells after 2 h of treatment with various concentrations of exogenous POA. Data 
are presented as means ± SEM (n = 12-19). 
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6.3.2 The alkaline-pH- and lipid-asymmetry-responsive Rim101 signaling pathway 
commits yeast to liponecrotic PCD by reducing the level of PE in the extracellular leaflet of 
the PM  
 The pH of culture media is known to affect phospholipid metabolism at a transcriptional 
level 
149
. To assess whether alterations to culture media pH are important in the induction of 
liponecrotic cell death, the pH of culture medium following an exposure of WT cells to various 
concentrations of POA was measured. Medium alkalinisation was observed in a concentration-
dependent manner (Figure 30A). To assess whether medium alkalinisation was essential for the 
commitment of yeast to liponecrotic PCD, susceptibility to POA was measured in buffered and 
unbuffered culture media. The pH of buffered culture media supplemented with different 
concentrations of POA was maintained at approximately 6.5 (Figure 30B) - i.e., close to the 
initial pH of unbuffered culture media containing the same POA concentrations (Figure 30A). 
The data indicated that an exposure of WT yeast to POA commits these cells to liponecrotic PCD 
as efficiently in buffered media as it does in unbuffered media (Figure 30C), implying that the 
POA-induced medium alkalinisation is apparently unrelated to liponecrotic cell death. 
Unpublished data validated this conclusion; as it was found that a hypomorphic allele of the gene 
encoding the PM ATPase Pma1p 
150







 antiporter Nha1p 
151





 exhibit considerable differential effects on the extent of culture medium 
alkalinisation by cells exposed to POA but do not alter the susceptibility of yeast to POA-
induced liponecrotic cell death. 
 In addition to medium alkalinisation, changes in the asymmetrical distribution of 
membrane phospholipids in the PM bilayer have been shown to induce the alkaline-pH- and 
lipid-asymmetry-responsive Rim101 signaling pathway in yeast cells 
140,153
. Importantly, an 
active maintenance of the proper phospholipid asymmetry in the PM bilayer depends on the 
abundance and composition of different species of phospholipids in this bilayer 
154–156
. As we 
found, the POA-induced alkalinisation of culture medium by yeast cells does not elicit 
liponecrotic PCD despite the known ability of such alkalinisation to trigger the Rim101 signaling 
pathway. However, the observed buildup of different POA-containing species of phospholipids 
within the PM of cells treated with POA may perturb proper phospholipid asymmetry in the PM 
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bilayer resulting in the induction of the Rim101 pathway. We therefore hypothesized that the 
Rim101 signaling pathway may operate as a pro-death process that commits yeast to liponecrotic 
PCD.  
 
Figure 30 The alkalinisation of culture medium by yeast exposed to POA is not essential for the ability of POA to 
trigger liponecrotic PCD. WT cells were recovered at days 1, 2 and 4 of culturing in a nutrient-rich YP medium 
initially containing 0.2% glucose as carbon source; the medium was buffered (25 mM HEPES-KOH, pH 6.5) or 
remained unbuffered. (A, B) The pH of culture medium after 2 h of treatment with various concentrations of 
exogenous POA, either in unbuffered medium (A) or in buffered medium (B); data are presented as means ± SEM 
(n = 5-7; *p < 0.01). (C) The survival of WT cells was assessed by measuring their clonogenicity after 2 h of 
treatment with various concentrations of exogenous POA, either in unbuffered medium or in buffered medium; data 
are presented as means ± SEM (n = 6-9). 
 The Rim101 signaling pathway includes: (I) the pH sensing protein complex confined to 
the PM; and (II) the attached to the endosomal membrane proteolytic processing complex for the 
transcriptional factor Rim101p 
153,157
. The pH sensing protein complex on the PM consists of the 
integral membrane proteins Rim21p which senses extracellular pH, as well as Rim9p and 
Dfg16p, and the peripheral membrane protein Rim8p 
153,158,159
 (Figure 31). Upon stimulation of 
the alkaline-pH- and lipid-asymmetry-responsive Rim101 signaling pathway, Rim8p promotes 
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endocytic internalization of the integral membrane components of the pH sensing protein 
complex 
153,160
. Following their internalization, Rim21p, Rim9p and Dfg16p stimulate the 
recruitment of the ESCRT (endosomal sorting complex required for transport) protein 
components Vps20p, Snf7p, Vps24p and Did4p of the ESCRT-III complex to the surface of the 
endosome 
153,161,162
 (Figure 31). A subsequent recruitment of the ATPase Vps4p to the 
endosomal ESCRT-III complex initiates its Vps4p-, Vps24- and Did4p- dependent disassembly 
and the resulting accumulation of the Snf7p-Vps20p protein subcomplex on the surface of the 
endosome 
153,162,163
. This protein subcomplex then interacts with Rim20p and Rim13p, thereby 
activating the proteolytic processing of the transcriptional factor Rim101p by the cysteine 
protease Rim13p 
153,162,164
 (Figure 31). The proteolytically cleaved form of Rim101p is delivered 
to the nucleus, where it activates transcription of the RSB1 gene by suppressing its transcriptional 
repressor, Nrg1p 
153,162,165
 (Figure 31). A protein product of the RSB1 gene is a putative 
sphingoid long-chain base-specific translocase/transporter within the PM 
140,166
. Rsb1p has been 
shown to: (I) stimulate the Lem3p-dependent transport of PE from the extracellular (outer) 
leaflet of the PM to its intracellular (inner) leaflet; and (II) suppress the Yor1p-dependent 
transport of PE in the opposite direction 
137,157,164,165
 (Figure 31).  
 Collectively, the above data suggest that an activation of the alkaline-pH- and lipid-
asymmetry-responsive Rim101 signaling pathway is likely to reduce the level of PE in the 
extracellular (outer) leaflet of the PM (Figure 31). This prospect was investigated by measuring 
the relative levels of PE in the two leaflets of the PM. To attain this objective, we used the 
tetracyclic peptide antibiotic cinnamycin which specifically binds to PE in the extracellular 
(outer) leaflet of the PM and causes cell lysis 
167,169
. For this reason, the level of PE in the outer 
leaflet of the PM bilayer would correlate with the sensitivity of yeast to cinnamycin 
140
. We 
found that treatment with POA decreased the sensitivity of yeast to cinnamycin (Figure 32). This 
indicates that POA treatment resulted in the reduction of the level of PE in the extracellular 
leaflet of the PM. Moreover, the yor1Δ mutation eliminating a protein required for the transport 
of PE from the intracellular (inner) leaflet of the PM to its extracellular leaflet
140,168
 further 
decreased the sensitivity of pre-treated with POA cells to cinnamycin (Figure 32). In contrast, the 
lem3Δ mutation eliminating a protein required for the transport of PE from the extracellular 
leaflet of the PM to its intracellular leaflet 
140,167
 increased the sensitivity of POA treated cells to 
cinnamycin (Figure 32). In sum, these findings imply that a depletion of PE in the extracellular 
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leaflet of the PM, likely due to its enhanced translocation to the intracellular leaflet of the PM, is 
a hallmark event of POA-induced liponecrotic PCD. It is conceivable that this characteristic trait 
of liponecrotic PCD is due to the ability of POA to trigger the Rim101 signaling pathway, 
thereby increasing the level of Rsb1p in the PM. The increased abundance of Rsb1p may 
enhance its stimulating effect on the Lem3p-dependent transport of PE from the extracellular 
leaflet to the intracellular leaflet of the PM and may also amplify its inhibitory effect on the 
Yor1p-dependent transport of PE within the PM bilayer in the opposite direction. 
 
Figure 31 - Outline of the alkaline-pH- and lipid-asymmetry-responsive Rim101 signalling pathway operating in 
yeast cells. (A) This signalling pathway can be induced by alkalinisation of culture medium and/or in response to 
certain changes in asymmetrical distribution of some species of phospholipids across the PM bilayer. The Rim101 
signalling pathway includes the pH sensing protein complex on the PM and the proteolytic processing complex for 
the transcriptional factor Rim101p on the endosomal membrane. After Rim101p is proteolytically processes by the 
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cysteine protease Rim13p on the surface of the endosome, its cleaved form is delivered to the nucleus. In the 
nucleus, cleaved Rim101p activates transcription of the RSB1 gene by suppressing its transcriptional repressor, 
Nrg1p. A protein product of the RSB1 gene is a putative sphingoid long-chain base-specific translocase/transporter 
within the PM. This protein stimulates the Lem3p-dependent transport of PE from the outer (extracellular) leaflet of 
the PM to its inner (intracellular) leaflet and suppresses the Yor1p-dependent transport of PE across the PM bilayer 
in the opposite direction. See text for additional details. The names of proteins whose lack causes a decrease or 
increase of the susceptibility of yeast to POA-induced liponecrotic PCD are displayed in blue or red color, 
respectively. Activation arrows and inhibition bars denote pro-death processes (displayed in red color) or pro-
survival processes (displayed in blue color) for the liponecrotic mode of PCD.  
 
Figure 32 – Treatment of yeast cells with POA results in an altered asymmetric distribution of PE in the plasma 
membrane. WT, lem3Δ and yor1Δ cells were recovered at day 1 of culturing in nutrient-rich YP medium initially 
containing 0.2% glucose as carbon source. Each cell suspension was divided into two equal aliquots. Cells in one of 
these aliquots were treated for 2 h with 0.15 mM POA; cells in the other aliquot remained untreated. Cells in each 
aliquot were then diluted in YP medium containing 2% glucose and supplemented with 25 µM cinnamycin. Both 
aliquots were incubated for 8 h, and the total number of cells in each aliquot was determined using a hemacytometer. 
Data are presented as means ± SEM (n = 5-6). Because specific binding of cinnamycin to PE in the outer leaflet of 
the PM causes cell lysis, the level of PE in this leaflet of the PM bilayer positively correlates with the sensitivity of 
yeast to cinnamycin. 
 To further verify whether the Rim101 signaling pathway operates as a pro-death process 
that commits yeast to liponecrotic PCD, we examined how various single-gene-deletion 
mutations eliminating different protein components of this pathway influence the susceptibility 
of yeast to liponecrosis. It was found that the rim21Δ, rim9Δ, dfg16Δ, rim8Δ, snf7Δ, vps20Δ, 
rim13Δ, rim20Δ and rim101Δ mutations reduce the susceptibility of yeast to POA-induced 
liponecrotic PCD (Figure 33A-I). All these mutations are known to impair the ability of the 
transcriptional factor Rim101p to activate transcription of the RSB1 gene 
153,162,165
(Figure 31), 
and are therefore expected to diminish the stimulating effect of Rsb1p on the Lem3p-dependent 




31). Moreover, all these mutations are also anticipated to lessen the inhibitory effect of Rsb1p on 
the Yor1p-dependent transport of PE across the PM bilayer in the opposite direction 
153,167,168
 
(Figure 31). In sum, the rim21Δ, rim9Δ, dfg16Δ, rim8Δ, snf7Δ, vps20Δ, rim13Δ, rim20Δ and 
rim101Δ mutations reducing the susceptibility of yeast to POA-induced liponecrotic PCD are 
likely to decrease the extent of PE depletion in the extracellular leaflet of the PM, a hallmark 
event of this PCD subroutine. Furthermore, the rsb1Δ and lem3Δ mutations made yeast less 
susceptible to POA-induced liponecrotic PCD (Figure 33 J, K). Because both these mutations are 
known to diminish the stimulating effect of Rsb1p on the Lem3p-dependent transport of PE from 
the extracellular leaflet of the PM to its intracellular leaflet 
153,167,168
 (Figure 31), they are 
expected to lessen the degree of PE depletion in the extracellular leaflet of the PM. It was also 
observed that the vps4Δ, vps24Δ and did4Δ mutations increase the susceptibility of yeast to 
POA-induced liponecrotic PCD (Figure 34A-C). Because all these mutations have been shown to 
enhance the ability of Rim101p to activate transcription of the RSB1 gene 
158,162
 (Figure 31), they 
are likely to increase the extent of PE depletion in the extracellular leaflet of the PM. 
Additionally, the nrg1Δ mutation eliminating a transcriptional repressor of the RSB1 gene 
153,162,165
(Figure 31) and the yor1Δ mutation impairing the transport of PE from the intracellular 
leaflet of the PM to its extracellular leaflet 
140,167,168
 (Figure 31) were demonstrated to make yeast 
more susceptible to POA-induced liponecrotic PCD (Figure 34 D,E). Because the nrg1Δ 
mutation is known to attenuate the Yor1p-dependent transport of PE from the intracellular leaflet 
of the PM to its extracellular leaflet and the yor1Δ mutation has been shown to abolish it 140,167,168 
(Figure 31), both these mutations are expected to increase the extent of PE depletion in the 
extracellular leaflet of the PM. Altogether, the observation that mutations eliminating different 
protein components of the Rim101 signaling pathway influence the susceptibility of yeast to 
POA-induced liponecrotic PCD support the proposed hypothesis that this pathway operates as a 




Figure 33 Various single-gene-deletion mutations eliminating different protein components of the Rim101 signalling 
pathway reduce the susceptibility of yeast to POA-induced liponecrotic PCD if they decrease the extent of PE 
depletion in the extracellular leaflet of the PM, a hallmark event of this PCD subroutine. WT, rim21Δ, rim9Δ, 
dfg16Δ, rim8Δ, snf7Δ, vps20Δ, rim13Δ, rim20Δ, rim101Δ, rsb1Δ and lem3Δ cells were recovered at days 1, 2 and 4 
of culturing in a nutrient-rich YP medium initially containing 0.2% glucose as carbon source. Cell survival was 
assessed by measuring the clonogenicity of WT and mutant cells after 2 h of treatment with various concentrations 
of exogenous POA. Data are presented as means ± SEM (n = 8-10). 
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Figure 34 Various single-gene-deletion mutations eliminating different protein components of the Rim101 signalling 
pathway make yeast more susceptible to POA-induced liponecrotic PCD if they increase the degree of PE depletion 
in the extracellular leaflet of the PM, a hallmark event of this PCD modality. WT, vps4Δ, vps24Δ, did4Δ, nrg1Δ and 
yor1Δ cells were recovered at days 1, 2 and 4 of culturing in a nutrient-rich YP medium initially containing 0.2% 
glucose as carbon source. Cell survival was assessed by measuring the clonogenicity of WT and mutant cells after 2 
h of treatment with various concentrations of exogenous POA. Data are presented as means ± SEM (n = 6-13). 
 
6.3.3 The commitment of yeast to liponecrotic PCD elevates the extent of oxidative damage 
to cellular proteins and lipids   
 Our lab has unpublished data indicating that liponecrotic PCD also results in the 
elevation of intracellular levels of ROS (courtesy of Adam Beach). To assess the role of elevated 
ROS production during liponecrotic cell death, the magnitude of oxidative damage to cellular 
proteins and lipids was measured. The data revealed that the concentration of exogenous POA 
added to WT cells positively correlates with both the degree of oxidative carbonylation of 
cellular proteins (Figure 35A,B) and the extent of oxidative damage to cellular lipids (Figure 
35C). Moreover, disruption of mitophagy significantly elevated the magnitude of oxidative 
damage to cellular proteins (Figure 35A,B) and lipids (Figure 35C) in yeast exposed to POA. 
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Because Atg32p-driven mitophagy plays an essential pro-survival role in protecting yeast from 
liponecrotic PCD, one could envision that a rise in oxidative damage to cellular proteins and 
lipids above certain critical level contributes to the commitment of yeast to this PCD subroutine. 
 
Figure 35 Yeast cells committed to liponecrotic PCD exhibit elevated oxidative damage to cellular proteins and 
lipids. WT and atg32Δ cells were recovered at days 1, 2 and 4 of culturing in nutrient-rich YP medium initially 
containing 0.2% glucose as carbon source. Immunodetection of carbonyl groups of oxidatively damaged cellular 
proteins (A) and biochemical assays for measuring oxidatively damaged cellular proteins (B) and lipids (C) were 
performed as described in Materials and Methods. Data are presented as means ± SEM (n = 3-5; *p < 0.01). 
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6.3.4 Various pathways of macroautophagy differ in their roles in POA-induced 
liponecrotic PCD  
 Based on the devised model for the underlying mechanism of POA induced liponecrotic 
cell death (Figure 23), it was hypothesized that different macroautophagic processes may act in a 
conflicting manner in regulating this cell death modality
138
. Macroautophagy is the major mode 
of autophagy initiated by the sequestration of cellular organelles and cytosolic proteins into 
double-membrane vesicles called autophagosomes 
128,170,171
 (Figure 36). The ensuing fusion of 
autophagosomes with the vacuole enables them to deliver the sequestered cargo of organelles 
and proteins to the vacuole lumen for proteolytic degradation by resident hydrolases 
128,170,171
 
(Figure 36). The working model for the mechanism underlying liponecrosis suggests that (I) the 
cytosolic serine/threonine protein kinase Atg1p 
172
 may orchestrate the execution of liponecrotic 
PCD by activating all currently known pathways for non-selective and selective autophagic 
degradation of dysfunctional and damaged organelles and macromolecules; and (II) Atg32p 
120,143
, may protect yeast from liponecrotic PCD by enabling the maintenance of a population of 
functional mitochondria needed for POA incorporation into neutral lipids 
138
 (Figure 36). The 
protein machinery orchestrating the diverse autophagic pathways in yeast is well known 
128
 
(Figure 36).  
 To investigate the apparently contrasting roles of these different autophagic processes, 
clonogenic survival was measured in mutants in various pathways of non-selective or selective 
autophagic pathways. The atg1Δ, atg11Δ and atg17Δ mutations have been shown to impair all of 
the known pathways for non-selective or selective autophagy, including (I) the non-selective 
autophagy pathway for massive degradation of various cellular organelles and macromolecules 
128,170,171
; (II) the cytoplasm-to-vacuole (Cvt) pathway for the delivery of several resident 
hydrolases to the vacuole 
128,170,171
; (III) the cargo-specific pexophagy pathway for selective 
autophagic degradation of aged, dysfunctional, damaged or excessive peroxisomes 
128,170,171
 and 
(IV) the cargo-specific mitophagy pathway for selective autophagic degradation of aged, 
dysfunctional, damaged or excessive mitochondria 
128,170,171
 (Figure 36).  
 The atg1Δ, atg11Δ and atg17Δ mutations decreased the susceptibility of yeast to POA-
induced liponecrotic PCD (Figure 37A-C). In contrast, the atg19Δ mutation, which is known to 
impair only the ʺbiosyntheticʺ Cvt pathway 128,170,171 (Figure 36), had no effect on the 
susceptibility of yeast to this mode of PCD (Figure 37D). Furthermore, the atg36Δ mutation, 
 94 
which has been shown to eliminate only the cargo-specific pexophagy pathway 
173
 (Figure 36), 
did not affect the susceptibility of yeast to POA-induced liponecrotic PCD (Figure 37E). 
Moreover, we confirmed our recent finding 
138
 that the atg32Δ mutation, which is known to 
impair only the cargo-specific mitophagy pathway 
120,143
 (Figure 36), increased the susceptibility 
of yeast to this mode of PCD (Figure 37F). 
 Altogether, these findings imply that various pathways of autophagy differ in their 
regulation of liponecrotic cell death. The ʺbiosyntheticʺ Cvt pathway and the cargo-specific 
pexophagy pathway are not involved in committing yeast to this PCD subroutine. The non-
selective autophagy pathway for massive degradation of various cellular organelles and 
macromolecules plays a pivotal role in executing the liponecrotic mode of PCD. In contrast, 
mitophagy is a crucial pro-survival process that protects yeast from liponecrotic cell death - 
likely by eliminating damaged and dysfunctional mitochondria, allowing for the sustenance of a 




Figure 36 - Outline of the pathways for non-selective and selective macroautophagic delivery of cellular organelles 
and macromolecules to the vacuole in yeast. Macroautophagy, hereafter referred to as autophagy, is initiated when a 
precursor compartment known as the phagophore sequesters cellular organelles and cytosolic proteins into double-
membrane vesicles called autophagosomes. Autophagosomes then fuse with the vacuole, thereby delivering the 
sequestered cargo organelles and proteins to the vacuole lumen for proteolytic degradation by resident hydrolases. 
These resident hydrolases, including aminopeptidase I, aspartyl aminopeptidase and α-mannosidase, are delivered to 
the vacuole via the ʺbiosyntheticʺ cytoplasm-to-vacuole (Cvt) pathway of autophagy. Atg1p, Atg11p and Atg17p 
proteins play essential roles in all four pathways for non-selective and selective macroautophagic delivery of cellular 
organelles and macromolecules to the vacuole, including the non-selective autophagy pathway for massive 
degradation of various cellular organelles and macromolecules, the Cvt pathway, the cargo-specific pexophagy 
pathway for selective autophagic degradation of peroxisomes and the cargo-specific mitophagy pathway for 
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selective autophagic degradation of mitochondria. Atg19p is a protein essential only for the ʺbiosyntheticʺ Cvt 
pathway of autophagy. Atg36p is involved only in the pexophagy pathway, whereas Atg32p plays an essential role 
only in the mitophagy pathway. 
   
 
Figure 37 – Various pathways of autophagy play different roles in POA-induced liponecrotic PCD. WT, atg1Δ, 
atg11Δ, atg17Δ, atg19Δ, atg36Δ and atg32Δ cells were recovered at days 1, 2 and 4 of culturing in a nutrient-rich 
YP medium initially containing 0.2% glucose as carbon source. Cell survival was assessed by measuring the 
clonogenicity of WT and mutant cells after 2 h of treatment with various concentrations of exogenous POA. Data 
are presented as means ± SEM (n = 11-19). 
 To verify whether non-selective autophagy plays an essential role in executing 
liponecrotic PCD, the recent finding of the ability of the natural polyamine called spermidine to 
extend yeast longevity by inducing autophagy was utilized 
123
. Noteworthy, the spe1Δ mutation 
which eliminates an enzyme catalyzing the first step of polyamine biosynthesis 
174,175
 (Figure 38) 
has been shown to greatly reduce the intracellular level of spermidine and shorten yeast 
longevity 
123
. Thus, the efficiency of spermidine synthesis in yeast cells positively correlates with 
the efficiency of a systemic biological effect which spermidine causes by inducing the non-
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selective autophagy pathway for massive degradation of various cellular organelles and 
macromolecules. We therefore first examined how the spe1Δ, spe2Δ and spe3Δ mutations 
influence the susceptibility of yeast cells to POA-induced liponecrotic PCD. Each of these 
single-gene-deletion mutations eliminates a different enzyme of the pathway for polyamine 
biosynthesis in yeast cells 
174,176,177
 (Figure 38) and, thus, is expected to impair the ability of 
spermidine to induce the non-selective autophagy pathway of autophagy. We found that (I) the 
spe1Δ, spe2Δ and spe3Δ mutations reduce the susceptibility of yeast to liponecrotic PCD (Figure 
38 B, D, F); (II) if added exogenously at the low concentration of 0.1 mM, spermidine reduces 
the protecting effect of each of these mutations against liponecrosis and restores the level of 
susceptibility to liponecrotic PCD seen for WT cells (Figure 38C,E, G); and (III) if added 
exogenously at the high concentration of 0.3 mM or 1 mM, spermidine makes spe1Δ, spe2Δ and 
spe3Δ cells even more susceptible to liponecrotic PCD than WT cells (Figure 38C,E,G). 
Moreover, we also found that while exogenous spermidine increases the susceptibility of WT 
cells to liponecrotic PCD in a concentration-dependent manner (Figure 38H), it does not alter the 
reduced susceptibility to liponecrosis of atg1Δ cells known to be deficient in the non-selective 




Figure 38 - The spermidine-inducible autophagy pathway for non-selective degradation of various cellular 
organelles and macromolecules plays an essential role in executing POA-induced liponecrotic PCD. 
(A) Outline of the pathway for polyamine biosynthesis in yeast cells. The natural polyamine called spermidine has 
been shown to stimulate transcription of the ATG1 and other ATAGgenes, thereby inducing the non-selective 
autophagy pathway for massive degradation of various cellular organelles and macromolecules. (B-I) WT, spe1Δ, 
spe2Δ, spe3Δ and atg1Δ cells were recovered at days 1, 2 and 4 of culturing in a nutrient-rich YP medium initially 
containing 0.2% glucose, either in the absence of spermidine or in the presence of spermidine at the indicated final 
 99 
concentration. Cell survival was assessed by measuring the clonogenicity of WT and mutant cells after 2 h of 
treatment with various concentrations of exogenous POA. Data are presented as means ± SEM (n = 6-11). 
 
 Collectively, these findings further validate our conclusion that the non-selective 
autophagy pathway for massive degradation of various cellular organelles and macromolecules 
plays a pivotal role in executing the liponecrotic mode of PCD. In addition, these findings 
suggest that (I) the intracellular level of spermidine positively correlates with the extent of yeast 
susceptibility to liponecrotic PCD; and (II) spermidine may increase such susceptibility by 
activating the non-selective pathway of autophagy, thereby triggering the process which executes 
this mode of PCD.  
 Based on the findings reported here and in chapter 5 
138
, we propose the following model 
for molecular mechanisms that in yeast cells underlie the opposing roles of various autophagy 
pathways in POA-induced liponecrotic PCD (Figure 39). In WT cells treated with POA and in 
cells of various mutants exposed to exogenous POA, some mitochondria become “stressed”, 
damaged and dysfunctional - likely due to the observed in these cells excessive production of 
ROS as by-products of mitochondrial respiration. In atg32Δ mutant cells, these “stressed”, 
damaged and dysfunctional mitochondria cannot be selectively eliminated as efficiently as in 
WT cells, due to the atg32Δ-dependent mutational block of mitophagy (Figure 39A). This 
intensifies cellular processes that cause the buildup of ROS and oxidatively damaged organelles 
and macromolecules; the resulting amplification of processes that create an excessive level of 
cellular stress accelerates the onset of liponecrotic PCD in yeast impaired in Atg32p-driven 
mitophagy (Figure 39A). In atg1Δ, atg11Δ, atg17Δ, spe1Δ, spe2Δ and spe3Δ mutant cells 
exposed to POA (Figure 39B), Atg32p-driven mitophagy eliminates the “stressed”, damaged and 
dysfunctional mitochondria as selectively and efficiently as it does in WT, atg19Δ and atg36Δ 
cells treated with POA (Figure 39C). Therefore, the dynamics of cellular processes creating an 
excessive level of cellular stress in atg1Δ, atg11Δ, atg17Δ, spe1Δ, spe2Δ and spe3Δ mutant cells 
exposed to POA (Figure 39B) is similar to the one in WT, atg19Δ and atg36Δ cells treated with 
POA (Figure 39C). However, unlike WT, atg19Δ and atg36Δ cells undergoing liponecrotic PCD 
when the level of cellular stress exceeds a toxic threshold (Figure 39C), atg1Δ, atg11Δ, atg17Δ, 
spe1Δ, spe2Δ and spe3Δ mutant cells exhibit a decelerated rate of the execution of this PCD 
 100 
subroutine because they are impaired in the non-selective autophagy pathway for massive 
degradation of various cellular organelles and macromolecules (Figure 39B). 
 
Figure 39 A model for molecular mechanisms that in yeast underlie the opposing roles of various autophagy 




 This study and our recent published data 
138
 suggest the following model for a mechanism 
underlying POA-induced liponecrotic PCD (Figure 40).  
 Exogenously added POA is incorporated into POA-containing PL. After being 
synthesized in the ER, excessive quantities of these POA-containing phospholipids initially 
accumulate in the ER membrane and then amass in mitochondrial membranes as well as in the 
PM. The buildup of the POA-containing phospholipids in the PM causes a reduction of PE level 
in its outer (extracellular) leaflet, thereby triggering the alkaline-pH- and lipid-asymmetry-
responsive Rim101 signalling pathway (Figure 40). This pathway stimulates transcription of the 
RSB1 gene; the resulting increased abundance of Rsb1p promotes further reduction of PE in the 
outer leaflet of the PM by (I) enhancing a stimulating effect of Rsb1p on the Lem3p-dependent 
transport of PE from the outer leaflet to the inner (intracellular) leaflet of the PM; and (II) 
amplifying an inhibitory effect of Rsb1p on the Yor1p-dependent transport of PE within the PM 
bilayer in the opposite direction. An ensuing depletion of PE in the outer leaflet of the PM 
elevates the permeability of this cellular membrane for small molecules (such as propidium 
iodide 
27,138
]), thereby contributing to the commitment of yeast to liponecrotic PCD. 
 The excessive accumulation of POA-containing phospholipids in both mitochondrial 
membranes of cells exposed to POA contributes to the commitment of yeast to liponecrotic PCD 
by impairing several mitochondrial processes that are indispensable for cell viability, such as 
respiration, membrane potential and ATP synthesis (Figure 40). These mitochondrial processes 
are essential for the ability of functional mitochondria to provide energy needed for the 
incorporation of POA into TAG, a pro-survival process which prevents the buildup of POA-
containing phospholipids within the ER membrane, mitochondrial membranes and the PM by 
reducing the flow of POA into pathways for phospholipids synthesis and interorganellar 
transport (Figure 40).  
 Moreover, the buildup of POA-containing phospholipids in both mitochondrial 
membranes of cells exposed to POA contributes to the commitment of yeast to liponecrotic PCD 
also by causing the excessive production of ROS in mitochondria. A significant rise in cellular 
ROS above a critical level contributes to such commitment by: (I) oxidatively damaging protein 
and lipid constituents of various cellular organelles, thereby triggering a non-selective 
autophagic degradation of numerous “stressed”, damaged and dysfunctional organelles in a pro-
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death process orchestrated by Atg1p, Atg11p and Atg17p; and (II) oxidatively damaging various 
cytosolic proteins, thereby impairing a pro-survival process of the maintenance of cellular 
proteostasis (Figure 40). 
 Several cellular processes in yeast exposed to POA can protect cells from liponecrosis. 
These pro-survival cellular processes include: (I) β-oxidation of POA within functional 
peroxisomes, which attenuates the excessive accumulation of POA-containing phospholipids in 
the ER membrane, mitochondrial membranes and the PM by lowering the flow of POA into 
pathways for phospholipids synthesis and interorganellar transport (Figure 40); (II) an 
incorporation of POA into TAG deposited in LD, which also prevents the buildup of POA-
containing phospholipids within the ER membrane, mitochondrial membranes and the PM by 
reducing the flow of POA into pathways for phospholipids synthesis and interorganellar 
transport (Figure 40); and (III) mitophagy, a selective autophagic degradation of “stressed”, 
damaged and dysfunctional mitochondria in an Atg32p-driven process which sustains a healthy 
population of functional mitochondria capable of providing energy for POA deposition within 
LD in the form of TAG (Figure 40).  
 In the future, it would be important to explore a mechanism through which the observed 
depletion of PE in the outer (extracellular) leaflet of the PM enclosing yeast cells exposed to 
POA elevates the permeability of this cellular membrane for small molecules, thereby 
committing yeast to liponecrotic PCD. Another challenge for the future will be to define 
mechanisms by which the observed buildup of POA-containing phospholipids in both 
mitochondrial membranes of yeast cells exposed to POA alters such vital mitochondrial 
processes as respiration, membrane potential maintenance, ATP synthesis and ROS production – 





Figure 40 A model for a mechanism underlying POA-induced liponecrotic PCD in yeast. Exogenously added POA 
is incorporated into POA-containing phospholipids that then amass in the ER membrane, mitochondrial membranes 
and the PM. The buildup of the POA-containing phospholipids in the PM reduces the level of 
phosphatidylethanolamine (PE) in its outer leaflet, thereby increasing PM permeability for small molecules and 
committing yeast to liponecrotic PCD. The excessive accumulation of POA-containing phospholipids in 
mitochondrial membranes impairs mitochondrial functionality and causes the excessive production of reactive 
oxygen species (ROS) in mitochondria. The resulting rise in cellular ROS above a critical level contributes to the 
commitment of yeast to liponecrotic PCD by: (I) oxidatively damaging cellular organelles, thereby triggering their 
autophagic degradation; and (II) oxidatively damaging cytosolic proteins, thus impairing cellular proteostasis. 
Several cellular processes in yeast exposed to POA can protect cells from liponecrosis. They include: (I) POA 
oxidation in peroxisomes, which reduces the flow of POA into phospholipids synthesis pathways; (II) POA 
incorporation into triacylglycerols, which prevents the excessive accumulation of POA-containing phospholipids in 
cellular membranes; (III) mitophagy, a selective autophagic degradation of dysfunctional mitochondria, which 
sustains a population of functional mitochondria needed for POA incorporation into TAG; and (IV) a degradation of 
damaged, dysfunctional and aggregated cytosolic proteins, which enables the maintenance of cellular proteostasis. 
See Activation arrows and inhibition bars denote pro-death processes (displayed in red color) or pro-survival 
processes (displayed in blue color) for the liponecrotic mode of PCD elicited by POA. 
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7. Conclusions and Future Directions 
 Our data provide the first evidence in yeast of a programmed form of cell death that is 
controlled in a concentration dependent manner by the levels of exogenously added POA, and 
that this form of PCD is related to processes that maintain the normal lipid composition of the 
mitochondria, as well as other organelles. The cell death modality due to POA exposure appears 
to represent a previously uncharacterized type of PCD evidenced by the accumulation of lipid 
droplets, mass autophagic degradation of cellular organelles without the appearance of excessive 
vacuolization as in autophagic cell death, as well as loss of integrity of the PM without rupturing 
of the plasma membrane - typical of programmed necrotic cell deaths 
121
.  In addition to this, 
mitochondrial quality control through macromitophagy was shown to be a critical process for 
yeast cells to cope with POA induced liponecrosis as evidenced by the increased susceptibility of 
the atg32Δ mutant to POA induced liponecrosis. These mutants did not display the characteristic 
accumulation of lipid droplets when treated with any concentration of POA. This suggests that 
processes that maintain a functional pool of mitochondria are also required for the proper 
deposition of FFAs into LD as neutral lipids. Without these processes, we hypothesized that cell 
would exist in a state of energy deficit as evidenced by the lower levels of ATP production, as 
well as loss of proper redox homeostasis contributing to the age-related accumulation of 
oxidatively damaged proteins and lipids in the cell – all of which could contribute to promoting 
cell death. Because the susceptibility of yeast cells to POA and especially atg32Δ mutants was 
more pronounced at later time points, this could indicate that FFA mediated liponecrosis is an 
age related mode of cell death.  
 This effect corresponds to the changes in the lipidome, where we observed an increase in 
triglycerides when treated with lower concentrations of POA, yet when POA is in excess the 
tendency is toward the incorporation of POA into membrane phospholipids. This effect became 
more pronounced at later time points. In accordance with our electron microscopy data that 
showed that the atg32Δ mutant did not produce lipid droplets in response to POA, we also see 
that POA treated atg32Δ mutants tend to increase the molar proportion of their lipidome with 
POA containing phospholipids.  This suggests that exogenously added POA enters yeast cells 
and is incorporated into triglycerides that are stored in lipid droplets when in present in the 
lowest tested concentrations. However, when POA is increased past a certain threshold, POA is 
instead incorporated into membrane phospholipids of the ER, Mitochondria, and PM. The extent 
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of this correlated with loss of clonogenicity as well as loss of membrane integrity as evidenced 
by permeability to propidium iodide 
27
. What is curious is that by genetically obstructing the cell 
from carrying out mitochondria specific macroautophagy, the extent of POA incorporation into 
phospholipids was greatly increased. This indicates that a functional pool of mitochondria is key 
to preventing this PCD modality. This could perhaps be due to an increase in the load of 
oxidatively stressed biomolecules as well as having lower net levels of ATP which would 
obstruct the capacity of the cell to store FFAs into neutral lipid stores in lipid droplets. More 
evidence from this came from our observation that the atg32Δ mutation completely abolished the 
presence of lipid droplets when cells were treated with POA.  
 Monitoring and maintenance of the proper asymmetrical distribution of membrane 
phospholipids is a an essential cellular process which is controlled by the Rim101 pathway 
140
 . 
We found that deletion of signalling components of the Rim101 pathway reduced susceptibility 
to POA induced liponecrotic cell death, while deletion of components that repress Rim101 
signalling sensitized those cells to POA. This suggests that POA induced liponecrosis requires 
the Rim101 signalling pathway to commit to cell death. It is highly plausible that when the 
cellular concentration of POA exceeds a certain threshold, it is incorporated into phospholipids 
within the ER and then ultimately the plasma and mitochondrial membranes as well as 
potentially other biomembranes. In so doing, it changes the normal distribution of phospholipids 
in the plasma membrane causing an accumulation of negatively charged phospholipids in the 
outer leaflet of the plasma membrane. This was validated by our finding that treatment of cells 
with POA altered the proper asymmetry of phospholipids in the plasma membrane, namely a 
reduction of PE in the outer leaflet.  This would likely induce the Rim101 pathway to commit 
yeast to PCD by further altering proper lipid asymmetry in the plasma membrane.  
 Because factors affecting lipid metabolism typically have pleiotropic effects it is likely 
that alterations to the cellular lipidome of POA treated cells with also have corresponding 
alterations to the mitochondrial lipidome. We found that a number of parameters of 
mitochondrial were altered by treatment with POA. In accordance with this model mitophagy 
plays an important role in maintaining a functional pool of mitochondria in the cell by 
maintaining their proper morphology, physiology, and lipid composition. This was demonstrated 
to be important for maintaining cellular redox homeostasis, where perturbations in mitochondrial 
quality control through mitochondria specific macroautophagy lead to increased accumulation of 
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protein carbonyls – which are indicative of oxidative stress to proteins – as well lipoperoxides – 
which are indicative of oxidatively damaged lipids. This may explain the observed increase in 
susceptibility of the atg32Δ mutant to liponecrotic cell death, as well as its generally shorter 
lifespan.  
 Our data also for the first time shows that mitophagy is necessary for caloric restriction to 
extend chronological lifespan in yeast, as well as for life extending bile acids to exert their 
effects. Lithocholic acid has previously been shown to greatly extend yeast chronological 
lifespan under both caloric restriction and normal conditions 
27
. Our data indicates that loss of 
mitophagy results in deleterious alterations to the mitochondrial lipidome thus shortening CLS, 
whereas treatment of yeast cells with LCA resulted in alterations to the mitochondrial lipidome 
which extend yeast CLS. Together these data point towards a role for the mitochondrial lipidome 
in defining yeast longevity. Although the exact mechanisms still need to be elucidated we have 
shown that LCA accumulates primarily in the inner mitochondrial membrane, and that a number 
of measures of mitochondrial fitness are increased when cells are treated with LCA. This 
corresponds with the observed changes in mitochondrial morphology to further support the idea 
of a network regulating lipid metabolism, mitochondrial quality control, and longevity. 
 Based on our data we constructed the following model; POA enters yeast cells and 
initially is stored in LDs as neutral lipids (including TAGs). When the level of POA is above a 
certain threshold, the cell can no longer shunt FFA toward TAG biosynthesis, and POA 
inevitably accumulates in the membrane phospholipids of the ER. Because lipid metabolism is 
known to exist as a network spanning numerous organelles through membrane junctions, the 
change in lipid composition in the ER will lead to changes in the mitochondrial and plasma 
membranes. In so doing, this leads to loss in the functional integrity of the mitochondria 
resulting in a net energy deficit as well as the concomitant increase in ROS production leads to 
an increase in the abundance of oxidatively stressed biomolecules as well as insoluble protein 
aggregates.  Furthermore, POA also alters the lipid composition of the PM that then will commit 
the cell to liponecrotic cell death. This is due to a change in the asymmetric distribution of PE 
across the outer leaflet of the plasma membrane. This imbalance in the proper lipid asymmetry 
homeostasis of the PM leads to the activation of the Rim101 signalling pathway which will 
activate the expression of Rsb1. Rsb1 then promotes a further exacerbation of the improper lipid 
asymmetry by negatively regulating Yor1 expression and negatively regulating Lem3 which is 
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known to be important for shuttling PE to outer or leaflet of the PM respectively. Thus, the 
extent of POA incorporation in phospholipids in the ER will determine the commitment of yeast 
cells to liponecrotic cell death. 
 
Future Directions 
 Left unmentioned was our findings that implicate components of both the apoptotic 
machinery (Richard et al. 2014 submitted) and the autophagic machinery 
121
 in regulating 
liponecrosis. With this in mind another challenge for the future will be to try and explain 
whether and how liponecrosis is integrated into a PCD network that includes the 
apoptotic, necrotic, and autophagic modules of PCD.  
 With regards to the importance of mitophagy as a pro-longevity process it would be 
interesting to understand which morphological and physiological features that 
dysfunctional mitochondria display are important for targeting these mitochondria for 
degradation via macromitophagy. 
 Based on our model of how exogenously added POA induces liponecrosis, it would be 
interesting to understand how the observed depletion of PE in the outer (extracellular) 
leaflet of the PM of yeast cells exposed to POA elevates the permeability of this cellular 
membrane for small molecules. Since POA would also accumulate in the mitochondrial 
membrane phospholipidome, it would be interesting to see if this would alter vital 
mitochondrial processes such as respiration, membrane potential maintenance, ATP 
synthesis and ROS production.  
 To further validate the role of the Rim101 pathway in committing yeast to liponecrotic 
cell death, it would be useful to use immunoblotting to verify that POA supplementation 
does in fact lead to the proteolytic activation of Rim101. 
 With regards to the role of LCA in extending yeast CLS it would be critical to find out 
what are the identities of cellular proteins involved in the translocation of exogenously 
added LCA across the plasma membrane and its subsequent incorporation into the both 
the inner and outer mitochondrial membranes. Once discovered, genetic manipulations 
eliminating these components will allow us to know whether it really is the accumulation 
of LCA in the mitochondrial membranes that is necessary for its ability to extend 
longevity. If it really is the presence of LCA in the IMM, then does it specifically alter 
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the functions of proteins involved in mitochondrial phospholipid biosynthetic machinery 
like Psd1p and Crd1p 
66
. Along these lines, it would be interesting to understand whether 
Ups1-dependent shuttling of PA from the OMM to the IMM, as well as the shuttling of 
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Appendix 
A. Metabolomic and Lipidomic Analyses of Chronologically Aging Yeast 
Summary 
Metabolomic and lipidomic analyses of yeast cells provide comprehensive empirical datasets for 
unveiling mechanisms underlying complex biological processes. In this chapter, we describe 
detailed protocols for using such analyses to study the age-related dynamics of changes in 
intracellular and extracellular levels of various metabolites and membrane lipids in 
chronologically aging yeast. The protocols for the following high-throughput analyses are 
described: (I) microanalytic biochemical assays for monitoring intracellular concentrations of 
trehalose and glycogen; (II) gas chromatographic quantitative assessment of extracellular 
concentrations of ethanol and acetic acid; and (III) mass spectrometric identification and 
quantitation of the entire complement of cellular lipids. These protocols are applicable to the 
exploration of the metabolic patterns associated not only with aging but also with many other 
vital processes in yeast. The described here methodology complements the powerful genetic 
approaches available for mechanistic studies of fundamental aspects of yeast biology. 
 
A.1 Introduction 
The replicative and chronological age of a eukaryotic cell is defined by the spatiotemporal 
dynamics of a plethora of cellular processes 
3,6,178–180
. To infer the relative contribution of each of 
these processes to cellular aging and to understand how certain genetic, dietary and 
pharmacological interventions delay cellular aging by modulating the chronology of critical 
cellular processes, the methodologies of metabolomic and lipidomic analyses can be 
advantageous 
6,13,126,181,182
. The application of metabolomics and lipidomics to the acquisition 
and quantitative analysis of vast empirical data on the metabolic history of a cell progressing 
through consecutive stages of aging process enables the systems level study of cellular aging 
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6,13,126,181,182
. It is conceivable that with the wealth of data that metabolomics and lipidomics can 
provide us, some of the most fundamental questions in cellular aging - such as whether it is a 
programmed process 
4,183–186
 or merely a result of the lifelong accumulation of unrepaired 
cellular and molecular damage 
1,187,188
 - can be answered.  
          Because longevity signaling pathways and mechanisms of their modulation by genetic, 
dietary and pharmacological interventions are evolutionarily conserved 
3,6,178–180
, the budding 
yeast Saccharomyces cerevisiae is a valuable unicellular model organism for studying 
mechanisms underlying cellular aging in multicellular eukaryotes 
3,6,178–180,189
. Due to the 
relatively short and easily monitored replicative and chronological lifespans of this genetically 
and biochemically manipulable unicellular eukaryote with annotated genome, it has been 
successfully used to (I) identify numerous novel longevity genes, many of which have been later 
implicated in regulating longevity of multicellular eukaryotic organisms; (II) establish the 
chemical nature of molecular damage that causes cellular and organismal aging and accelerates 
the onset of age-related diseases; and (III) identify a number of longevity-extending small 
molecules, many of which have been later shown to slow down aging, improve health, attenuate 
age-related pathologies and delay the onset of age-related diseases in multicellular eukaryotes 
6,13,27,32,37,102,123,126,141,179,189–193
.  
 Recent metabolomic and lipidomic analyses of the metabolic history of chronologically 
aging yeast cells strongly suggest that their longevity is defined by a pattern of metabolism and 
organelle dynamics established prior to cell entry into a non-proliferative state in a genotype-, 
diet- and pharmacological intervention-dependent manner 
13,32,37,102,123,126,141,191,193
. This chapter 
describes detailed protocols for such high-throughput analyses that have been used to measure 
the levels of trehalose, glycogen, ethanol and acetic acid as well as to quantitatively assess the 
entire complement of cellular lipids. These metabolites have been shown to play a pivotal role in 
defining the chronological lifespan of a yeast cell 
13,32,37,102,123,126,141,191,193
. It should be 
emphasized that the metabolic and lipidomic analyses described here provide powerful empirical 
tools for studying mechanisms that underlie not only aging but also many other paradigms of 
yeast biology. As such, these high-throughput analyses are complementary to the great power of 
yeast genetics in exploring fundamental biological phenomena. 
 
A.1.1 Trehalose Concentration Measurement 
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Trehalose is a nonreducing disaccharide that has been for a long time considered only as a 
reserve carbohydrate 
194
. However, recent findings suggested a role for trehalose metabolism in 
regulating a variety of cellular processes, including redox homeostasis and protein folding and 
aging 
126,195–197
. Our studies on the effect of caloric restriction on the metabolic history of 
chronologically aging yeast provided evidence for the essential role of trehalose in defining yeast 
lifespan through its effects on protein homeostasis (proteostasis) 
13,141
. Therefore, the existence 
of a modulated by trehalose regulatory network of cellular proteostasis has been suggested; by 
maintaining proper synthesis, post-translational modifications, folding, trafficking, degradation 
and turnover of proteins within a cell, this network defines its chronological and replicative age 
141
. In this chapter, we describe a robust microanalytic biochemical assay for monitoring 
trehalose concentration in chronologically aging yeast cells.  
 
A.1.2 Glycogen Concentration Measurement 
Glycogen, which is known to be the major storage form of yeast glucose 
194
, has recently been 
implicated in defining yeast longevity. Our metabolomic and proteomic analyses of 
chronologically aging yeast provided evidence that a proper balance between the biosynthesis 
and degradation of glycogen are obligatory for lifespan extension by caloric restriction 
3
. In this 
chapter, we describe a robust microanalytic biochemical assay for monitoring glycogen 
concentration in chronologically aging yeast cells. 
 
A.1.3 Ethanol and Acetic Acid Concentration Measurement 
A reduction of initial glucose concentration in nutrient-rich growth medium from 2% to 0.5% 
almost doubles the chronological lifespan of yeast 
3
. Ethanol, a product of glucose fermentation 
by yeast cells, operates as a redox sink that regulates energy flux from deposited in lipid bodies 
neutral lipids to mitochondria 
32,37,102,193
. By suppressing peroxisomal enzymes involved in fatty 
acid oxidation, high ethanol concentrations reduce the energy flux to mitochondria 
3,32,37,102,193
. 
The resulting decline of the electrochemical potential across the inner mitochondrial membrane 
promotes mitochondrial fragmentation, which in turn stimulates the release of pro-apoptotic 
proteins from the mitochondrial intermembrane space and ultimately causes apoptotic cell death 
32,37,102,193
. Low ethanol concentrations promote peroxisomal fatty acid oxidation, thereby 
elevating the energy flux to mitochondria. The resulting increase of the electrochemical potential 
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across the inner mitochondrial membrane promotes mitochondrial fusion and maintains 
mitochondrially produced reactive oxygen species at a level that is insufficient to damage 
cellular macromolecules but can activate several longevity-extending stress response pathways 
3,32,37,102,193
.  
 Acetate is another product of glucose fermentation by yeast cells. Akin to ethanol 
amassed by yeast cultured in nutrient-rich growth medium, acetic acid accumulated by yeast 
cells grown in minimal medium accelerates chronological aging 
6,179,191,192
.  
 Both ethanol and acetic acid pass freely across the cell membrane and are thus easily 
assayed in the growth media. Gas chromatography (GC) is an ideal way to measure these two 
volatile species due to its speed, high sensitivity, large linear dynamic range and ease of sample 
preparation. Furthermore, ethanol and acetic acid can be monitored using a flame ionization 
detector (FID), with which virtually every GC system is equipped. Like other chromatographic 
techniques, GC relies on the differential solubility of molecules between the mobile (gas) phase 
and the stationary (liquid) phase on the inside surface of the column. Unlike other 
chromatographic techniques, however, changing the temperature of the GC oven, not by 
changing the mobile phase composition, controls the elution of molecules in GC. Thus, 
separation by GC is controlled by the vapor pressure of the separated molecules and the linear 
flow rate of the carrier gas. The described in this chapter quantitative assessment of extracellular 
concentrations of ethanol and acetic acid with the help of GC takes advantage of this fact to 
separate them from non-volatile contaminants, such as amino acids and sugars.  
 
A.1.4 Mass Spectrometric Quantitative Assessment of the Yeast Lipidome 
Lipids are one of the major classes of biomolecules and play important roles in membrane 
dynamics, energy storage and signaling 
198
. A body of evidence supports the view that lipid 
metabolism plays an important role in longevity regulation across phyla 
32,37,102,193
. The budding 
yeast Saccharomyces cerevisiae is a valuable model organism for studying molecular 
mechanisms linking cellular aging and metabolism of various lipid species in multicellular 
eukaryotes 
32,37,78,102,193
. In studying these mechanisms, it is crucial to have an analytical method 
for the robust and accurate quantitative assessment of the entire complement of yeast lipids 
(lipidome) 
64,199
. In this chapter we describe such a method, namely quantitative shotgun mass 
spectrometry (MS) using a high resolution Thermo Orbitrap Velos instrument. The method 
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employs a modified version of the Bligh and Dyer lipid extraction 
43
 followed by Fourier 
transform tandem mass spectrometry (FT-MS/MS) to separate numerous lipid species. The raw 
data are then imported into the open source software LipidXplorer 
200
, which interprets extensive 
datasets of shotgun mass spectra to enable the quantitative characterization of all lipid species 




A.2.1 Trehalose Concentration Measurement 
 
7.2.1.1 Buffers, Solutions, and Growth Mediums 
Prepare the following solutions in distilled water unless otherwise stated. 
1. YP medium: 1% (w/v) yeast extract and 2% (w/v) bactopeptone. Media should be autoclaved 
at 15 psi/121°C for 45 min prior to use. We typically use 0.2%, 0.5%, 1% or 2% glucose (w/v) as 
the carbon source. 
2. PBS: 20 mM KH2PO4/KOH (pH 7.5) and 150 mM NaCl. 
3. SHE solution: 50 mM NaOH and 1 mM EDTA. 
4. THA solution: 100 mM Tris/HCl (pH 8.1) and 50 mM HCl. 
5. Trehalose reagent: 25 mM KH2PO4/KOH (pH 7.5) and 0.02% BSA; with or without 15 mU 
trehalase (Sigma-Aldrich, St. Louis MO). 
6. Glucose reagent: 100 mM Tris/HCl (pH 8.1), 2 mM MgCl2, 1 mM DTT, 1 mM ATP, 0.2 mM 
NADP
+
, and mixture of hexokinase (7 U) and glucose-6-phosphate dehydrogenase (8 U) (Sigma-
Aldrich, St. Louis MO).    
 
A.2.1.2 Yeast Strains and Growth Conditions 
Wild-type (WT) strain BY4742 (MATα his31 leu20 lys20 ura30) and single-gene-deletion 
mutant strains in the BY4742 genetic background (all from Open Biosystems) can be grown in 
YP medium containing 0.2%, 0.5%, 1% or 2% glucose (w/v) as the carbon source. Cells should 
be cultured at 30
o
C with rotational shaking at 200 rpm in Erlenmeyer flasks at a flask 
volume/medium volume ratio of 5:1. 
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A.2.2 Glycogen Concentration Measurement 
 
A.2.2.1 Buffers, Solutions, and Growth Mediums 
Prepare the following solutions in distilled water unless otherwise stated. 
1. YP medium: 1% (w/v) yeast extract and 2% (w/v) bactopeptone. Media should be autoclaved 
at 15 psi/121°C for 45 min prior to use. We typically use 0.2%, 0.5%, 1% or 2% glucose (w/v) as 
the carbon source. 
2. PBS: 20 mM KH2PO4/KOH (pH 7.5) and 150 mM NaCl. 
3. SHE solution: 50 mM NaOH and 1 mM EDTA. 
4. THA solution: 100 mM Tris/HCl (pH 8.1) and 50 mM HCl. 
5. Glycogen reagent: 50 mM sodium acetate (pH 4.6) and 0.02% BSA; with and without 5 μg/ml 
amyloglucosidase 14 U/mg (Roche, Basel, Switzerland). 
6. Glucose reagent: 100 mM Tris/HCl (pH 8.1), 2 mM MgCl2, 1 mM DTT, 1 mM ATP, 0.2 mM 
NADP
+
, and mixture of hexokinase (7 U) and glucose-6-phosphate dehydrogenase (8 U) (Sigma-
Aldrich, St. Louis MO). 
 
A.2.2.2 Yeast Strains and Growth Conditions 
Wild-type (WT) strain BY4742 (MATα his31 leu20 lys20 ura30) and single-gene-deletion 
mutant strains in the BY4742 genetic background (all from Open Biosystems) can be grown in 
YP medium containing 0.2%, 0.5%, 1% or 2% glucose (w/v) as the carbon source. Cells should 
be cultured at 30
o
C with rotational shaking at 200 rpm in Erlenmeyer flasks at a flask 
volume/medium volume ratio of 5:1. 
 
A.2.3 Ethanol and Acetic Acid Concentration Measurement 
1. Sample vials with cap/septum are available from many suppliers. 
2. GC system equipped with an FID detector (see Note 1). 
3. Column: The Equity-1 column from Supelco (0.32 mm I.D. × 30 m). This column has a 
simple stationary phase chemistry and provides good separation for ethanol and acetic acid. It is 
robust and widely available (see Note 2). 
 
A.2.4 Mass Spectrometric Quantitative Assessment of the Yeast Lipidome 
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A.2.4.1 Yeast Strains and Growth Conditions 
1. YP medium: 1% (w/v) yeast extract and 2% (w/v) bactopeptone. Media should be autoclaved 
at 15 psi/121°C for 45 min prior to use. We typically use 0.2%, 0.5%, 1% or 2% glucose (w/v) as 
the carbon source. 
2. Wild-type strain BY4742 (MATα his31 leu20 lys20 ura30) and single-gene-deletion 
mutant strains in the BY4742 genetic background (all from Open Biosystems) can be grown in 
YP medium containing 0.2%, 0.5%, 1% or 2% glucose (w/v) as the carbon source. Cells should 
be cultured at 30
o
C with rotational shaking at 200 rpm in Erlenmeyer flasks at a flask 
volume/medium volume ratio of 5:1. 
 
A.2.4.2 Lipid Extraction and Mass Spectrometry 
1. Chromasolv HPLC (>99.9%) chloroform and methanol or equivalent (Sigma-Aldrich, St. 
Louis MO). 
2. 28% ammonium hydroxide (Sigma-Aldrich, St. Louis MO). 
3. Glass beads, acid-washed, 425-600 μM (Sigma-Aldrich, St. Louis MO). 
4. Vortex with appropriate adapter. 
5. 15 ml high-speed glass centrifuge tubes with Teflon lined caps (Fisher Scientific). 
6. Chloroform/Methanol mixtures: 17:1, 2:1 and 1:2 mixtures of chloroform and methanol, as 
well as a chloroform/methanol (2:1) mixture with 0.1% ammonium hydroxide (v/v). 
7. ABC: 155 mM ammonium bicarbonate (pH 8.0). 
8. Internal Standards: Triacylglycerol (13:0/13:0/13:0) (Larodan, Malmo, Sweden) as well as 
various species of phospholipids - including phosphatidylcholine (13:0/13:0), 
phosphatidylethanolamine (14:0/14:0), phosphatidylserine (14:0/14:0), phosphatidic acid 
(14:0/14:0), and cardiolipin (14:0/14:0/14:0/14:0) (all from Avanti Polar Lipid, Alabaster, AL, 
USA). 
9. Glass 2 mL sample vials with Teflon lined caps. 
 
A.2.4.3 Software 
1. LipidXplorer: (https://wiki.mpi-cbg.de/wiki/lipidx/index.php/Main_Page) 





A.3.1 Trehalose Concentration Measurement 
 
A.3.1.1 Preparation of Alkali Cellular Extract 
1. Measure the cell titer by taking 10 μL aliquots of cell culture, diluting appropriately, and 
counting cells with a hemacytometer. 
2. Harvest 2 × 10
9 
cells by centrifugation for 1 min at 16,000 × g at 4
o
C. 
3. Wash the cell pellet three times in ice-cold PBS and then resuspend in 200 μL of ice-cold SHE 
solution. Add an additional 800 μL of ice-cold SHE solution to the cell suspension (~ 1 ml total 
volume). 
4. Incubate the resulting alkali extract at 60
o
C for 30 min to destroy endogenous enzyme 
activities and pyridine nucleotides. 
5. Neutralize the extract by adding 500 μL of THA solution. 
6. Divide the extract into 150 μL aliquots and quickly freeze them in liquid nitrogen. Store at - 
80
o
C prior to use. 
 
A.3.1.2 A Microanalytic Biochemical Assay for Measuring Trehalose Concentration 
1. Add 50 μL of alkali extract to 150 μL of trehalose reagent with and without trehalase. 
2. Incubate the mixture for 60 min at 37
oC. Add 800 μL of glucose reagent and incubate the 
mixture for 30 min at 25
o
C. 
3. Measure the NADPH generated from NADP
+
 fluorimetrically (excitation at 365 nm, emission 
monitored at 460 nm). 
 
A.3.2 Glycogen Concentration Measurement 
 
A.3.2.1 Preparation of Alkali Cellular Extract 
1. Measure the cell titer by taking 10 μL aliquots of cell culture, diluting appropriately, and 
counting cells with a hemacytometer. 
2. Harvest 2 × 10
9 




3. Wash the cell pellet three times in ice-cold PBS and then resuspend in 200 μL of ice-cold SHE 
solution. Add an additional 800 μL of ice-cold SHE solution to the cell suspension (~ 1 ml total 
volume). 
4. Incubate the resulting alkali extract at 60
o
C for 30 min to destroy endogenous enzyme 
activities and pyridine nucleotides. 
5. Neutralize the extract by adding 500 μL of THA solution. 
6. Divide the extract into 150 μL aliquots and quickly freeze them in liquid nitrogen. Store at - 
80
o
C prior to use. 
 
A.3.2.2 A Microanalytic Biochemical Assay for Measuring Glycogen Concentration 
1. Add 50 μL of alkali extract to 500 μL of glycogen reagent and incubate at 25˚C for 30 min. 
2. Add 500 μL of glucose reagent and incubate at 25˚C for 30 min. 
3. Measure the NADPH generated from NADP
+
 fluorimetrically (excitation at 365 nm, emission 
monitored at 460 nm). 
 
A.3.3 Ethanol and Acetic Acid Concentration Measurement 
 
A.3.3.1 Yeast Strains and Growth Conditions 
The wildtype strain BY4742 (MATα his31 leu20 lys20 ura30) was grown in YP medium 
(1% yeast extract, 2% bactopeptone) containing 0.2%, 0.5%, 1% or 2% glucose as carbon 
source. Cells were cultured at 30
o
C with rotational shaking at 200 rpm in Erlenmeyer flasks at a 
flask volume/medium volume ratio of 5:1. 
 
A.3.3.2 Sample Preparation for Gas Chromatography 
1. Collect aliquots of yeast cultures and harvest cells by centrifugation at 16,000 × g for 2 min at 
room temperature. 
2. The supernatant collected can either be used immediately or stored at -80ºC prior to use. 
  
A.3.3.3 Gas Chromatographic Measurement of Ethanol and Acetic Acid 
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1. Place 100 µL of supernatant in auto-sampler vials; to avoid growth in the vials, samples must 
be run at once for approximately 4 h. If you have a cooled auto sampler, you can load more 
samples. 
2. Inject 1 µL of sample in a splitless injector (see Note 3), with constant back pressure, nitrogen 
as carrier gas and a temperature curve of: 
a. 45 ºC for 30 sec 
b. 45-72 ºC for 45 sec 
c. 72-80 ºC for 2 min 
d. Increase to maximal temperature at highest rate and hold for 3 min to elute higher boiling 
point contaminants 
Using this temperature profile, ethanol and acetic acid should elute after about 3 min, and the 
total run time will be about 20 min, including the cool-down time for the oven (see Note 4). 
 
A.3.4 Mass Spectrometric Quantitative Assessment of the Yeast Lipidome 
 
A.4.1 Yeast Culture Conditions and Glass Bead Lysate 
1. Culture yeast in YPD medium (1% yeast extract, 2% bactopeptone, 2% glucose) at 30°C with 
rotational shaking at 200 rpm in Erlenmeyer flasks at a flask volume/medium volume ratio of 
5:1. Cultures should be grown to whichever growth phase is desired for the study. 
2. Harvest 5 × 10
7
 cells (~5 mL of the culture for cells recovered in logarithmic growth phase) by 
centrifugation at 3000 × g for 5 min at room temperature. 
3. Wash the cell pellet with ice-cold ABC, transfer to a 2 mL microfuge tube; centrifuge at 
16,000 × g for 1 min at 4
o
C. 
4. Resuspend the pellet in 1 ml of ice-cold ABC. 
5. Add 200 µL of glass beads and vortex for 5 min, then place the sample on ice for 1 min. 
Repeat this step three times. 
6. Assess protein content of cell lysate using standard methods. 
7. The cell lysate should be stored at -80°C until lipid extraction. 
 
A.3.4.2 Lipid Extraction 
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1. Calculate the amount of the lysate needed for approximately 50 µg of protein equivalent per 
replicate. Transfer to 15 ml glass centrifuge tubes. 
2. Add 1 mL of nanopure water. 
3. Add 20 µL of internal standard mix prepared in chloroform according to Table 1. 
4. Add 3 mL of chloroform/methanol (17:1) mixture and vortex at 4°C for 2 h (see Notes 5, 6 
and 7). 
5. Separate phases by centrifugation at 3000 × g for 5 min at room temperature. Transfer the 
lower organic phase to a new 15 ml glass tube. 
6. Add 1.5 ml of chloroform/methanol (2:1) mixture to the remaining aqueous phase and vortex 
at 4°C for 2 h. 
7. Separate phases by centrifugation at 3000 × g for 5 min at room temperature and combine with 
the organic phase from the chloroform/methanol (17:1) extract. 
8. Evaporate off the solvent under nitrogen flow or in a vacuum evaporator. 
9. Dissolve the lipid film in 100 µL of methanol/chloroform (2:1) mixture and transfer to a 2 ml 
glass sample vial with either Teflon or aluminum lined caps. 
10. Samples should be stored at -20°C until ready to be analyzed by MS (see Note 8). 
 
 




A.3.4.3 Mass Spectrometric Analysis of Yeast Lipids 
1. Prior to running samples for the first time, it is recommended to run a standard curve for your 
lipid standards (see Notes 9 and 10). This can be done by preparing dilutions spanning ~ 0.005 to 
50 µM and analyzing them in both negative and positive ion modes. 
2. Dilute the lipid extract appropriately in chloroform/methanol (1:2) mixture with 0.1% 
NH4OH, so that your signal falls within the range of your calibration curve. 
3. Resolve lipids by direct injection using a Thermo Orbitrap Velos mass spectrometer equipped 
with a HESI-II ion source (Thermo Scientific, Waltham, MA, USA) at a flow rate of 5 μL/min 
(see Note 11). Use an instrument method for data-dependent acquisition. The first segment is a 
full survey scan using the FT-MS; it is followed by 9 dependent MS/MS scans to sequentially 
perform MS/MS on all peaks above the set threshold from high to low intensity. Those peaks are 
then added to an exclusion list and the cycle will continue for 5 min (see Note 12). The tune 
settings and instrument methods that we routinely use are summarized in (Table 2, Table 3). 
 
Table 2 – Orbitrap instrument settings 
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Table 3 – Orbitrap instrument method summary 
 
A.3.4.4 Identification and Quantitation of Lipids Following Their Separation by Mass 
Spectrometry 
1. Convert mass spectra to an open format (mzXML, mzML) using the ProteoWizard 
MSConvert software, which is freely available from http://proteowizard.sourceforge.net/. 
2. Spectra can then be imported into LipidXplorer for the automated detection of lipid species. 
(https://wiki.mpi-cbg.de/wiki/lipidx/index.php/Main_Page; see Figure 41). 
3. Data are normalized by taking the ratio of signal intensity of precursor ions to that of their 
respective lipid class-specific internal standard (spiked standard), multiplied by the concentration 
of that standard to give a molar quantity. The ratio of an individual molar quantity by the sum of 
that contributed by all other detected lipid species will give the molar ratio, which should be 




1. Because the FID detects sample by burning it and reading the current across the flame, it is 
sensitive to how oxidized your analyte is - which is why it is more sensitive to ethanol than 
acetic acid. 
2. The method and instrumentation are very robust and no further sample preparation is required 
beyond spinning down the cells. Unfortunately, this means the samples are quite dirty and your 
local GC owner may be hesitant to let you use their equipment. Offering to supply your own 
column, injection syringes and vaporization chambers may help. 
 
Figure 41 - Import setting for LipidXplorer 
Following conversion to an open format (mzXML, mzML) using the ProteoWizard MSConvert 
software (http://proteowizard.sourceforge.net/), mass spectra can be imported into LipidXplorer 
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(https://wiki.mpi-cbg.de/wiki/lipidx/index.php/Main_Page) for the automated detection of lipid 
species. 
 
3. Be sure to rinse the injection syringe several times after each run and, at the end of the day, 
remove it and clean it very well - otherwise sugars and other contaminants will render it 
unusable. It is good practice to run a standard curve at the beginning of each day. If many 
samples are analyzed, run a single point standard now and then to ensure the machine is 
operating properly; 0.1% (v/v) for both ethanol and acetic acid work well. If you start seeing drift 
in retention times or differences in sensitivity, you should replace the vaporization chamber or 
the glass fibre inside it. At worst you will have to remove a few centimetres at the beginning of 
the column, since you have 30 m to work with; it will not seriously affect its separation abilities. 
Vaporization chambers can also be rejuvenated with an intensive acid wash. Over the course of 
several hundred injections, we replaced or washed the vaporization chamber perhaps twice and 
never had to cut the column. 
4. In nutrient-rich cultural media initially containing 2% glucose, we can see ethanol 
concentrations up to ~6%, and acetic acid ~0.3% in the cultures collected at logarithmic growth 
phase. Detection limits and linear dynamic range will vary from instrument to instrument, but 
0.001% to 10%+ for ethanol and 0.01% to 10%+ for acetate are reasonable. 
5. Handle chloroform and methanol with caution as they are both fairly toxic and readily leech 
contaminants from a number of sources including plastics, your skin, the air etc. If you have 
these solvents in large volumes (more than half a liter), it is advised to carefully transfer a 
smaller portion to a meticulously cleaned smaller glass container. 
6. Never access solvents directly! Pour the appropriate volume into smaller glassware first. This 
will reduce the likelihood of accidental contamination of your solvents. Any contaminants within 
the solvent will be concentrated into the lipid film following extraction, so for that reason it is 
important to not skimp on the grade of solvents that you use! 
7. It is very important to avoid the use of plastics in steps that involve any kind of manipulation 
of organic solvents - since they will leech contaminants into your samples, greatly complicating 
your spectra and potentially causing ion suppression effects. Use borosilicate glass pipettes for 
these steps. It is recommended to rinse pipettes with chloroform and methanol prior to use. When 
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handling lipid standards, it is a good idea to let them warm to room temperature and sonicate 
them prior to spiking your samples. This will help ensure the solubility of your standards. 
8. Because the relative stabilities of different lipids are not very well known, it is important to be 
careful during all steps of the procedure to prevent sample degradation. Extraction and drying of 
lipid films should be done at 4°C. When injecting samples, try to keep those that will not be 
immediately run cold. When finished running the sample, it is advisable to return any remainder 
to -20°C for any further analysis. 
9. Prior to running samples, it is a good idea to record baseline spectra of your solvents (in this 
case, it is a chloroform/methanol (1:2) mixture with 0.1% NH4OH). 
10. For the same reason as point 5, it is not recommended to store lipid extracts for extended 
periods of time prior to running. In our workflow, we try to arrange extractions to take place 
during the same week that we will be running the samples. 
11. Although we have access to an LTQ Orbitrap Velos, any reasonably high-resolution mass 
spectrometer can be used with some modification to this protocol. 
12. We typically use an instrument method for data-dependent acquisition, which automatically 
performs tandem MS on peaks in primary spectra. Depending on your specific needs, this may 
not be necessary. 
 
